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Abstract 
 
Human embryonic stem cells (hESCs) are able to proliferate indefinitely 
without losing their ability to differentiate into multiple cell types of all three germ layers. 
Due to these fascinating properties, hESCs have promise as a robust cell source for 
regenerative medicine and as an in vitro model for the study of human development. In 
my PhD study, I have investigated the neural differentiation process of hESCs using 
our established protocol, identified characteristics associated with each stage of the 
differentiation and explored possible signalling pathways underlying these dynamic 
changes.  
It was found that neural differentiation of hESCs could be divided into 5 stages 
according to their morphology, marker expression and differentiation potencies: 
hESCs, neural initiation, neural epithelium/rosette, neuronal progenitor cells and neural 
progenitor/stem cells (NPSCs) and 4 of these stages have been studied in more detail. 
At the neural initiation, hESCs firstly lose TRA-1-81 expression but retain SSEA4 
expression.  This transient cell population shows several similar properties to the 
primitive ectoderm.  After neural-tube like structure/neural rosette formation, neural 
progenitor cells appear as typical bipolar structures and exhibit several properties of 
radial glial cells, including gene expression and pro-neuronal differentiation.  The 
neural progenitor cells are able to grow in culture for a long time in the presence of 
growth factors bFGF and EGF.  However, they gradually lose their bipolar morphology 
to triangular cell type and become pro-glial upon further differentiation.  In addition, the 
state of neural progenitor and stem cells can be distinguished by their differential 
response to canonical Notch effector, C protein-binding factor 1.  It was also found that 
delta like1 homolog (DLK-1) is temporally upregulated upon initial neural differentiation, 
but becomes undetectable after the neural progenitor stage. Overexpression of DLK-1 
in NPSCs enhances neuronal differentiation in the presence of serum by blocking BMP 
and Notch pathways.  These results show that neural differentiation of hESCs is a 
dynamic process in which cells go through sequential changes, and the events are 
reminiscent of the in vivo neurodevelopment process.   
Moreover, I have characterized stably transfected nestin-GFP reporter hESC 
lines and found that the cell lines maintained the features of hESCs and the expression 
of GFP is restricted to the neural lineage after differentiation.  Therefore, these reporter 
lines will be useful for the study of factors that regulate neural differentiation and for the 
enrichment of neural progenitors from other lineages.  
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 Taken together, this study has demonstrated that hESCs are a good in vitro 
model to study the mechanisms and pathways that are involved in neural 
differentiation.  The availability of hESCs allows us to explore previously inaccessible 
processes that occur during human embryogenesis, such as gastrulation and 
neurogenesis.  
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Chapter 1: General introduction 
 
1.1. The development of the central nervous system 
Development of the vertebrate central nervous system (CNS) is one of the earliest 
events in embryonic germ layer induction, and it has long been thought of as a step 
following formation of the embryonic ectoderm (Hamburger, 1988). This development 
involves multiple steps, beginning with the induction of neuroepithelium from the 
embryonic ectoderm and completing with the patterning of different parts of the brain. 
The CNS is a complex tissue, both in term of the number of cells and the variety of cell 
types.  In addition, billions of neurons have to interact in a very precise manner in order 
to form functional neuronal networks. The CNS is formed over time during 
embryogenesis and is rapidly converted from simple neural plate to a brain and spinal 
cord.  To form a many different types of neurons and glial cells in the adult CNS, 
embryonic cells have to proliferate and differentiate in a strictly controlled manner, and 
during the last few years rapid progress has been made in understanding the molecular 
mechanisms underlying the initiation, proliferation and differentiation of the CNS.  
 
1.1.1. The embryonic and adult neurogenesis 
In vertebrate embryos, the first oversight of CNS formation is the appearance of neural 
plate from dorsal ectoderm.  Before neurogenesis, the neural plate and neural tube are 
composed of a single layer of neuroepithelial cells, which form the neuroepithelium.  
The neuroepithelium is pseudo-stratified because the nuclei of neuroepithelial cells 
migrate up and down the apical-basal axis during the cell cycles, referred to as 
“interkinetic movement” (McConnell, 1995).  The neuroepithelium folds and develops 
into the neural groove which then closed and generated the neural tube.  Proliferation 
is largely confined to embryogenesis, with the exception of the cerebellum, the 
hippocampus and the subventricular zone in which it continues into postnatal stages. 
The neuroepithelial cells within the neural tube undergo symmetric proliferation 
generating daughter stem cells.  These cells then divide asymmetrically, giving rise to 
more differentiated cells that are able to develop into terminally differentiated 
postmitotic neuron/glial cells and migrate out from the neural tube (Chenn & McConell, 
1995). The migrating neurons build up new cell layers, thus creating the layered CNS.  
Six distinct layers can be identified in the developing cortex: the ventricular, 
subventricular, intermediate, subplate, cortical plate and marginal zone (Molnar et al., 
2006).   
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In most regions of the neural tube, neuronal development proceeds according to the 
„inside-out‟ principle, i.e. neurons are born in ventricular layer and migrate to the 
cortical plate, where the first neurons settle down in the innermost region and later 
neurons localize successively further out.  As young neurons move out from the inner 
ventricular zone to build up the mature brain and spinal cord, it is critical that the 
correct type of neurons arrive at the correct positions.  It was found that young neurons 
migrate out from the ventricular zone along the specialized cell type, called the radial 
glial cells. Radial glial cells differentiate from neuroepithelial cells at the beginning of 
neurogenesis and are a transient population with highly elongated morphology.  In 
order to guide newly generated neurons, they have endfeet structures and span the 
neuroepithelium from the ventricular to the pial side (Rakic 1972).  Neurons migrating 
along radial glial cells form columns, which could produce a highly ordered cortex 
based on the pattern of underlying neural tube.  In addition to acting as a guidance of 
newly generated neurons, radial glial cells, which exhibit both neuroepithelial and 
astroglial properties, represent more fate-restricted progenitors, compared to 
neuroepithelial cells, and successively replace the latter (Campbell & Gotz, 2002).  As 
a consequence, most of the neurons in the brain are derived, either directly or 
indirectly, from radial glial cells.  Radial glial cells generate mainly neurons when 
isolated during early neurogenesis (Anthony et al., 2004); they produce both neurons 
and astrocytes if isolated during late embryonic development (Malatesta et al., 2003).  
At late-embryonic and postnatal stages, radial glial cells give rise to neural stem cells 
responsible for adult neurogenesis (Malatesta et al., 2008; Merkle et al., 2004) which is 
now accepted to exist in specific areas of  the adult brain (Gage, 2000). 
 
Adult neurogenesis has been shown to occur throughout adulthood in two neurogenic 
areas of the adult mammalian CNS; the subventricular zone (SVZ) of the lateral 
ventricles and the subgranular zone (SGZ) of the dentate gyrus in the hippocampus 
(Taupin and Gage, 2002), however, neurogenesis declines with aging in both areas 
(Molofsky et al., 2006).  Immature neurons generated in the SVZ travel along the 
rostral migratory stream and become postmitotic interneurons in the olfactory bulb.  
Outside these two regions, proliferating cells give rise to new glia but not to neurons in 
the intact adult CNS  (Horner et al., 2000).   
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1.1.2. The mechanisms of neural induction 
Neural tissue is derived from the embryonic ectoderm which is also the source of 
epidermis.  The term „neural induction‟ refers to the step whereby embryonic ectoderm 
cells are committed to neural ectoderm unless exposed to signals that divert them to 
alternative fate.  In amphibians, neuroepithelia form on the dorsal side of the ectoderm, 
whereas epidermis comes from the ventral ectoderm.  The first insight into the 
mechanism of neural induction came from transplantation studies done in amphibian 
embryos (Spemann and Mangold, 1923). These studies, which were performed mainly 
in frog Xenopus laevis, showed that transplantation of a dorsal blastopore lip of early 
gastrula into the ventral side of another early gastrula embryo causes the formation of 
a complete second nervous system (Figure 1.1).  This region of the dorsal blastopore 
lip was named as the „Spemann‟s organizer‟. It is proposed that in normal development 
this region of the embryo induces and organizes the nervous system in the neighboring 
dorsal ectoderm (Spemann and Mangold, 1923). In the absence of this influence, as on 
the ventral side, the ectoderm differentiates as epidermis.  
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Figure 1.1: Experimental demonstration that the dorsal blastopore lip is an 
organizer.  (A): The blastopore lip from an early gastrula of a donor newt embryo was 
transplanted to the ventral vegetal side of a recipient embryo.  (B): The donor tissue 
induced the recipient tissue to form a secondary embryonic nervous tissue containing a 
notochord and neural tube. (adapted from S. C. Gilbert, 1994, Developmental Biology, 
4th ed., Sinauer) 
 
The embryological equivalences of the blastopore lip in other vertebrates, for example 
Hensen‟s node in birds, can induce neural tissue in vivo and in vitro, suggesting that 
the mechanism of neural induction is conserved among vertebrates (Waddington & 
Schmidt, 1933).  Thus the general conclusions from these embryological experiments 
were that dorsal mesoderm potentiates the overlying embryonic ectoderm toward 
neural tissue.  It was hypothesized that the dorsal mesoderm emits a signalling 
molecule effecting neural/epidermis lineage commitment. 
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Although the organizer was shown to be present in various species (Hamburger, 1988), 
the nature of its signaling mechanism remained obscure until experiments in Xenopus 
laevis revealed the molecular events that might underlie the phenomenon of neural 
induction in vertebrates (Hemmati-Brivanlou & Melton, 1994).  Bone morphogenetic 
proteins (BMPs) are found to normally prevent embryonic ectoderm to differentiate into 
neural tissue.  It has been shown that dissociated animal caps cultured in the presence 
of BMP4 form epidermis after reaggregation and culture expressing epidermal keratin 
while the neural marker, neural cell adhesion molecule (NCAM), is expressed after 
prolonged dispersal in the absence of added factors (Wilson & Hemmati-Brivanlou, 
1995).  Consistent with this hypothesis, it was shown that normally in the Xenopus 
embryos, BMP mRNA is initially expressed ubiquitously, but as gastrulation proceeds, 
BMP mRNA is cleared from the neural territory (the neural plate) as the organizer 
begins to form (Fainsod et al., 1994).  This suggests that the inhibition of BMP 
signaling is required for neural induction.  Several molecules with direct neural activity 
were described, including noggin, follistatin, and chordin (Lamb et al., 1993; Sasai et 
al., 1995; Weinstein & Hemmati-Brivanlou, 1999).  It is known that noggin can directly 
interact with BMP2, 4 and 7 protein with high affinity and interferes with the BMP 
receptor binding (Zimmerman et al., 1996), whereas follistatin has high binding affinity 
for activin but low affinity for BMPs and its antagonizing effects of BMPs through 
different mechanisms rather than interfering with the binding of receptors (Sasai et al., 
1995).  Chordin shows neuralizing activity through the inhibition of BMP4 activity, 
however; there is no biochemical evidence to show that this inhibition is direct (Piccolo 
et al., 1996).  These BMP inhibitors are expressed in the organizer region of Xenopus 
embryos and can induce neural markers in blastula stage of animal cap explants 
(Hemmati-Brivanlou & Melton, 1994).  Dominant negative forms of the BMPs 
introduced into early Xenopus embryos also promote neurogenesis (Hawley et al., 
1995).  Taken together, it is implied that the suppression of BMP signaling is sufficient 
to induce neural differentiation and that naïve ectoderm has a natural tendency to 
differentiate into neural tissue unless it is instructed by BMP to become epidermis.  
 
In addition to the inhibition of BMP signaling, it has been proposed that at least two 
additional signaling pathways are also involved in selecting neural and epidermal fate 
in Xenopus.  It has been postulated that fibroblast growth factors (FGFs) can act as 
direct neural inducers (Lamb & Harland, 1995).  FGFs are a large class of secreted 
diffusible glycoproteins that bind to four classes of extracellular receptors (called 
FGFR1-4)  to mediate their effects (Launay et al., 1996).  It has been suggested that 
intact FGF signaling is required for neural induction.  The evidence for this comes 
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largely from the overexpression of dominant negative forms of FGF receptors which 
contains the FGF-binding domain but lack the intracellular domain.  Overexpression of 
these dominant negative in animal cap cells blocks the ability of noggin or chordin to 
induce neural cells (Lamb and Harland, 1995; Launay et al., 1996).  Furthermore, 
wildtype FGF alone is able to induce a neural character in animal cap cells (Kengaku 
and Okamoto, 1995).  However, these experiments were performed after the brief 
dissociation of the ectoderm, a procedure that is known to decrease BMP signaling 
(Launay et al., 1996).  Wnt signaling has also been implicated in the selection of neural 
or epidermis fate in Xenopus (McGrew et al., 1997).  The acquisition of neural fate is a 
direct consequence of the establishment of the dorsoventral axis of the embryos (Cui et 
al., 1995).  This axis is defined during the first cell cycle by cytoplasmic rearrangement 
that results in the activation of Wnt signaling pathway on the dorsal side of the cells  
(Kuhl & Pandur, 2008).  Wnts are a large class of secreted glycoproteins which can be 
divided into functionally distinct groups.  Introduction of mRNA encoding Wnts or their 
effectors into the animal hemisphere of one-cell embryos generates an „over-
dorsalized‟ embryo with ectopic neural tissue (Baker et al., 1999).  It was also found 
that ectopic activation of Wnt signaling in isolated animal cap tissue is sufficient to 
extinguish BMP4 mRNA expression and is sufficient to result in neural development 
(Baker et al., 1999).  This evidence indicates that early Wnt signaling is important in 
dorsoventral patterning of the Xenopus embryo and consequently in the generation of 
neural tissues (Baker et al., 1999).  Overall, the current evidence indicates that FGFs 
and Wnts play a role in promoting the elimination of BMP signals at different levels, a 
step that is necessary in the acquisition of neural fate.  Although the mechanisms might 
vary between species, the abrogation of BMP signaling remains the central event that 
precedes this acquisition. 
 
1.1.3. The regional identity of the nervous system 
Patterning of the body axis occurs through signaling systems that impart positional 
information.  Gradients of signaling molecules can regionally specify a population of 
progenitor cells if the cells respond differently to different concentrations of the signals 
(Wolpert 1994).  In the nervous system, the prominent patterning in dorsal-ventral (DV) 
and anterior-posterior (AP) axes occurs early, concomitantly with neural induction 
(Altmann & Brivanlou, 2001).   
 
As development proceeds, the dorsal edges of the neural fold converge at the midline 
to form the neural tube, at which stage the dorsal-ventral polarity is established (Figure 
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1.2).  At the dorsal midline, a group of specialized cells known as a roof plate, while at 
the ventral midline, another group of specialized cells, the floor plate, develop 
(Litingtung & Chiang, 2000).  The induction of roof plate is thought to be mediated by 
members of the BMP family, secreted from the overlying surface ectoderm (Lee & 
Jessell, 1999).  The roof plate itself also expresses BMP4/5/7 and these proteins 
induce dorsal markers such as PAX3 and MSX (Liem et al., 1995).  The BMP mutant 
zebra fish showed restriction of the number of dorsal sensory neurons (Nguyen et al., 
2000).  On the other hand, several lines of evidence indicate that sonic hedgehog 
(SHH), a notochord-derived signal, is required to pattern the ventral neural tube 
(Shimamura & Rubenstein, 1997).  Ectopic expression of SHH is capable of producing 
diverse cell types, characteristic of those normally situated in the ventral neural tube 
(Shimamura & Rubenstein, 1997).  The requirement for SHH is also demonstrated by 
reduced generation of ventral cell types when neutralizing SHH antibodies is applied to 
the notochord (Ericson et al., 1996).  Soon after the neural induction, AP neural 
patterning occurs at open neural plate stages.  Classical embryological experiments 
performed in the amphibian embryo have suggested that the organizer is a source of 
signals for AP patterning of the neural tube (Harland & Gerhart, 1997).  When 
ectoderm explants are conjugated with the organizer in vitro, neural tissue is induced, 
and it is patterned along its AP axis.  It is interesting to note that, in these 
recombinants, the organizer tissue from early gastrula embryos induces an equal set of 
anterior and posterior markers, while organizers dissected from later gastrula induce 
progressively more posterior neural genes (Sharpe & Gurdon, 1990).  The AP 
patterned neural tube further develops into different domains of the developing and 
adult brains; forebrain, midbrain, hindbrain and spinal cord, successively.  The 
boundaries of each domain defined by morphology and marker genes are being 
identified and further subdivide the CNS into distinct regions.  
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Figure 1.2: The process of neural induction.  The CNS arises from a specialized 
epithelium, the neural plate.  (A): This process relies on the inhibition of BMP signaling. 
(B): Folding of the neural plate to produce the neural groove is triggered by the 
formation of a distinct hinge point in the ventral region (the floor plate).  (C): At the end, 
the lateral edges of the neural plate fuse and (D): segregate from the non-neural 
epithelium to form a neural tube.  The roof plate and floor plate form at the dorsal and 
ventral midline of the neural tube, respectively. (adapted from Liu & Niswander, 2005) 
 
 
To form the many different types of neuronal and glial cells in the CNS, embryonic cells 
have to proliferate and differentiate in a strictly controlled manner. It has been 
discovered the existence of the CNS stem cells that may play a pivotal role during brain 
development.  Identifying signaling pathways and regulators that control neural stem 
cell self renewal and differentiation is essential for the better understanding of 
neurodevelopment as well as the improvement of neural stem cell-based cell 
replacement for neurodegenerative diseases and brain injuries.  
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1.2.  Neural stem cells: properties and regulation 
 
1.2.1. The properties of neural stem cells 
There are several lines of evidence to suggest that stem cells exist in the adult CNS 
(Gage et al., 2000).  Neural stem cells exist not only in the developing brain, but also in 
the adult nervous system of all mammalian organisms, including human. Neural stem 
cells can be distinguished from neural progenitor cells by acknowledging a few key 
features (Weiss et al., 1996), including proliferation and self renewal, multipotency and 
molecular markers.  These features make neural stem cells as an important element in 
embryonic CNS development and in adult nervous tissues for maintenance of cell 
number following injuries and diseases or natural cell turnover (Parent, 2003). 
 
Proliferation and self renewal:   To reach the correct number of differentiated cells in 
the CNS, neural stem cells have to be strictly controlled a balance between 
proliferation and differentiation during the embryonic CNS development. This balance 
is modulated by both excitatory and inhibitory signals to meet the demands of the 
tissues which neural stem cells supply newly differentiated cells. Proliferation potential 
is one of the most essential characteristics of neural stem cells and it was shown that 
adult neural stem cells can be propagated in vitro for years (Reynolds & Weiss, 1992).  
In order to generating a sufficient number of neural stem cells, it is assumed that cell 
proliferation may be predominant in the early phases, and that more cells differentiate 
during later stages. This implies that there is higher probability for generating two 
undifferentiated daughter cells at early stages (symmetric division), and later division 
favour the production of neurons and later glial cells (asymmetric division).  Neural 
stem cells in the developing neocortex undergo both symmetrical and asymmetrical 
divisions (Cai et al., 1997).  Several pathways that interact to regulate cell proliferation 
have been identified.  Perhaps the best understood are those triggered by growth 
factors.  All neural stem cells respond to multiple growth factors, but the exact subset of 
growth factors acting at a specific stage may be unique for a particular stage of neural 
stem cell differentiation.  Early neural stem cells respond solely to fibroblast growth 
factor2 (FGF2), and loss of FGFs or FGF receptors leads to a significant reduction in 
neural stem cell proliferation (Raballo et al., 2000).  Later appearing neural stem cells 
require either FGF2 or epidermal growth factor (EGF) for proliferation (Tropepe et al., 
1999).  It is marked that cell self renewal is tightly linked to this potential.  Self-renewal 
is essential for neural stem cells because it is required for the cells to perpetuate 
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themselves, so that at least one of the daughter cells retains the molecular 
characteristics of the original cells.  It is important to note that while a process of self-
renewal occurs, neural stem cells may undergo changes in their abilities to produce 
different progeny during development (Shen et al., 1998).    
 
Multipotency:   To be considered as a stem cell in the CNS, a cell must have potential 
to differentiate into neurons, astrocytes and oligodendrocytes (McKay, 1997).  It is 
noted that neural stem cell plasticity is progressively restricted as development 
advances, for example early neural stem cells appear to be specified a wide range of 
phenotypes, from anterior to posterior parts of the brain, while late neural stem cells is 
only restricted to its origin (Qian, 2000).  It was shown that adult neural stem cells exist 
mainly in two areas of the brain, SVZ and SGZ and can be propagated in vitro for years 
(Reynolds & Weiss, 1992). Neural stem cells in the SVZ differentiate into olfactory 
neurons, while neural stem cells of SGZ differentiate into granular neuron of the 
dentate gyrus.  However, when transplanting SVZ neural stem cells into dentate gyrus, 
they differentiate into calbindin-positive granule cells (Gage et al., 1995), whereas 
transplanting SGZ neural stem cells in the olfactory bulb, calretinin- and tyrosine 
hydroxylase-positive cells were detected.  Furthermore, when grafted into the 
developing eyes, adult hippocampus-derived neural stem cells expressed several 
morphological and immunological features of retinal cells, including photoreceptors 
(Takahashi et al., 1998).  This implies that the fate of adult neural stem cells could be 
influenced by environmental cues (Gaiano & Fishell, 1998).  In addition to the effects 
from environment, cell intrinsic programs also influence cell differentiation capacity.  
The robust intrinsic differences, with respect to distinct differentiation potential, has 
been shown to exist between neural stem cells isolated from different brain regions 
(Seaberg et al., 2005).    
 
Molecular Markers:  Many efforts have attempted to define neural stem cells 
according to their biological properties and molecular markers. In addition to those 
biological parameters, a series of immunoreactive antigens could also distinguish 
neural stem cells from others.  Markers that define this population are now being 
developed; hence, they are usually identified retrospectively on the basis of their 
behaviours.  The evaluation of self-renewal of neural stem cells can be achieved by the 
expression of molecular markers, distinguishing them from postmitotically differentiated 
cells.  The sequential expression of different members of the intermediate filament 
gene family has proven useful to identify various cell types in the early embryonic 
neural stem cells.  The intermediate filament protein nestin and vimentin are expressed 
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in the proliferating cells of the early neural tube (Lendahl et al., 1990).  Embryonic 
neural stem cells express several astrocytic markers, such as astrocyte specific 
glutamate transporter, brain lipid-binding protein, S100β, RC2 and 3CB2 (Gotz et al., 
2002). Together with their differentiation potential, these astrocytic features distinguish 
embryonic neural stem cells from other types of astrocytes and differentiated cells.  On 
the other hand, adult SVZ neural stem cells in vivo are slowly dividing, long-term BrdU-
retaining cells and express GFAP and the glycoprotein CD133 (Prominin-1) (Garcia et 
al., 2004). Anatomical features and comprehensive panels of immunohistochemical 
markers help ascertain adult SVZ neural stem cell identity.  A subset of these cells is 
characterized as positive for the intermediate filament nestin, GFAP, transcription 
factor SOX2, and the RNA binding protein Musashi1, while negative for differentiated 
markers CD24, O4, and NeuN (Doetsch et al., 1999).  In the SGZ of the dentate gyrus, 
a similar subset of cells expressing GFAP, nestin and SOX2 corresponds to quiescent 
or dormant adult neural stem cells which can give rise to mature astrocytes and 
neuroblasts (Suh et al., 2007). 
 
1.2.2. The regulation of neural stem cell identity 
The regulation mechanisms of neural stem cell self renewal and differentiation have 
been extensively documented. It seems that there is a complex regulating network 
which acts at different cellular levels, including extracellular signalling and intrinsic 
regulators.  Unraveling the influence of individual cascades will be essential for the 
better understanding of the biology of neural stem cells.  
 
1.2.2.1. Extracellular signaling pathways 
The self renewal and differentiation of neural stem cells is known to be regulated by the 
specialized microenvironment, or niche, where these cells reside.  Direct physical 
interaction between neural stem cells and their niche are critical for maintaining their 
characteristics.  Signaling molecules in the niche, including fibroblast growth factors, 
epidermal growth factor, Notch signaling, Sonic hedgehog and bone morphogenetic 
proteins, have been implicated in the regulation of neural stem cell self renewal and 
differentiation .  
 
Fibroblast growth factors and epidermal growth factor (FGFs & EGF): FGFs and 
EGF are extracellular ligands of their tyrosine kinase (RTKs) receptors, FGF receptors 
(FGFR) and EGF receptors (EGFR), respectively.  Both FGFs and EGF play critical 
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roles in the proliferation of neural stem cells (Vescovi et al., 1993).  FGF2 stimulates 
proliferation of neural stem cells and inhibits neuronal differentiation in vitro as well as 
promotes cell division in the developing forebrain in vivo (Raballo et al., 2000).  FGF2 
is expressed in the dorsolateral cortical neuroepithelium of the forebrain and acts 
primarily through FGFR1.  Targeted deletion of FGFR1 causes defect in cell 
proliferation and embryonic lethality (Tropepe et al., 1999), while FGF2 null mice show 
significant reduction in cortical progenitor cell proliferation before neurogenesis begins 
(Raballo et al., 2000).  Intraventricular delivery of FGF2 increases cell proliferation 
within the adult SVZ, (Craig et al., 1996).  Cyclin D2 has been recently suggested to be 
an effector of the FGF signaling which promoted early G1 cell cycle progression 
(Lobjois et al., 2004).  EGF is expressed in neurogenic regions such as the adult SVZ 
(Kornblum et al., 1997). Targeted disruption of EGFR causes forebrain cortical 
dysgenesis at late embryonic and postnatal ages (Threadgill et al., 1995).  In vivo 
administration of EGF via intraventricular infusion increases neural stem cell 
proliferation in the adult brains (Bain et al., 1995).  In vitro experiments have also 
shown that SVZ-derived progenitor cells can be expanded by EGF administration 
(Reynolds and Weiss, 1992).  In addition to promoting cell proliferation, EGF has 
various effects on different cell types at each developmental stage; EGF has been 
reported to inhibit differentiation of oligodendrocyte-type 2 astrocyte (O2A) progenitors 
(Sheng et al., 1998) and overexpression of the EGFR may bias progenitor cells toward 
a glial fate (Burrows et al., 1997).  
 
Sonic hedgehog (SHH):   SHH is a member of hedgehog family of signaling 
molecules identified by the homolog to the Drosophila hedgehog.  At the cell surface, 
SHH binds with high affinity to patched (Ptc), preventing the normal inhibition of 
smoothened (Smo) which is a signaling component of SHH-receptor complex (Murone 
et al., 1999).  Another regulator of the pathway acting at the cell surface of SHH-
responding cells has been identified in the vertebrate CNS, Hedgehog-interacting 
protein (Hip).  Hip is a type I transmembrane protein that attenuates SHH signaling by 
binding SHH with an affinity similar to that Ptc (Chuang & McMahon, 1999).  The 
hedgehog signaling is mediated through the zinc-finger containing transcription factor 
Gli1 (Siebzehnrubl et al., 2007) to promote proliferation and maintain population of 
neural progenitors in the postnatal brains (Machold et al., 2003).  SHH is also a potent 
mitogen for neural progenitor cells of the adult brains (Lai et al., 2003).  In SHH null 
mice, the telencephalon is greatly dysmorphic and much reduced in size and both 
dorsoventral patterning and general brain proliferation are significantly affected (Chiang 
et al., 1996).  Overexpression of SHH near the dentate gyrus increases proliferation 
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and neurogenesis of hippocampal subgranular zone cells (Lai et al., 2003).  In vitro, 
SHH maintains proliferation of adult hippocampal neural progenitors and increases the 
SVZ cell proliferation (Lai et al., 2003). 
 
Notch signaling:  Notch signaling is classically deployed to restrict the spread of cell 
differentiation, a process called lateral inhibition (Artavanis-Tsakonas et al., 1999).  
Notch signaling is activated when a Notch receptor on one cell interacts with Notch 
ligands, such as Delta, on an adjacent cell (Bray et al., 2006).  This interaction triggers 
proteolytic release of the active Notch intracellular domain (NICD) and its translocation 
into the nucleus, where it binds to transcriptional regulators CBF1/Su(H)/Lag2 (CSL, 
also called RBP-JK) and induce downstream effector expression (Lasky & Wu, 2005).  
The best known Notch target genes are members of the HES family, including HES1 
and HES5 (Yoon & Gaiano, 2005), which are the repressor-type bHLH genes and 
inhibit neuronal differentiation of neural stem cells.  The core Notch signaling pathway 
has been illustrated in Figure 1.3.  One of the first Notch pathway genes to be knocked 
out was Notch1 (Swiatek et al., 1994).  Consistent with the view that Notch activity is 
needed for stem cell maintenance, increased neuronal differentiation was detected in 
Notch1 mutant brains (Bray et al., 2005).  Conditional deletion of either Notch1 or RBP-
JK in the neural progenitor pools was also found to result in precocious neuronal 
differentiation and earlier neural progenitor pool depletion (Imayoshi et al., 2010; Yang 
et al., 2004).  In addition, many Notch ligand mutations have been examined.  
However, although Notch signaling is widely known as an inhibitory pathway to neural 
stem cell differentiation, some studies have shown Notch selectively promoted the 
differentiation of neural stem cells into astrocytes.  One such study found that deleting 
Delta-like1 (Dll1) led to a decrease in radial glial progenitor marker RC2 and an 
increase in neuronal marker expression in embryonic brains (Grandbarbe et al., 2003). 
This apparent discrepancy is likely to be due to differential actions of Notch at different 
phases during the course of differentiation.  These results can be explained by the idea 
that Notch regulates the differentiation of neural stem cells at two steps: firstly, Notch 
inhibits the transition from neural stem cells to intermediate neuronal progenitors, and 
secondly, an astrocyte lineage is exclusively selected by Notch (Mitzutani et al., 2007; 
Song et al., 2002).  
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Figure 1.3:  The core Notch signaling pathway. The four core elements of the Notch 
signaling system are diagrammed, including Notch receptors, DSL-containing ligands, 
CSL transcriptional cofactors, and target genes such as the HES family of basic helix-
loop-helix transcriptional regulators. (adapted from Mumm et al., 2000).  
 
 
Bone morphogenetic proteins (BMPs):   BMPs are members of the transforming 
growth factor-β (TGF-β) protein family of extracellular ligands.  They bind with weak 
affinity to type I and type II ligands specific receptors alone, but with high affinity to type 
I/II heteromeric complex. Upon BMP-induced heteromeric complex formation, the 
constitutively active serine/threonine kinase of the type II receptor phosphorylates type 
I receptor (Shi and Massague, 2003).  The intracellular messengers downstream from 
the activated receptors are the Smad proteins divided into three classes: receptor-
mediated Smad (R-Smads or Samd1/5/8) that are phosphorylated in a ligand-specific 
manner by activated-receptor complexes, the common mediator Smad (co-Smad or 
Smad4), and the inhibitory Smad (I-Smad or Smad6/7) that negatively regulate the 
Smad signal transduction pathway.  Upon phosphorylation by activated type I receptor, 
the BMP R-Smads form a complex with Smad4.  The heterometric BMP-regulated 
Smad complex then translocates into the nucleus where it can bind directly or through 
transcriptional partners to specific sequences in the promoter of BMP target gene to 
regulate transcription (Shi and Massague, 2003). In neural tissues, BMPs are essential 
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for many steps of neurodevelopment; an early cell fate decision that determines 
whether cells will form neural or non-neural ectoderm, and region definition from which 
the neural crest will be generated (Streit & Stern, 1999).  In addition, it has been 
recently demonstrated that BMP2/4 inhibits neurogenesis of mouse neuroepithelial 
cells (Di-Gregorio et al., 2007) and play an important role in astrocyte differentiation.  
The anti-neurogenic effect of BMP2 is thought to be partly mediated via induction of 
gene expression for ID1, ID3 and HES5 in the neuroepithelial cells, among which 
HES5 is also known to be induced by Notch activation (Hollnagel et al., 1999; 
Takizawa et al., 2003).  BMP2 and leukemia inhibitory factor (LIF) could synergistically 
induce astrocyte differentiation from mouse neuron epithelium cells (Nakashima et al., 
1999).  SMAD1 and a transcription factor activated by LIF stimulation, i.e. STAT3, form 
a complex bridge by p300 and cooperate in synergy to induce the expression of the 
gene GFAP, an astrocyte specific marker (Fukuda et al., 2007; Fukuda & Taga, 2005). 
 
It is noted that individual signaling pathway could cooperatively act on maintaining and 
determining the fate of neural stem cells (Faux et al., 2001; Nagao et al., 2007).  These 
extrinsic factors may interact with intrinsic regulators by various distinct cascades, for 
example SHH/Gli1, Notch/HES, and BMP/ID.  Distinct molecular consequence of 
signaling pathways may impact the balance between stimulatory and inhibitory effects 
of neural stem cells differently leading to cell self renewal and differentiation.   
 
1.2.2.2. Intrinsic regulators 
Endogenous factors play a pivotal role in many aspects of normal human development, 
including directing the formation of the CNS.  SOXB1 group, PAX6, Musashi1 RNA-
binding protein, and bHLH transcription factors have been extensively studied and 
found their key functions involving neural stem cell properties.   
 
SRY-box containing genes (SOX):  The SOX family of high-mobility-group (HMG) 
DNA binding proteins play a role in maintaining the undifferentiated state of neural 
stem cells in a context-dependent manner.  In vertebrate SOXB1 factors (SOX1, SOX2 
and SOX3) are widely expressed in proliferating neural stem cells, throughout 
development and adulthood (Pevny & Placzek, 2005). Throughout evolution, the 
expression of SOXB1 directly correlates firstly with the generation of ectodermal cells 
that are competent to acquire a neural fate, and secondly with the commitment of 
ectoderm to a neural fate (Pevny et al., 1998; Zhao et a, 2004).   After neural induction, 
SOX1, SOX2 and SOX3 are co-expressed in proliferating neural precursors 
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(Uwanogoh et al., 1995). The overexpression of SOX2 and/or SOX3 inhibits neuronal 
differentiation of chick neural progenitors (Graham et al., 2003) and causes them to 
retain their undifferentiated properties, including the ability to proliferate and express 
progenitor markers (Bylund et al., 2003).  Similarly, SOX1 is expressed in mitotically 
active neural progenitors that are not yet committed to a final fate (Pevny et al., 1998). 
Downregulation of SOX1 expression is coincident with neuroepithelial cells leaving the 
proliferative state throughout most of the CNS (Pevny et al., 1998).  These 
observations have led to the perception that SOXB1 factors all function similarly to 
maintain the progenitor cell state.  
 
PAX6:   PAX6 was first identified as a paired box (PAX) family member and cloned on 
the basis of its homology to the Drosophila gene paired (Walther & Gruss, 1991).  
PAX6 is a highly conserved transcription factor, containing a paired-domain and a 
homeodomain, and is crucial for the development of the CNS (Hanson & Van 
Heyningen, 1995).  PAX6 is expressed in a specific spatiotemporal pattern during 
mammalian brain development and thus is thought to be upstream of gene networks 
involved in brain patterning, neuronal migration, and neuronal circuit formation (Osumi, 
2001).  In the developing CNS, PAX6 is strongly expressed in neural progenitor/stem 
cells (Simpson & Price 2002).  PAX6 mutant mice showed severe impairment of cortex 
development and dramatic reduction of neurons as well as a thinner ventricular zone 
with reduced expression of PCNA, a marker for proliferating cells (Fukuda et al., 2000).  
It was suggested that the absence of PAX6 accelerated cortical neurogenesis in vivo 
(Estivill-Torrus et al., 2002).  It has been proposed that PAX6 functions early in cortical 
development to prevent precocious neuronal differentiation and depletion of the 
progenitor pool.  Similarly, in adult mammalian eyes, PAX6 is required for the 
proliferation and expansion of retinal stem cells (Xu et al., 2007).  Precocious neuronal 
differentiation of retinal stem cells was reported with the upregulation of Mash1 in 
PAX6 mutant embryos (Philips et al., 2005). 
 
Musashi1 gene:  Musashi1, a member of the MUSASHI family, is strongly expressed 
in undifferentiated neural precursor cells in vertebrates (Kaneko et al., 2000). The 
disruption of Musashi1 causes hydrocephalus (Sakakibara et al., 2002).  The abnormal 
proliferation and/or differentiation of ependymal cells lining the aqueduct may be the 
primary cause of the obstruction of the cerebrospinal cord fluid passage, which results 
in the perinatal onset of hydrocephalus in Musashi1 -/- mice.  In addition, Musashi1-
mutant neural stem cells exhibit the sharp reduction of neurosphere formation 
(Sakakibara et al., 2002).  Musushi1 is not simply a marker for neural stem cells, but is 
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involved in the regulation neural stem cell properties through regulation of the 
translation of specific mRNA, such as the Notch signal repressor m-Numb.  Based on 
the results of the analysis in Drosophila, m-Numb protein binds to the intracellular 
domain of Notch protein, directing to the endosomal degradation pathway and 
diminishing Notch activity (Jafar-Nejad et al., 2002).  It is now clear that activation of 
the Notch signal positively regulates neural stem cell self renewal (Androutsellis-
Theotokis et al., 2006), and because Musashi1 exerts an enhancing effect of the Notch 
signal, it is thought to contribute to retention of the properties of neural stem cells.  
 
Basic helix-loop-helix genes (bHLH):   There are two types of bHLH genes involved 
in neuronal differentiation; the repressor type and activator type (Bertrand et al., 2002). 
The repressor-type bHLH genes include HES genes, whilst the activator-bHLH genes 
include Mash1 and Neurogenin (Ngn). Neural stem cells express HES proteins and its 
overexpression caused the inhibition of neuronal differentiation (Ishibashi et al., 1994). 
Conversely, HES5 mutation, like HES1 mutation, leads to premature neuronal 
differentiation, and that in the HES1; HES5 double mutation, the severity of premature 
differentiation was enhanced, indicating the functional redundancy of the two HES 
genes (Ohtsuka et al., 1999).   Moreover, HES1 (-/-):HES5 (-/-) neurospheres do not 
expand properly even in the presence of FGF2 and EGF while the wild-type 
neurospheres do extensively (Ohtsuka et al., 1999).  Thus, HES1 and HES5 are 
essential factors for the maintenance and proliferation of neural stem cells.  The 
activator-type bHLH genes, Mash1 and Ngn, are expressed by differentiating neurons 
(Kageyama et al., 2005).  Overexpression of these genes in neural stem cells induces 
the pan-neuronal gene expression and determines the neuronal fate, whilst the cells 
from Mash1:Ngn2 double knock-out mice become glial cells (Nieto et al., 2001). Thus, 
there is a fate switch from neurons to glia in the absence of the activator-type bHLH 
genes.  In addition, the activator-type bHLH factors are also important for maintenance 
of neural stem cells (Hatakeyama et al., 2004).   
 
An emerging regulatory network controlling neural stem cell self renewal and 
differentiation is defined by integration of multiple cell-intrinsic regulators with the cell-
extrinsic signals from an environment or culture condition.  Uncovering how these 
regulatory cascade function to control neural stem cells is essential to better 
understand of neural stem cell biology.  Ultimately, it will also facilitate the development 
of new and targeted therapy using neural stem cells for a host of neurological 
disorders, including brain injuries, brain tumours and neurodegenerative diseases, 
such as Huntington‟s, Alzheimer‟s and Parkinson‟s diseases. 
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1.3. Embryonic stem cells  
 
1.3.1. Characteristics of embryonic stem cells 
Pluripotent mouse embryonic stem cells (mESCs) were first isolated in 1981 (Evans 
and Kaufman, 1981; Martin 1981) from the inner cell mass (ICM) of the pre-
implantation mouse embryos.  The methods which were used to derive and grow 
mESCs have changed very little since the first establishment.  First, expanded 
blastocyst-stage embryos are either directly plated or plated after the ICM is 
immunosurgically isolated to remove trophectoderm (Solter & Knowles, 1975).  In 
either case, the cells were plated on a feeder layer of mouse embryonic fibroblasts 
(MEFs) that have been mitotically inactivated with gamma radiation or mitomycin-C.  
mESCs exhibit as a compact and dome-like structure which can be propagated in 
culture continuously on a feeder layer of MEFs or in the presence of LIF without 
feeders (Williams et al., 1988).  The pluripotent mESCs are able to generate teratomas, 
a well-organized derivative of three germ layers, when implanted into SCID mice 
(Evans & Kaufman, 1983). The most fascinating attribute of mESCs is that, even after 
extended propagation and manipulation in vitro, they retain the capacity to produce 
chimera offspring when injected into mouse blastocysts. In this case, mESCs can 
contribute to every tissue, including the germ line, but not the placenta (Tanaka et al., 
2009).      
 
Several decades after the establishment of mESCs, non-human primate and human 
ESC lines have been isolated.  The first hESC lines were derived from the isolation and 
culturing of the human ICM (Thomson et al, 1998).  The methodology for deriving 
hESCs has remained the same as the original one for the derivation of mESCs.  Since 
then, the methods have been modified to avoid potential contamination with 
xenoproteins and xenogenic tissues, such as replacing the MEF feeder layers and 
bovine serum with the human counterparts (Richards et al., 2002). In addition, the 
reports of successful derivation of pluripotent stem cells from human embryos without 
the use of feeder layers have also emerged, which eliminates the risk of contamination 
with pathogenic agents capable of transmitting diseases to patients (Klimanskaya et 
al., 2005).  Undifferentiated hESCs exhibit high nucleus to cytoplasmic ratio like the 
mESCs.  hESCs retain pluripotent ability both in vivo and in vitro experiments.  They 
are able to form embryoid bodies which lead to spontaneous differentiation to three 
embryonic germ layers (Itskovitz-Eldor et al., 2000).  hESCs can also form teratomas 
following the injection of cells into nude mice (Lensch et al., 2007; Tzukerman et al., 
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2003), which reflects their in vivo differentiation capability.  However, due to ethical 
restrains, chimerism cannot be tested in human system.       
 
Although a few great characteristics are shared between mESCs and hESCs, there are 
differences in several ways in these two ESCs.  For example, the derivation of mESCs 
and their propagation in an undifferentiated state requires leukemia inhibitory factor 
(LIF) (Niwa et al., 1998; Sato et al., 2004), while hESCs self renewal requires FGF2 
supplemented in culture (Thomson et al., 1998; Xu, et al., 2001).  Besides that and 
their morphological differences, hESCs express a distinctive set of cell surface 
antigens, which is principally different from that present in mESCs.  hESCs express 
high levels of stage-specific embryonic antigen (SSEA) 3, SSEA4, TRA-1-60 and TRA-
1-81, but do not express SSEA1, whereas mESCs are positive for SSEA1, but not 
SSEA3 SSEA4 and TRA1-60 or -81 (Shevinsky et al., 1982).  It was shown that the 
expression pattern of these surface antigens is present in the ICM of human blastocyst, 
providing evidence that hESCs continue to resemble the cells in the ICM (Henderson et 
al., 2002).  In addition the discrepancy of cell surface markers, mESCs fail to contribute 
to the trophoblast both in vivo and in vitro experiments (Beddington & Robertson, 1989) 
while hESCs can differentiate toward trophectodermal lineage in the presence of BMP4 
(Xu et al., 2002).  As these differences are further characterized, they provide new 
information about early developmental events that differ significantly between mice and 
humans.   
 
1.3.2. Regulation of self-renewal and pluripotency in undifferentiated 
embryonic stem cells 
Self-renewal of ESCs is regulated by both intrinsic and extrinsic factors.  Intrinsic 
factors are transcription factors that are important for maintaining ESCs identity.  The 
best studied intrinsic factors are OCT4, nanog and Sox2, which play essential roles in 
both mESCs and hESCs.  OCT4, encoded by the POU5F1 locus, is a homeodomain 
transcription factor of the POU family. OCT4 is necessary for pluripotency, as defined 
by gene knockout and transgenic experiments in mice (Nichols et al., 1998).  
Knockdown OCT4 by RNAi in hESCs forced them to differentiate into extra-embryonic 
endoderm lineages (Hay et al., 2004).  Studies have defined several target genes of 
OCT4.  Genes dependent on OCT4 activity for their expression includes FGF4 (Yuan 
et al., 1995), REX1 (Ben-Shushan et al., 1998), and Lefty-1 (Niwa et al., 2000) while 
human chorionic gonadotropin (HCG) is repressed by OCT4 activity (Liu and Roberts, 
1996).  Nanog and SOX2 are also highly expressed in ESCs and dramatically 
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downregulated upon cell differentiation (Fong et al., 2008; Reubinoff et al., 2000; 
Rogers et al., 1991; Chambers et al., 2003).  Like OCT4, nanog expression appears to 
be crucial for the maintenance of ICM and hESCs; removal of nanog results in ICM 
cells adopting a visceral and parietal endoderm fate while overexpression retards 
differentiation of hESCs and forces the maintenance of undifferentiated phenotype 
(Darr et al., 2006).  Similar to OCT4, SOX2 is important to maintain pluripotent state of 
hESCs. The deficiency of SOX2 mediated by RNAi is able to cause hESC 
differentiation toward the trophectoderm (Fong et al., 2008).  The significant roles of 
SOX2 in pluripotency have been confirmed by the ability to reprogram human 
fibroblasts to become pluripotent cells by expression of SOX2 along with OCT4, KLF4 
and c-Myc (Takahashi et al., 2007). 
 
Extrinsic factors, such as growth factor signaling pathways, are also very important for 
regulating self-renewal of ESCs.  However, unlike intrinsic factors, the signaling 
pathways required for maintaining self-renewal of mESCs and hESCs seem very 
different.  Although both human and mouse ESCs were originally isolated and 
maintained by coculture on mitotically inactivated MEF feeder cells, they may require 
different signals from the feeder cells for retaining their undifferentiation status.  
Whereas the derivation of mESCs and their propagation in an undifferentiated state 
requires LIF (Sato et al., 2004), hESC self-renewal requires FGF2 (Reubinoff et al., 
2000).  One possible reason for this difference may result from the different growth 
factor receptor expression profiles in mouse and human ESCs.  mESCs express LIF 
receptor (LIFR)/gp130 complexes, which bind LIF and mediate pluripotency through 
downstream activation of STAT3 (Carpenter et al., 2004).   It was recently found that 
BMP and LIF are sufficient to sustain self-renewal and maintain mESCs in an 
undifferentiated state without the need of serum or feeder layers (Ying et al., 2003).   In 
contrast, hESCs do not express LIF receptors or gp130 receptors (Brandenberger et 
al., 2004).  FGF signaling is thought currently to be the predominant mechanism by 
which hESC pluripotency is maintained in culture.  It was found that undifferentiated 
hESCs express FGFR1, the cognate receptor for FGF2, more abundantly than 
differentiated cells (Brandenberger et al., 2004; Carpenter et al., 2004).  Other FGFRs, 
including FGFR2, FGFR3 and FGFR4, also appear to be enriched in the 
undifferentiated hESCs (Dvorak & Hampl, 2005).  In addition to FGF signaling, 
activin/Nodal pathway also maintains pluripotency of hESCs through mechanisms in 
which FGF2 acts as a competence factor (Vallier et al., 2005).  It is hoped that as the 
different mechanisms underlying self renewal in mouse and human ESCs are revealed, 
essential growth factors, cytokines, and signaling molecules will be discovered that 
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could be used to maintain hESCs in simplified culture systems for prolonged periods of 
time.  In addition, hESCs show high level of alkaline phosphatase and telomerase 
activity.  Human telomerase, a ribonucleoprotein, is responsible for maintaining the 
length of chromosome and its activity is highly correlated with immortality in 
mammalian tissue culture cells (Zeng, 2007). 
 
1.3.3. Potential applications of hESCs 
Although the recent success in establishing hESCs raised numerous ethical concerns, 
hESCs provide a new useful cell source for several potential applications in both basic 
science and medical treatment. To direct hESC differentiation in vitro along chosen 
pathways would allow for the investigation of early human development events, 
including regulatory signals for cell commitment and morphogenesis.  Additionally, the 
cells could also be used for the screening of new drugs and carcinogenic or toxic 
compounds that cannot be analyzed in vivo due to ethical constraints. However, 
investigations into the potential utility of hESCs in treating human diseases are just 
beginning because there are several issues need to be taken in to account, i.e. 
efficiency, safety and functionality.   
 
Cell-based therapy and tissue engineering:  The most urgent problem today in 
transplantation medicine is the lack of suitable donor organs and tissues.  The 
pluripotent developmental potential of hESCs and the success of transplanting their 
differentiated derivatives in animal disease models demonstrated the principle of using 
hESC-derived cells as a regenerative source for transplantation therapies of human 
diseases.  One of the key issues causing hESCs technology to be useful for cell and 
tissue therapy in humans is the histocompatibility.  Recent data support the concept 
that hESCs and their differentiated derivatives possess immune-privileged properties 
(Li et al., 2004), suggesting that cells derived from hESCs may provide a potential tool 
for induction of immunotolerance (Menendez et al., 2005).  In another scenario for 
which the term „personalized pluripotent cells‟ has been coined; people could use their 
own somatic cells to be reprogrammed back to the pluripotent cell state.  The feasibility 
of reprogramming was first demonstrated by somatic cell nuclear transfer (SCNT) or 
cloning.   Somatic cells of patients are fused with enucleated oocytes; thereafter, 
hESCs could be established in culture and be induced to in vitro differentiation to 
provide patient-specific cells and tissues (French et al., 2006).  However, the 
reprogramming of somatic nucleus in an oocyte is still inefficient.  In addition, to access 
to a source of human oocytes is not only a rare opportunity, also an ethical concern of 
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the moment (Einsiedel et al., 2009).  As an alternative to reprogramming by SCNT, 
adult human fibroblasts can be directly reprogrammed into a state that is similar to 
hESCs by expression of only four factors; OCT4, KLF4, SOX2 and c-Myc (Takahashi 
et al., 2007) and term such reprogrammed cells as „induced pluripotent stem cells‟ or 
iPSCs.  However, iPSCs, to date, present technical challenges and regulatory issues 
that must be addressed before they can be used for treatment of human patients (Saha 
& Jaenisch, 2009).  
 
Evaluation of drugs and toxins:   hESCs and their differentiated derivatives can be 
used in screening assays for the development of new potential pharmaceuticals and 
toxic or mutagenic compounds.  While primary cell cultures or established cell lines are 
commonly used for both purposes, hESCs offer several advantages. hESCs have the 
ability to differentiate and efficiently produce unlimited numbers of cells representative 
of the three germ layers of embryos.  The developmental equivalence of hESC-derived 
and embryo populations provides a more rigorous system for evaluating the teratogenic 
and embryotoxic effects of a substance, in addition to general mutagenic and cytotoxic 
effects (Rohwedel et al., 2001).   A protocol based on hESC differentiation has been 
established and validated for use in toxicity testing (Bremer, 2002).  Additionally, 
genetic modification enables the tailoring of hESC lines for specific purposes.  For 
example, specific genes can be altered to increase sensitivity to mutagens or drugs 
(Lorico et al., 1996; Ogi et al., 2002), or tissue-specific reporter genes can be 
introduced to detect changes in gene expression induced by toxic chemicals or 
therapeutic agents (Li et al., 2002). 
 
Understanding embryogenesis through hESC modeling: Understanding 
mammalian embryogenesis through analysis of the early embryo is complicated by a 
number of factors, including size, availability and the complexity of the embryo and 
uterine environment.  hESCs are precursors to all embryonic lineages; thus, these cells 
should allow tracing the history from the root to individual branches of the cell lineage 
tree in a simplified and controllable culture environment.  System for differentiation of 
hESCs in vitro provides experimental models that can be used to augment in vitro 
studies of in vivo mammalian embryogenesis, promoting a greater understanding of 
genes and signaling pathways regulating developmental decisions.  One concern is 
that cell culture does not have a complex cell and tissue interactions that are critical to 
embryonic induction at distinct developmental stages. These cellular interactions, 
however, can be largely recreated in culture in the future with combination of tissue 
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engineering in order to reflect the in vivo environment, allowing the better system to 
study of embryogenesis. 
 
 
1.4. Embryonic stem cells: a tool to study neural differentiation 
Although the mechanism of neurogenesis has been well documented in other 
organisms, there might be fundamental differences between human and those species 
referring to species-specific context. Based on principles learned from other species 
(Mizuseki et al., 2003), it is found that the signaling pathways required for neural 
induction and specification of hESCs recapitulate those in the embryo development in 
vivo. This underscores the usefulness of hESCs in understanding early human neural 
development and reinforces the need to integrate the principles of developmental 
biology and hESC biology for efficient neural differentiation (Anderson 2001).  
 
1.4.1. Knowledge from mESCs 
mESCs tend to differentiate spontaneously under conditions that do not favor self 
renewal, for example removal from feeder cells or withdrawal of LIF (Smith, 2001).  To 
bias the differentiation process toward a neural fate, culture conditions are modified to 
promote the differentiation, survival and proliferation of neural stem cells from mESCs. 
Two model systems have been widely used to study neuroectoderm specification from 
mESCs, either in free floating aggregates or in an adherent culture. These culture 
systems yield robust neuroectoderm differentiation while preserving complex cellular 
interactions.  The most commonly used approach for neural differentiation from mESCs 
is the spontaneous aggregation into embryoid bodies (EBs) followed by treatment of 
these EBs with retinoic acid (McDonald et al., 1999).  The EB structure recapitulates 
certain aspects of early embryogenesis with the appearance of lineage specific regions 
similar to that found in embryos; early highly neurogenic FGF-responsive neural 
progenitor stem cells and late EGF-responsive gliogenic cells (Okada et al., 2008).  
The treatment of retinoic acid to EBs robustly increased the proportion of neuronal cells 
which predominantly differentiate to glutaminergic and γ-aminobutyric acid- 
(GABA)ergic neurons (Strubing et al., 1995).  However, EBs exhibit stochastic 
differentiation into variety of cell lineages and yield only a small fraction of neural 
lineage cells (Bain et al., 1995) and this issue can be overcome by well defined 
cultures of monolayer systems.  Direct differentiation of mESCs to neural progenitor 
cells can be obtained under serum-free conditions in monolayer culture at moderate 
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cell densities. The protocol was established using the genetically manipulated mESC 
line 46C, in which green fluorescence protein (GFP) cDNA is inserted into the Sox1 
locus and its expression is controlled by Sox1 regulatory elements (Ying et al., 2003).  
46C mESCs were plated onto gelatin-coated plates in the absence of LIF in serum free 
defined media (N2B27) and efficiently differentiated into GFP positive cells in 5 days 
(Ying et al., 2003).  The transition to neural progenitor cells is not homogeneous and is 
accompanied by the death of significant number of GFP-negative cells in the cultures.  
Survival of GFP-positive cells form rosettes in which cells elongate and align radially, in 
a manner reminiscent of neural tube formation.  BMP signaling appears to inhibit, while 
FGFs support neural progenitor cell production (Tropepe et al., 2001; Kunath et al., 
2007).  It has shown a trend of applying the principles of developmental biology to 
directing neural differentiation from mESCs.  In order to harness neural progenitor cells 
from hESCs, it is essential to gain a clear understanding of how hESCs are restricted 
and patterned to neural lineage.  This will require the integration of developmental 
neurobiology and stem cell biology (Anderson, 2001) as well as lessons learned from 
mESC studies.  
 
 
1.4.2. The derivation of neural lineage from hESCs 
Several approaches have been used to achieve in vitro neural differentiation from 
hESCs, aimed at generating regionally specified neural progenitors or differentiated 
neurons/glial subtypes (Erceg et al., 2009).  This was initially achieved through cell 
aggregation or EB formation in the presence of retinoic acid as a starting point for the 
isolation and culture of highly purified populations of neural progenitor cells (Carpenter 
et al., 2001).  These progenitors could be cultivated for about 25 population doublings 
as neurospheres in suspension culture, and they express markers of the early 
neuroectoderm, such as nestin, poly-sialylated (PSA) N-CAM, Musashi1 and PAX6 
(Carpenter et al, 2001).  The neural progenitor cells could differentiate into neurons, 
astrocytes and, to a minor degree, into cells expressing oligodendrocyte markers.  
However, as hESCs are pluripotent, the efficiency of neural conversion is limited and 
lineage selection is usually needed to ensure the enrichment of specific differentiated 
population. Most of the lineage induction protocols employ the addition of morphogens 
or growth factors to the hESC aggregates in suspension cultures. For this reason, EB 
formation has some drawbacks. Because a high concentration of morphogens or 
growth factors is required in order for the factors to reach cells inside the aggregates 
(Wichterle et al., 2002), cells on the surface and those inside the aggregates will have 
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a varied degree of exposure to morphogens, thus creating a wide range of cell lineages 
or cell at various developmental stages.  In addition, because of the cluster nature, it is 
impossible to visualize the continual change of cell morphology in response to 
treatment. 
 
To overcome these drawbacks, a simpler way to reconstitute neural commitment in 
vitro and achieve efficient neural production relies upon monolayer differentiation from 
hESCs.  However, when applying similar monolayer differentiation system used for 
directing mESCs to neural lineage, hESCs generated a large proportion of non-neural 
lineage cells.  This is mainly due to the active BMP signaling pathway in hESCs (Pera 
et al., 2004).  Therefore, the only approach that has been shown to induce efficient 
hESC neural differentiation is by directly inhibiting the BMP and/or SMAD signaling 
pathways (Gerrard et al., 2005; Chambers et al., 2009).  Treatment of hESCs with 
noggin, a BMP antagonist, generated a homogeneous, morphologically distinct 
population of cells that expressed neuroectodermal markers, including PAX6, 
Musashi1 and SOX2 and no detection of mesoderm and endoderm lineage markers 
(Gerrard et al., 2005).  Thus noggin alone appears to, at least, initiate hESCs 
differentiate toward neural lineage.  
 
Formation of „neural rosettes‟ is another morphological marker of in vitro differentiation 
of hESCs to neural cells which reminiscent of the in vivo structural formation of 
developing neural tube (O‟Rahilly & Muller, 1994).  The culture of hESCs in chemically-
defined medium with noggin resulted in PAX6+/SOX1- neural rosettes, and additional 
supplementation of FGF2 induced PAX6+/SOX1+ neural rosettes (Yao et al., 2006).  
Rosette-forming neural stem cells expressing anterior markers of the nervous system, 
such as Forse1, have shown the broadest differentiation potential (Elkabetz et al., 
2008).  These cells propagated in the presence of FGF2 and retained Forse1 
expression, even though FGF2 was considered to caudalize the cell fate of neural stem 
cells (Zhang et al., 2006).  Moreover, the cells in neural rosettes are capable of 
multiplying by symmetrical division over period of time and are able to differentiate to 
cell types of both anterior-posterior, central-peripheral types of the nervous system and 
could be maintained in long term culture by stimulating SHH and Notch pathways 
(Elkabetz et al., 2008).  Neural progenitor cells derived from hESCs are also capable of 
producing astrocytes and oligodendrocytes either under basal conditions or with 
medium supplemented with ciliary neurotrophic factor or platelet-derived growth factor 
(PDGF) (Brustle et al., 1999).  Mature astrocytes express specific astroglial markers 
such as GFAP and S100β.  However, the proportion of oligodendrocytes differentiation 
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from hESCs among the differentiated progeny is generally very low (Zhang et al., 
2001).  It has been shown that Olig2+ neural progenitors can be readily differentiated 
from hESCs in response to SHH and RA (Li et al., 2005).  These Olig2+ progenitors 
generate mostly motor neurons during the neurogenic period; however, Olig2+ 
progenitors persist after neurogenesis and become oligodendrocytes.  This suggests 
that the Olig2+ progenitors may differentiate into oligodendrocytes, and highlights the 
importance of Olig2 in oligodendrocyte development (Du et al., 2006).  
 
It is noted that during embryonic neurodevelopment, glial cells, e.g. astrocytes and 
oligodendrocytes, are generated after the birth of major neuronal types (Temple, 2001). 
The same neurogenesis to gliogenesis transition is preserved when neuroectodermal 
cells are cultured (Qian et al., 2000) or ESCs are differentiated along the neural lineage 
(Zhang et al., 2005).  The temporal sequence of neuronal and glial differentiation 
noteworthy corresponds to the timeline observed from limited samples of fetal tissues 
(Sidman & Rakic, 1982).  This is suggested that the intrinsic program governing 
neuronal and glial lineage development is retrained in vitro, and highlighted the 
feasibility of using hESCs as a tool to study neural differentiation process. 
 
1.4.3. hESCs could be a model system for human neurodevelopment 
Mice, chicken and zebrafish have long been considered model organisms for the study 
of vertebrate development.  Studies of these organisms have provided many insights 
into the molecular mechanisms underlying normal development, and are beginning to 
suggest potential pathophysiological mechanisms of some important development 
/congenital abnormalities in humans.  However, in the ultimate quest to understand the 
mechanisms of human development with the goal of preventing and treating 
developmental defects in humans, these studies fall short.  Important questions arise 
whether how the findings of these studies reflect mechanisms and events that occur 
specifically in human development. Understanding molecular interactions underlying 
human development is hindered by limited accessibility to early embryos and 
inadequate amount of stage- and cell type-specific materials. These problems may now 
be solved by the uses of stem cells, particularly hESCs.  Recent results indicate that 
the differentiation of hESCs in culture follows the hierarchical sets of signals that 
regulate embryonic development in the generation of the germ layers and specific cell 
types (Schuldiner et al., 2000). Establishment of in vitro differentiation models that 
recapitulate normal development will form the foundation for dissecting molecular 
interactions. The ability to access and manipulate populations representing early 
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developmental stages in the hESC differentiation cultures provides a new approach for 
addressing questions of lineage commitment, such as neurodevelopment.  This system 
provides a model of early mammalian development that enables manipulations 
comparable to those carried out in other organisms such as Xenopus and zebrafish.  
 
The investigation of neural-induction paradigms in hESCs has important implications 
for the development of neural differentiation protocols.  In recent years, more 
sophisticated and chemically-defined culture systems have been developed.  Anti-BMP 
signaling is thought to play a crucial role in neural induction (Chambers et al., 2009; 
Gerrard et al., 2005).  Further studies found that the high efficiency of neural induction 
with BMP antagonist treatment is consistent with its role in the default model of neural 
induction (Weinstein & Hemmati-Brivanlou, 1999).  In addition to the shared signaling 
pathways, temporal consequences are similar between in vivo and in vitro systems. For 
example, during the in vivo development, the neural plate forms and then eventually 
the neural tube when the human embryo is approximately 3 weeks old.  On the other 
hand, in vitro differentiation of hESCs toward neural lineage is characterized by 
formation of neural rosette observed at about day 15-17 of differentiation (Zhang et al., 
2001; Gerrard et al 2005), reminiscent of transverse-section of neural tube. It can be 
speculated that in vivo development events in term of spatial and temporal changes are 
grossly recapitulated during the in vitro formation of neural rosettes.  One of the 
characteristic features of neural progenitor cells is the positional identity they acquire 
during neural induction and patterning, which plays a key role in the fate specification 
of neuronal subtypes.  The positional information is imparted upon neural progenitor 
cells via morphogen gradients secreted by surrounding tissues.  Partially to mimic the 
positional information in a culture petri dish, morphogens that affect rostro-caudal and 
dorso-ventral fate choices are applied together or in sequence.  By applying FGF8, 
which influences mid-hindbrain fate, and sonic hedgehog, a ventralizing molecule, 
further induce hESC-derived neuroepithelial cells into midbrain dopaminergic neurons 
(Lee et al., 2000).  Absence of these positional morphogens in the in vitro 
differentiation system leads to production of mixed neuronal subtypes.  This would 
mean that the addition of morphogens at a specific timing and space are needed to 
pattern neural progenitor cells into a particular neuronal subtype, and the foundation of 
this knowledge is originally based on the current understanding of neurodevelopment. 
These studies reinforce the importance of applying developmental insights toward 
advancing the potential of hESCs. More importantly, neural differentiation system of 
hESCs could provide a dynamic model to figure out molecular mechanisms underlying 
decision-making process along each individual lineage tree. 
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1.5. Aims and objectives of the current project 
1.5.1. Overall aims  
It is noted that the current knowledge of neurodevelopment is mainly obtained from an 
animal study which is due to the lack of human samples.  However, there are questions 
about the physiological differences between human and animal, and as such findings 
from animal studies may not be directly translatable to the human system.  There is a 
need to find a source of human cells for a better feasibility of this study and hESCs is 
one of the promising resources.  hESCs sit on top of the cell lineage tree; hence, they 
can provide an ideal system to analyze early embryonic induction, especially neural 
lineage specification.  The protocol to derive neural progenitor cells from hESCs has 
previously been established in our laboratory (Gerrard et. al., 2005).  This system can 
efficiently differentiate hESCs to neural progenitor cells in a chemically defined 
medium, without using multicellular aggregates or coculture, thus providing a good 
system to investigate signaling pathways in controlling the process of neural 
differentiation.  In addition, this adherent culture system facilitates the visualization of 
the process of neural conversion/progression from hESCs. Importantly, it is suggested 
that the process of neural differentiation of hESCs in our system seems to recapitulate 
the steps of the nervous system development in vivo, for example, the formation of 
neural-tube like structures at the early stage of the differentiation.  There is also 
increasing evidence from others indicating the significant degrees of similarity between 
neural derivatives generated from hESCs and the in vivo neurodevelopment (Cazillis et 
al., 2006; Ghosh et al., 2009).  As the process of neural differentiation from hESCs is 
dynamic and multistage, the demonstration of this differentiation sequence will 
illuminate molecular mechanisms underlying human neurodevelopment.  Therefore, the 
aim of the current project is to analyze and characterize the multistage neural 
differentiation of hESCs in order to understanding better the molecular mechanisms 
regulating the neural differentiation process and neural cell fate determination.  The 
results obtained from this study will provide useful information and platform to approach 
questions remained in neurobiology. 
 
1.5.2. Project objectives 
We have observed that neural differentiation of hESCs in our system is a multistage 
process.  In order to fulfill the primary aim of this study, several objectives have been 
proposed here; 
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1. To further define the multistage differentiation process.  
hESCs will be differentiated into neural progenitor cells with our established adherent 
culture system.  This process will be carefully studied and more detailed analysis will 
be carried out to define their multistage process. 
 
2. To characterize the cells in each representative stages  
Several temporal characteristics of cells, including morphology, differentiation potential 
and gene expression, will be carefully examined at each stage of cells.    
 
3. To study functions of candidate gene(s) on neural progenitor/stem cells 
Candidate gene(s) that shows temporal expression pattern will be studied the functions 
on neural progenitor stem cells, including the effect on cell proliferation and 
differentiation.  
 
4. To characterize the nestin-GFP hESC reporter cell lines 
Stably transfected nestin-GFP hESC clones have been generated in our laboratory and 
I will characterize these lines to examine whether they are valuable as a neural lineage 
reporter. 
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Chapter 2: Materials and methods 
 
2.1. Cell biology materials & methods 
 
2.1.1. Cell culture materials 
Item Supplier Cat. No. 
2-mercaptoethanol Invitrogen 31350-010 
Ampicillin Fisher BPE1760-5 
Apo-transferrin Sigma T1147 
Ascorbic Acid Sigma A7631 
B27 Supplement Invitrogen 17504-044 
20% Bovine serum albumin (BSA) Sigma A9418 
Collagenase Invitrogen 17104-019 
Dulbecco‟s modified eagles medium (DMEM) Invitrogen 11960-044 
D-MEM:F12 (1:1) Invitrogen 21331-020 
DMSO Sigma D2650 
0.02% EDTA  Sigma E8008 
EGF Peprotech 100-15 
Fetal bovine serum (FBS) Sigma F7524 
FGF2 Peprotech 100-18C 
Forskolin Sigma F6886 
Gelatin Sigma G1393 
Geneticin (G418) Invitrogen 10131027 
Insulin Sigma I1882 
Knockout Dulbecco‟s modified eagles medium 
(KO-DMEM)  Invitrogen 10829-018 
Knockout serum replacement (KSR) Invitrogen 10828-028 
100X L-Glutamine  Invitrogen 25030-024 
Mouse laminin Sigma L2020 
Matrigel  Invitrogen 12760021 
Neurobasal medium Invitrogen 21103-049 
Noggin R&D systems 719-NG-050 
100X Non Essential Amino Acids (NEAA) Invitrogen 11140-035 
phosphate buffer saline (PBS) Invitrogen 14190-094 
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Item Supplier Cat. No. 
PBS without Ca2+& Mg2+ Invitrogen 14190-169 
platelet-derived growth factor (PDGF) Peprotech 100-13A 
100X Penicillin/Streptomycin (P/S) Invitrogen 15140-122 
Poly-L-lysine Sigma P4707 
Progesterone Sigma P6149 
Puromycin Sigma P8833 
Putrescine Sigma P5780 
Sodium Selenite  Sigma S5261 
Tri-iodothyronine  Sigma T6397 
Tryple Express Invitrogen 12604-013 
Trypsin EDTA Sigma T3924 
 
 
2.1.2. Cell culture stock solutions 
 
0.5% Gelatin  
Component Amount (ml) Final Conc. 
2% stock gelatin 100 0.50% 
PBS 300 -- 
 
 
Mouse embryonic fibroblast (MEF) medium 
Component Amount (ml) Final Conc. 
DMEM 440 -- 
FBS 50 10% 
100X L-Glutamine 5 1X 
100X P/S 5 1X 
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Knockout Serum-Replacement (KSR) medium 
Component Amount (ml) Final Conc. 
KO-DMEM 400 -- 
KO-SR 100 20% 
10ng/ml FGF2 0.2 4ng/ml 
100X NEAA 5 1X  
2-mercaptoethanol 1 0.1mM 
100X L-Glutamine 5 1X  
100X P/S 5 1X  
 
 
Embryoid body differentiating (EB) medium 
Component Amount (ml) Final Conc. 
KO-DMEM 400 -- 
FBS 100 20% 
100X NEAA 5  1X 
2-mercaptoethanol 1 0.1mM 
100X L-Glutamine 1  1X 
100X P/S 1  1X 
 
 
Human fibroblast growth factor 2 
Component Amount  Final Conc. 
FGF2 250 μg 10 ng/ml 
PBS 25 ml -- 
20% BSA 250 μl 0.2% 
 
 
Collagenase (200U/ml) 
Component Amount  Final Conc. 
collagenase IV 20,000 units 200 units/ml 
KO-DMEM 100 ml -- 
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100X N2 supplement 
Component Amount  Final Conc. 
10 mg/ml insulin in 0.01M HCL 0.5 ml 500 μg/ml 
100 mg/ml transferin in dH2O 1 ml 10  mg/ml 
75 mg/ml BSA in PBS 0.67 μl l 5  μg/ml 
0.6 mg/ml progesterone in ethanol 33 μl 2  μg/ml 
160 mg/ml putrecine in dH2O 100 μl 1.6 mg/ml 
1 mg/ml selenite in dH2O 5.2 μl 0.5 μg/ml 
DMEM/F12 7.187 ml -- 
 
 
N2B27 medium 
Component Amount  Final Conc. 
DMEM/F12 50 -- 
Neurobasal 50 -- 
100X N2 0.5 1X 
50X B27 1 1X 
100X L-Glutamine 1 1X 
100X P/S 1 1X 
 
 
1x freezing mix 
Component Amount  Final Conc. 
N2B27 medium or KSR 9 ml 90% 
DMSO 1 ml 10% 
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2.1.3.  Culture and differentiation of human embryonic stem cells 
2.1.3.1. Generation of mouse embryonic fibroblast-conditioned medium  
Mouse embryonic fibroblasts (MEF) were grown and expanded in MEF culture medium 
to passage 3. Cells were then trypsinised and collected into 50ml Falcon tube and cell 
number was counted.  Cells were irradiated at 40grays (4000rads) prior to 
centrifugation at 800rpm for 4 minutes.  Meanwhile, a number of T225 flasks were 
coated with gelatin by adding 12 ml of 0.5% gelatin to each flask and leaving in a 
culture hood for 10 minutes.  Cells were resuspended in the same medium after 
centrifugation and plated 1.88 x 107 cells into each gelatin-coated T225 flasks with 
MEF medium.  Subsequently, 150 ml KSR medium, supplemented with 4ng/ml FGF2, 
was added to replace MEF medium and incubated for overnight prior to the collection. 
Fresh KSR medium was added into the flasks for the collection next day.  For each 
flask of MEF, collection was carried out for continuous 7 days. This collected medium, 
named mouse embryonic fibroblast-conditioned medium (MEF-CM), was stored at -
80○C.  Upon use, MEF-CM was defrosted and mixed with L-glutamine and P/S before 
being filtered and kept at 4○C. 
 
2.1.3.2. Preparation of matrigel coated plates 
Stock matrigel was slowly thawed at 4○C overnight and diluted 1 in 2 with cold KO-
DMEM.  This solution was aliquoted 1 ml working volume into 15-ml tube and stored at 
-20○C.  Upon use, matrigel was gently defrosted under 4○C and diluted with 14 ml cold 
KO-DMEM.  The diluted matrigel was plated onto 6-well plate, 1ml/well and incubated 
overnight at 4○C.  In an emergency, the coating could be shortened to 1 hour at room 
temperature. 
 
2.1.3.3. Culture of hESCs 
H1 (passage number between 40 to 80) and H7 (passage number between 50 to 100) 
ESCs were cultured in MEF–CM supplemented with 4-8 ng/ml FGF2 in matrigel coated 
plates and medium was changed daily. Cells were routinely passaged at a 1:3 dilution 
by treatment with 200U/ml collagenase IV prior mechanic dissection. Cytogenetic G-
Banding was carried out regularly in order to confirming normal karyotypes of hESCs in 
a long term culture. 
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2.1.3.4. Freezing and resuscitating hESCs 
Confluent monolayer cultures were harvested similar as routine propagation but 
mechanically dissected in 1x freezing mix.  1ml aliquots were frozen overnight at -80○C 
in Mr Froster before being transferred to liquid N2 for long-term storage.  Cells were 
recovered from long-term storage by thawing rapidly at 37○C and resuspended in MEF-
conditioned medium. Cells were then pelleted at 800rpm for 5 minutes to removed 
trace of DMSO, and then plated on complete growth medium. 
 
2.1.3.5. Generation of embryoid bodies from hESCs 
hESCs were grown until confluent and then split mechanically after treatment with 
200U/ml collagenase IV. Dissociated small cell clumps were transferred to low-
adherent petri-dishes and cultured in suspension with EB medium unless stated.  After 
approximately 7 days, embryoid bodies were disassociated and transferred into 
chamber slides pre-coated with 0.5% gelatin. 
 
2.1.3.6. Neural progenitor/stem cell differentiation from hESCs 
hESCs was differentiated to neural lineage using published protocol (Gerrard et al., 
2005).  Briefly, confluent hESCs were split with EDTA/ PBS in 1:5 ratios into culture 
dishes coated with poly-L-lysine/laminin and cultured in N2B27 medium supplemented 
with 100ng/ml mouse recombinant noggin.  At this stage, cells were defined as 
passage 1 (P1).  Medium was changed every other day.  Cells of P1 and P2 were split 
by collagenase IV into small clumps, similar to that of hESC culture, and continuously 
cultured in N2B27 medium plus noggin until formation of neural progenitor cells at P3.  
 
 
2.1.4. Differentiation and culture of neural progenitor/stem cells (NPSCs)  
2.1.4.1. Preparation of poly-L-lysine/laminin 
Poly-L-Lysine (PLL) was diluted 1 in 6 in PBS added 1ml per well of a 6-well plate, 
incubated in hood at room temperature for 1 hour.  Mouse laminin was diluted with 6ml 
PBS to a final concentration of 20 g/ml, plated 1ml per well of a 6-well plate and 
incubated overnight at 4○C. 
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2.1.4.2. Culture of neural progenitor/stem cells 
Neural progenitor cells were disassociated into single cell by TrypLE express and 
cultured in N2B27 medium with the addition of 20ng/ml FGF2 and/or 20ng/ml EGF. To 
induce postmitotic cell types, growth factors were either withdrawn from the medium or 
replaced with 1% FBS for 3 weeks.  
 
2.1.4.3. Differentiation of oligodendrocyte progenitor cells 
Neural progenitor stem cells were plated on PLL/laminin-coated dishes and the neural 
stem cell expansion medium (N2B27) was replaced by DMEM/F12 supplemented with 
N2 (N2 medium).  Cells were proliferated in the presence of 10 ng/ml PDGF and10 mM 
forskolin for 7 days to support a glial precursor stage.  Further differentiation was 
induced by a 7-day-growth culture in the presence of 10 ng/ml PDGF, 30 ng/ml 3, 3, 5-
triiodothyronine (T3), and 200 μM ascorbic acid (AA).  
 
2.1.4.4. Differentiation of dopaminergic neurons 
Cells were cultured in N2B27 medium without the addition of growth factors. They were 
induced for ventral midbrain/ hindbrain fates by exposure to 100 ng/ml FGF8, and 400 
ng/ml SHH  for 2 weeks, followed by treatment with brain-derived 20ng/ml neurotrophic 
factor (BDNF) 20 ng/ml glial-derived neurotrophic factor (GDNF), 160 μM ascorbic acid 
and 0.5 μg/ml mouse laminin for another week. 
 
2.1.4.5. Clonal analysis of neural progenitor/stem cells  
Cells were diluted to a single cell density and seeded into PLL/Lam-coated 96 well 
plates.  To enhance viability, the cell was initially maintained in the mixture of fresh and 
conditioned N2B27 medium supplemented with 20 ng/ml of FGF2 and EGF. 
Conditioned medium was collected from routine culture of NPSCs.  Small colonies 
were formed from single cells after about 2 weeks.  Each clone was then transferred 
subsequently to a 24-well and 6-well plate for the expansion.  
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2.1.5. Genetic manipulation of cells 
2.1.5.1. Transfection by lipofectamine 2000 
Lipofectamine 2000 was used to transfect hESCs and hESC-NPSCs.  All transfections 
were carried out in 6-well plate with cells seeded at 1:3 split for hESCs or at a density 
of 5X105 for NPSCs the day before the transfection.  2μg of DNA was diluted in 250μl 
Opti-MEM and mixed gently.  6μl of lipofectamine was added into the DNA mix and 
incubated for 10 minutes at room temperature.  The complex was added carefully in a 
drop-wise manner to each well and mixed gently by rocking the plate. Cells were 
incubated at 37
○
C for 6 hours whence the complex was replaced by fresh medium. 
Selection with 400ng/ml geniticin were applied 24 and 48 hours post-transfection to the 
NPSCs and hESCs, respectively, while 48 and 72 hours with 2 µg/ml puromycin. 
 
2.1.5.2. Lonza nucleofection 
The supplied primary neural stem cell Nucleofector solution was pre-warmed to 37○C.  
NPSCs were harvested by trypsinization and counted for cell number to determine the 
cell density. The required number of cells was centrifuged (5x105 cells per 
nucleofection sample) and the supernatant was discarded. Cell pellet was resuspended 
with 100μl Nucleofector solution to a final concentration of 5x105cells/100μl, and 
plasmid DNA was added to the mixture. The nucleofection sample mix was transferred 
into an Amaxa certified cuvette which was inserted into the cuvette holder and 
transfected with an appropriated program. The sample mix was then mixed with 500μl 
of pre-warmed culture medium and transferred into a PLL/laminin pre-coated 6-well 
plate.  Same selection regimes described above were applied. 
 
 
2.1.6. Other cell biology assays 
2.1.6.1. Immunocytochemistry 
Cells were fixed at room temperature with 4% paraformaldehyde for 15 minutes, 
washed with PBS, and incubated with 10% goat serum and 0.1% Triton X-100 for 1 
hour. The cells were then incubated with primary antibodies at the appropriate dilution 
at 4°C overnight. Secondary antibody was applied for 30 minutes in dark after washing 
with PBS.  The cells were finally mounted with Mowiol mounting media and then 
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visualized and captured using Nikon TE2000-U.  The list of primary antibodies and 
secondary antibody used in project is provided in the appendix.  
 
2.1.6.2. Flow cytometry analysis 
Cell were detached by trypsin/EDTA solution and washed with PBS.  Cells were then 
stained on ice with antibodies against cell surface antigen and analyzed in FACScan 
(BD Biosciences) using CELLQUEST software (BD Biosciences).  Ten to twenty 
thousand cells were acquired for each sample.  For antibodies against nuclear 
proteins, the cells were fixed with 4% paraformaldehyde for 15 minutes, permeated 
with 100% ethanol for 2 minutes and treated with 10% goat serum for 15 minutes after 
washing with PBS.  Cells were then incubated with primary antibody for 30 minutes and 
secondary antibody for 30 minutes prior to FACScan analysis.  
 
2.1.6.3. Magnetic-activated cell sorting (MACS) 
Enrichment of specific cell populations was carried out by MACS using Dynal magnetic 
beads following manufacturer‟s instruction. Briefly, 25μl (1x107) Dynabeads were pre-
coated with 1 μg primary antibody by incubation at 4○C for 30 minutes with gentle tilting 
and rotation in 1ml buffer 1.  Pre-coated beads were resuspended in 0.5ml buffer1 after 
washing, and then incubated with cells (0.5ml) at 4○C for 30 minutes with gentle tilting 
and rotation.  2ml buffer1 was added into the tube to limit trapping of unbound cells and 
placed tube onto the magnet for 2 minutes. For negative selection, the supernatant, 
containing the unbound cells, was transferred to a fresh tube for further experiments.  
For positive isolation, the supernatant was discarded and the bead-bound cells were 
gently washed by buffer1 and collected for further experiments. 
 
2.1.6.4. Bromo deoxyuridine (BrdU) assay 
Cells cultured on PLL/laminin pre-coated cover slip in 24-well plates were incubated 
with BrdU at a final concentration of 10μM at 37○C for 2 hours.  After washing with 
PBS, cells were fixed for 10 minutes in freshly prepared 4% paraformaldehyde.  After 
washing again, cells were incubated with 2M HCl at 37○C for 1 hour to denature the 
DNA, followed by incubation for 1 hour in blocking buffer containing 10% goat serum, 
0.5% TritonX-100. The cells were then treated with monoclonal antibody against BrdU 
for 1 hour and secondary antibody for 30 minutes in dark with PBS washing between.  
The slides were mounted and left dry before visualization. 
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2.2 Molecular biology materials & methods 
 
2.2.1. Molecular biology materials 
 
Item Supplier Cat. No. 
100 BP DNA ladder Invitrogen 15628019 
Acrylogel 3 solution VWR 443733R 
Agarose Sigma A9539 
Ammonium persulfate (APS) VWR 443073E 
BCA protein assay kit Pierce 23225 
CL-XPosure file Fisher 34090 
Enhanced chemiluminescence substrate Pierce 32209 
DH5α Competent Cells Active motif 11096 
DNase I Sigma AMPD1-1KT 
Dual Luciferase assay system Promega E1910 
Glycine BDH BDH4156 
Immobilon-P membrane, PVDF Millipore IPVH-000-10 
Large flagmen of DNA Pol I Invitrogen 18012-021 
Lipofectamine 2000 Invitrogen 11668019 
Oligo dT 12 18 Primer Invitrogen 18418012 
Orange G VWR 4375252Q 
PCR-graded water Invitrogen 10977-023 
40% Polyacrylamide solution Merck UN3426 
Protease Inhibitor Sigma P8340 
Protein ladder Fermentas SM1811 
QIAEX II gel extraction kit Qiagen 20021 
Qiagen plasmid Midi kit Qiagen 12143 
Resolving gel buffer BioRad 161-0798 
Restore Western blot stripping buffer Pierce 21059 
RNase OUT  Invitrogen 10777019 
Separating gel buffer BioRad 161-0799 
Shrimp alkaline phosphatase Promega M820A 
Site-directed mutagenesis kit Agilent Inc 200519 
SuperScript II RT Invitrogen 18064014 
SYBR GREEN Sigma S9430 
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Item Supplier Cat. No. 
T4 DNA ligase Invitrogen 15224-041 
Taq DNA Polymerase Invitrogen 10342020 
Tetramethylethylenediamine (TEMED) VWR 443083G 
Tri reagent Sigma T9424 
Tris Base Sigma 93349 
 
  
2.2.2. Molecular biology stock solutions 
 
10X Orange-G loading buffer  
Component Amount  Final Conc. 
Ficoll 7.5 g 750 μg/ml 
Orange G 100 mg 10 mg/ml 
dH2O 10 ml -- 
  
 
2.5mM dNTP mix for PCR 
Component Amount  Final Conc. 
dATP 10 μl 2.5 mM 
dCTP 10 μl 2.5 mM 
dGTP 10 μl 2.5 mM 
dTTP 10 μl 2.5 mM 
dH2O 360 μl -- 
 
 
10mM dNTP mix for reverse transcription 
Component Amount  Final Conc. 
dATP 10 μl 10 mM 
dCTP 10 μl 10 mM 
dGTP 10 μl 10 mM 
dTTP 10 μl 10 mM 
dH2O 60 μl -- 
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10X TE buffer 
Component Amount  Final Conc. 
1 M Tris-HCL (pH 7.5) 100 ml 10X 
500 mM EDTA (pH8.0) 20 ml 10X 
dH2O 880 ml -- 
 
 
10X TAE buffer  
Component Amount  Final Conc. 
Tris base 48.4 g 400 mmol/L 
0.5M EDTA 20 ml 50 mM 
Glacial acetic acid 11.42 ml 0.2 mM 
dH2O 968.58 ml --  
 
 
8% (w/v) resolving gel  
Component Amount  Final Conc. 
40% Acrylamide 2.7 ml 8% 
Resolving gel buffer 2.5 ml  -- 
10% SDS 100 μl 0.1% 
10% APS 50 μl 0.05% 
TEMED 5 μl   
dH2O 4.7 ml -- 
* Resolving gel buffer is 1.5M Tris-HCl buffer pH8.8. 
 
 
4% (w/v) stacking gel  
Component Amount  Final Conc. 
40% Acrylamide 1.3 ml 4% 
Stacking gel buffer 2.5 ml --  
10% SDS 100 μl 0.1% 
10% APS 50 μl 0.05% 
TEMED 5 μl   
dH2O 6.1 ml -- 
* Stacking gel buffer is 0.5M Tris-HCl buffer pH6.8  
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10 x SDS-running buffer  
Component Amount  Final Conc. 
Tris Base 30.3 250 mmol/L 
Glycine 144.2 1.9 mol/L 
20% SDS 50 ml 1% 
dH2O 950 ml -- 
 
 
Western transfer buffer  
Component Amount  Final Conc. 
Tris Base 5.82 g 48 mmol/L 
Glycine  2.93 g 39 mmol/L 
10% SDS 3.75 ml 0.04% 
Methanol 200 ml 20% 
dH2O 800 ml -- 
 
 
FACS Staining Buffer 
Component Amount  Final Conc. 
PBS 48 ml -- 
FBS 1 ml 2% 
0.5M EDTA 200 μl 2 mM 
  
 
 
2.2.3. Plasmid construction and isolation 
2.2.3.1. DNA quantification 
Spectrophotometer (Eppendorf) was used to determine both the quantity and quality of 
DNA preparations.  Typically, a DNA sample was diluted 1:200 with dH2O and the 
absorbance read at 260 nm to give the concentration of nucleic acid in the samples.  
An optical density (OD) of 1 corresponds to approximately 50μg/ml of double-stranded 
DNA.  The ratio between reading at 260 nm and 280 nm provided an estimation of the 
purity and quality of the DNA preparations.  Pure DNA has an OD260/OD280 ratio of 1.8-
2.0.  
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2.2.3.2. Restriction endonuclease digestion 
Digestion mix was prepared a 1.5-ml DNase free tube as shown below and incubated 
at 37○C for the required period of time.  The reaction was stopped by 10mM EDTA pH 
8.0, and the digested product was analyzed by agarose gel electrophoresis.  
 
 DNA 0.2-1µg  X µl 
 10x RE buffer  2 µl 
 RE (1-2 unit)  Y µl 
 dH2O   Z µl 
 Total volume  20 µl 
 
2.2.3.3. Agarose gel electrophoresis 
Agarose powder was dissolved in 1X TAE buffer (0.8-1.5%) by microwave heating and 
allowed to cool. Ethidium bromide was added to a final concentration of 0.5μg/ml, prior 
to pouring the gel onto a horizontal electrophoresis set-up.  DNA samples were mixed 
with 10X DNA loading buffer prior to loading onto gels; at least one lane was reserved 
for 5μl of a molecular weight marker.  An electric current between 85 and 100 volts was 
allied.  Following electrophoresis, DNA was visualized by a UV transillumunator and 
images captured using Multi-Analysis software (Biorad). 
 
2.2.3.4. Purification of DNA fragment from agarose gel 
QIAEX II gel extraction kit was used to recover DNA from agarose gel following the 
manufacturer‟s protocol.  Briefly, the DNA band was excised from the agarose gel with 
a clean, sharp scalpel.  3 volumes of buffer QX I was added to 1 volume of the gel. 
Buffer QX II was resuspended by vortexing and added to the sample 30μl for the 
amount of 2-10μg DNA.  The sample was incubated at 50○C for 10 minutes to 
solubilize the gel and bind the DNA prior to centrifugation at high speed for 30 seconds 
and careful removing the supernatant.  The pellet was firstly washed with 500μl buffer 
QX I and secondly washed with 500μl buffer PE before air-dried for 15 minutes.  DNA 
was eluted from the pellet by adding 20μl of 10mM Tris-HCl, pH 8.5 or dH2O, and 
resuspended the pellet by vortexing.  The mixture was centrifuged at high speed for 30 
seconds and the supernatant was carefully transferred to a 1.5-ml tube.  The purified 
DNA solution was kept at -80○C. 
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2.2.3.5. Ligation 
The ligation reaction was prepared as followed; 4μl 5X ligation buffer, 3:1 inserts: 
vector ratio, 1 unit of T4 DNA ligase and toped up with dH2O to 20μl.  The reaction mix 
was incubated at 15○C for overnight, and was ready for transformation. 
 
2.2.3.6. Plasmid transformation 
Plasmid (1-5 µl) and 50μl competent cells were mixed and incubated on ice for 30 
minutes prior to heat shock at 42○C for 1 minute.  The mix was leaved at room 
temperature for 2 minutes before adding 900μl LB broth and incubating at 37○C with 
gentle shake for 1 hour. The mix was centrifuged at 8,500rpm for 30 seconds and 
plated on LB-agar plate with appropriate selection antibiotics. 
 
2.2.3.7. Plasmid isolation 
Plasmid DNA was purified by Qiagen plasmid Midi kit by followed the manufacturer‟s 
protocol.  Briefly, a single colony of a transformant was picked and inoculated a starter 
culture of 5ml LB broth which was incubated overnight at 37○C, 300rpm.  The starter 
culture was diluted 1:100 into selective LB broth and grew overnight at 37○C, 300rpm.  
The cells were harvested by centrifuged at 6,000xg for 15 minutes at 4○C which later 
resuspended in 4ml buffer P1 and mixed well by vortexing.  The cell mixture was added 
buffer P2, mixed vigorously by inverting and incubated at room temperature for 5 
minutes prior to the addition 4ml of pre-chilled buffer P3 which was mixed vigorously 
and incubated on ice for 15 minutes. The mixture was centrifuged at over 20,000X g for 
30 minutes and the supernatant containing plasmid DNA was transferred to a 15-ml 
tube. The column was equilibrated by the addition of 4 ml of QBT buffer which was 
empty by gravity flow. The plasmid DNA containing supernatant was added into the 
column and allowed to enter the resin by gravity flow before washed by 20ml of QC 
washing buffer.  Plasmid DNA was eluted by 5ml QF elution buffer and precipitated by 
3.5 ml isopropanol.  The solution was centrifuged immediately at over 15,000X g for 30 
minutes.  The plasmid DNA pellet was washed by 2 ml 70% ethanol and centrifuged at 
over 15,000X g for 10 minutes. The supernatant was discarded and the pellet was air-
dried at room temperature for 10 minutes prior to dissolving in the suitable volume of 
buffer (TE buffer, pH 8.0 or 10mM Tris-HCl, pH 8.5). 
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2.2.4. Site-directed mutagenesis 
Mutant strand synthesis reaction was performed by using QuickChange Site-Directed 
Mutagenesis Kit by followed the manufacturer‟s protocol.  Briefly, two complimentary 
oligonucleotide primers were synthesized and contained the desired mutation as 
followed: 
 
Deletion of OCT-binding site:  
Forward: 5'-CTTGGACAATGGCAGCATGAGAATCGGTCCCC-3' 
Reverse: 5'-GGGGACCGATTCTCATGCTGCCATTGTCCAAG-3' 
 
Deletion of SOX-binding site: 
Forward:  5'-CTCCAGATGGTGGCTTGGCAGCAATTAGCATGAG-3' 
Reverse:  5'-CTCATGCTAATTGCTGCCAAGCCACCATCTGGAG-3' 
 
Control Primer (for wild type enhancer): 
Forward: 5'-GCCTGGGGTGGGAGGAGGAG-3' 
Reverse: 5'-GGGGCCGGATCCTCTAGAGTCG-3' 
 
The sample reaction was prepared by 5μl 10X reaction buffer, 50ng double strand DNA 
template, 125ng forward/reverse primers, 1μl dNTP mix, 1μl of Pfu Turbo DNA 
polymerase and topped up with dH2O to a final volume of 50μl.  The reaction mixture 
was put into the thermal cycler programmed as; pre-heated at 95○C for 30 seconds and 
cycled for 18 rounds of 95○C for 30 seconds, 55○C for 1 minute and 68○C for 1 minute.  
Following the temperature cycling, the reaction tubes were placed on ice for 2 minutes 
prior to addition of 1μl Dpn I restriction enzyme.  The reaction mixtures were mixed 
thoroughly and incubated at 37○C for 1 hour to digest the parental supercoiled double 
strand DNA.  The mix was ready for transformation.  
 
 
2.2.5. Reverse transcription and polymerase chain reaction 
2.2.5.1. Preparation of total RNA from cultured cells 
Total RNA was extracted using TRI reagent according to the manufacturer‟s guidelines.  
Briefly, cells grown on a monolayer were harvested, washed twice with PBS and 
disrupted by 500μl TRI reagent.  Samples were homogenized by passing several times 
through a pipette. Samples were allowed to stand for 5 minutes at room temperature 
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prior to the addition of 100μl chloroform.  Samples were covered tightly and vortexed 
vigorously then allowed to stand at room temperature for 10 minutes.  The resulting 
mixture was centrifuged at 12,000X g for 15 minutes at 4○C. The aqueous phase was 
transferred to an RNase-free tube, and 250μl isopropanol was added and mixed.  The 
mixture was allowed to stand for 10 minutes at room temperature prior to centrifugation 
at 12,000X g for 10 minutes at 4○C. The supernatant was discarded, and RNA pellet 
was washed by adding 500μl 75% ethanol.  Centrifugation was applied to the mixture 
at 7,500X g for 15 minutes at 4○C. RNA pellet was briefly air-dry and an appropriate 
volume of dH2O was added. RNA solution was kept at -80
○C. 
 
2.2.5.2. RNA quantification 
Spectrophotometer (Eppendorf) was used to determine both the quantity and quality of 
RNA preparations.  Typically, an RNA sample was diluted 1:200 with TE buffer and the 
absorbance read at 260 nm to give the concentration of nucleic acid in the samples.  
An optical density (OD) of 1 corresponds to approximately 40 μg/ml of single-stranded 
DNA. The ratio between reading at 260 nm and 280 nm provided an estimation of the 
purity and hence quality of the RNA preparations.  Pure RNA has an OD260/OD280 ratio 
of 1.8-2.0. Spectrophotometric measurements were verified by agarose gel 
electrophoresis using 1-2μl of RNA. 
 
2.2.5.3. First strand cDNA synthesis 
The Super Script II Reverse Transcriptase (RT) was used to catalyze the synthesis of 
single-stranded cDNA from total isolated RNA. A total reaction volume was prepared 
using the following components: 2μg RNA diluted to a final volume of 11μl using 
RNase-free water, 4μl 5x RT buffer, 1μl oligo (dT) primer, 1μl 10mM dNTP, 1μl DTT 
and 1μl  RNase inhibitor. The 19-μl reaction was pre-heated at 42○C for 2 minutes prior 
to the addition of 1μl RT.  This 20-μl mix was incubated at 42○C for an hour followed by 
the inactivation step at 70○C for 15 minutes.  Samples were diluted 1:10 in dH2O, 
centrifuged briefly and stored at -20○C.   
 
2.2.5.4. Primer design and alignment 
A Primer-BLAST was conducted using the NCBI search engine, with the sequence of 
designed primers as a query sequence. Database of human genome and reference 
sequence for RNA were compared to identify the specificity and size of PCR products.  
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2.2.5.5. Quantitative-reverse transcription polymerase chain reaction 
(qRT-PCR) 
The qRT-PCR reaction mixture was prepared with 2μl cDNA, 15μl of SYBR green-Taq 
mixed solution, 9 pmol each of 5‟ and 3‟ primers and top up with dH2O to 30μl. cDNA 
was amplified in a thermal cycler (Opticon monitortm, Biorad).  For all primer pair 
denaturation at 95°C for 15 seconds, annealing at 60°C for 30 seconds and extension 
at 72°C for 30 seconds was used for 40 cycles.  As negative controls, the reverse 
transcriptase was omitted at the cDNA synthesis step and the samples then proceeded 
to the PCR reaction in the same manner as above.  These control experiments gave no 
positive amplification.  The target gene primers used are listed in the appendix. The 
expression level of target genes was calculated by calibrating the C(T) values with 
housekeeping gene (HPRT) as the formula below; 
 
[∆]Ct = Ct, sample - Ct, house keeping 
 
This will give a final CT value which will be later converted to a fold difference by; 
 
Fold difference = 2∆Ct 
 
To relatively compare the expression level, a fold difference value of experimental 
samples was normalized by a reference sample. The reference sample was changed 
according to a target gene of interest in order to provide a feasible value. 
 
 
2.2.6. Western Blotting 
2.2.6.1. Protein extraction 
Cells were washed twice by PBS and trypsinised for 5 minutes before collecting the 
pellets in a 1.5-ml tube by centrifugation at 14,000 rpm for 15 minutes. The supernatant 
was removed and pre-heated 1% SDS was added 150 μl. The pellet was homogenised 
by passing it at least 10 times through a blunt 20-gauge needle (0.9 mm diameter) 
fitted to a syringe and spin down at 14,000 rpm for 20 minutes. The supernatant was 
collected and assay for protein concentration by bicinchoninic acid (BCA) protein assay 
kit prior to aliquoting and storing at 80○C. 
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2.2.6.2. Measurement of protein concentration 
A bovine serum albumin (BSA) standard curve was set up to determine protein 
concentration of samples. Typically, a BSA standard range 0-2μg/μl was used where 
10μl of each BSA concentrations was mixed with 200μl BCA working reagent (Pierce).  
1% SDS was used to dilute BSA standards to the desired concentrations. 5μl of each 
protein lysis sample and 200μl BCA working reagent were added. All standards and 
samples were prepared in a 96-well plate and incubated at 37○C for 30 minutes.  A 
spectrophotometer plate reader was used to read absorbance at 562 nm.  All samples 
were measured in duplicate and average 562 nm absorbance measurement of the 
blank standards, subtracted from average measurements of each particular sample.  A 
standard curve was prepared by plotting the average blank-corrected 562 nm 
measurement for each BSA standard versus its concentration in μg/ml.  This standard 
curve was used to determine the protein concentration of each unknown sample. 
 
2.2.6.3. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
A total of 50μg protein from each sample was used to prepare a boiling mix containing 
5x sample loading buffer (50mM Tris-HCl pH 6.8, 25% glycerol, 2% SDS, 50mM DTT, 
5% β-Mercaptoethanol and 0.1%bromophenol blue). The mix was boiled at 95○C for 5 
minutes prior to separation on an 8% vertical polyacrylamide separating gel.  A 4% 
polyacrylamide mixture was used as the stacking gel. Polyacrylamide gel 
electrophoresis (PAGE) was conducted at 200 volts for approximately 1 hour using 1X 
SDS running buffer.  5μl of the Rainbow molecular weight marker was run on either 
side of the sample lanes.  
 
2.2.6.4. Gel-membrane transfer and antibody hybridization 
Protein was transferred onto a polyvinylidene fluoride (PVDF) membrane at room 
temperature using a semi-dry transfer apparatus in 1X transfer buffer at 20 volts for 1 
hour.  Membranes were blocked for 1 hour in TBS containing 0.1%Tween (TBST) and 
5%milk prior to incubation with specific antibodies overnight at 4ºC using the indicated 
dilution (see appendix).  Membranes were washed three times with TBST, 10 minutes 
each, followed by incubation with the secondary antibody at a dilution of 1:2000 for 1 
hour at room temperature.  Protein was detected using an enhanced 
chemiluminescence (ECL) HRP detection substrate.  Briefly, 1ml of luminol and 1ml of 
peroxide were mixed and poured onto the membranes prior to 2 minutes incubation at 
room temperature. Blots were drained, covered with plastic wrap and exposed to 
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autoradiography film for 30 seconds to 30 minutes.  To re-probe, membranes were 
stripped for 1 hour using pre-heated stripping buffer, and washed 3 times with TBST 
buffer followed by blocking in 10% milk TBST for 1 hour at room temperature.  In order 
to checking complete stripping, blots were re-exposed to autoradiography film.  Blots 
were re-probed for a loading control or other antibodies.  Membranes were washed 3 
times with TBST, 15 minutes each, followed by incubation with the secondary antibody. 
Membrane was exposed to autoradiography film as described previously.  
 
 
2.2.7. Luciferase activity assay 
Dual-luciferase reporter (DLR) assay system (Promega inc.) was used to determine 
luciferase activity following the manufacturer‟s protocol.  Briefly, to prepare stock 
solution, luciferase assay reagent II (LAR II) was prepared by resuspended the 
lyophilized substrate in 10ml of the supplied buffer II.  LAR II solution was kept at -80○C 
until used.  Stop&Glo reagent was diluted just prior to the assay for a desired volume 
with the provided buffer.  Cells were transfected for 48 hours with the firefly reporter 
and renilla luciferase vectors, and then lysed by 500μl passive lysis buffer (PLB) before 
transferred to a 1.5-ml tube.  100μl of LAR II was predispensed into the appropriate 
number of luminometer plate to complete the desired number of DLR assay.  20μl of 
cell lysate was carefully transferred into the luminometer plate containing LAR II, mixed 
by pipetting and initiated reading by the luminometer.  Next, 100μl of prepared 
Stop&Glo reagent was added into the previous mixture, mixed by pipetting and initiated 
reading.  Calculation of luciferase activity was determined by relatively compared the 
activity of firefly and renilla luciferase.  
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Chapter 3: Direct neural lineage differentiation of hESCs 
through primitive ectoderm-like stage 
 
3.1. Introduction 
The current understanding of human embryonic development is largely based on an 
assumption that the process is similar to that in mice. Although undoubtedly similar in 
many aspects, critical differences are clearly present. For example, mice and humans 
differ in the overall morphology of the early embryos (egg cylinder in mice vs. disc in 
human) and in the process by which the embryo proceeds through gastrulation. The 
direct study of early human embryo development is severely restricted by the inability 
to obtain adequate amounts of tissues at all developmental stages. Furthermore, 
ethical considerations and laws prohibit the manipulation of human embryos. The 
limited available information relating specifically to human development comes only 
from observations made on tissue sections of human embryos which have passed the 
critical period of early embryo development. It is almost impossible to obtain human 
embryos within the first several weeks of implantation, a period critical for embryonic 
induction and patterning. Because hESCs are pluripotent and can be induced toward 
all lineages like their in vivo origin of inner cell mass (ICM) of blastocyst, they are a 
unique tool that could provide important information about the cellular and molecular 
basis of cell fate commitment and determination events during early human 
development, even the incident of earliest lineage commitment (Dvash & Benvensity 
2004).   
 
Early developmental events within the mammalian embryos entail the formation of 
extra-embryonic cell lineages and the construction of an embryonic environment in 
which later embryonic development can continue. The resulting blastocyst contains two 
cell populations; trophectoderm which will develop to placenta, and the ICM, precursors 
for embryonic proper.  At around the time of implantation, the ICM cells proliferate 
rapidly and differentiate to generate the second pluripotent cell population known as 
the primitive ectoderm.  Although they retain pluripotency, the primitive ectoderm cells 
can be distinguished from the ICM by the fact that they have upregulated fibroblast 
growth factor 5 (FGF5) expression (Haub & Goldfarb, 1991) and downregulated REX1 
expression (Rogers et al., 1991), and by the fact that they can no longer contribute to 
chimera formation following blastocyst injection (Beddington, 1983). The notion that 
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although mESCs are routinely derived from the ICM of blastocyst stage embryos, they 
can undergo conversion to a primitive ectoderm-like state upon changes in culture 
conditions (Rathjen et al., 1999). These cells were marked by expression of FGF5 and 
downregulation of REX1, but could be reversed back to FGF5-negative and REX1-
positive mESCs. This evidence in vitro reflects early development progression of the 
ICM in vivo toward the primitive ectoderm.   
 
As it is noted that neural differentiation of hESCs is dynamic and resembles early in 
vivo neural development to a certain degree, the identification of the early population 
derived from hESCs cultured in this differentiation system may enable us to capture the 
initial event of neural lineage commitment from hESCs.  Thus, the objective for this 
study is to identify the early events of neural differentiation using hESC surface 
markers and to characterize the cells for their gene expression pattern and 
differentiation potency.  
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Results 
 
3.2. Identification of a transient population at early stage of neural 
differentiation form hESCs 
Undifferentiated hESCs express several unique cell surface markers which were first 
identified in human embryonic carcinomas (Andrews, 1987), such as stage-specific 
embryonic antigens (SSEA) 3 and 4, TRA-1-60,and TRA-1-81, but unlike mESCs, they 
do not express SSEA1 (Drapper et al., 2002; Krupnick et al., 1994). Although the 
functional significance of these antigens is unknown, it has been demonstrated that 
these markers are expressed in both ICM of the pre-implantation human embryos and 
hESCs (Henderson et al., 2002).  In addition to cell surface markers, a set of 
transcription factors are also expressed at high levels in the ICM and hESCs and play 
an important role in maintaining cell pluripotency. These include the POU domain 
transcription factor OCT4 (POU5F1); the zinc finger protein REX1; the homeobox 
domain transcription factor SOX2; and the homeobox domain transcription factor 
nanog.  
 
To make sure that the hESCs cultured under feeder-free and serum-free conditions in 
our laboratory (see materials and methods, Xu et al., 2001) are undifferentiated, I 
examined the cells for the expression of those markers by immunocytochemistry and 
flow cytometry analysis. The results showed, as expected, that hESCs in this culture 
condition were immunoreactive to OCT4 and SOX2 and that the overwhelming majority 
of cells in the culture expressed OCT4, Nanog and SOX2. The majority of cells in the 
culture were also positive for hESC specific cell surface antigens, SSEA3, SSEA4, and 
TRA-1-81. Representative data from H1 hESCs are shown in Figure 3.1. The small 
group of negative cells represents spontaneously differentiated cells. These results 
suggest that our current culture condition is sufficient to maintain hESC self-renewal 
and pluripotency; thus, they could be further experimented for downstream 
experiments. 
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Figure 3.1: Expression of pluripotent markers of H1 hESCs. (A-D): 
Immunocytochemistry staining for transcription factors OCT4 and SOX2 (A & B) and 
the corresponding of DAPI staining (C & D).  (E): Flow cytometry analysis of the 
expression of hESC markers as indicated.  
 
 
In order to capture the early event of hESC neural differentiation, H1 hESCs were 
differentiated by our established neural differentiation protocol (Gerrard et al 2005), and 
closely examined for their changes in morphology and hESC-specific cell surface 
markers.  H1 hESCs were split with EDTA and plated into neural-inducing condition 
(see materials and methods). Small clumps of cells (5-10 cells) were plated in the 
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neural-inducing condition (Figure 3.2 A, see materials and methods). The colonies 
gradually expanded in culture with few significant morphological changes except the 
prickly-edge colonies and noticeable number of cell death (Figure 3.2 D-F). This cell 
death may due to a selective pressure under the neural-inducing condition which is 
only suitable for a sub-population of hESCs to differentiate toward neural lineage, while 
others not responsive died under this condition. 
 
 
 
 
Figure 3.2: Morphological changes during the early phase of neural lineage 
differentiation from hESCs.  (A): H1 hESC colonies in the self-renewal culture 
condition; (B-F):  hESCs were subjected to neural differentiation for the indicated 
number of days. Scale bar represented 50 μm for all images. 
 
 
Flow cytometry analysis showed that the major population of hESCs expressed 
SSEA3, SSEA4 and TRA-1-81, but not SSEA1 in the self-renewal culture condition 
(Figure 3.3 A, top panel). In contrast, it is noted that after 9 days in neural 
differentiating condition, the cells completely lost SSEA3 and TRA-1-81 expression but 
still maintained the expression of SSEA4 though at a lower level than undifferentiated 
hESCs (Figure 3.3 A, middle panel).  SSEA4 expression gradually disappeared after 
further differentiation (Figure 3.3 A, bottom panel). To further confirm that these early 
changes are not unique to H1 hESCs, flow cytometry analyses were also carried out 
for H7 hESCs, which showed similar results as those of H1 hESCs (Figure 3.3 B).  
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These data led to the identification of the population, named SSEA4+/TRA-1-81- cells, 
which appeared early, but transiently, during neural differentiation of hESCs.  
 
 
Figure 3.3: The expression profile of surface markers during the early neural 
differentiation of hESCs.  Expression of hESC-specific surface markers in H1 and H7 
hESCs was analyzed during early neural differentiation (A & B respectively).  Days of 
differentiation were indicated and percentage of positive cells was labeled. The dataset 
here was a reprentative which was repeated several times. 
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The existence of SSEA4+/TRA-1-81- cells raised the questions of the state of their 
development in vitro. It was interesting to further characterize these cells, regarding 
their gene expression and differentiation potential, which will provide useful information 
of the early differentiation process of hESCs, and, ultimately, elucidate the mechanisms 
of lineage commitment.  
 
 
3.3. Gene expression profiles in SSEA4+/ TRA-1-81- cells 
The pluripotent cell population can be discriminated from differentiated cell lineages in 
embryos by morphological and developmental criteria (Gardner, 1985) as well as by 
the temporal and spatial expression of marker genes (Hebert et al., 1991; Rogers et al. 
1991). Because of the time course, it was hypothesized that SSEA4+/TRA-1-81- cells 
may serve as an intermediate population between hESCs and neural progenitor cells. If 
this hypothesis was correct, SSEA4+/TRA-1-81- cells will provide a good cell source to 
study early changes in neural differentiation and factors important in regulation of 
neural differentiation. In order to better understand the transient population of 
SSEA4+/TRA-1-81- cells, I examined gene expression profile in purified SSEA4+/TRA-
1-81- cells by qRT-PCR, immunocytochemistry and flow cytometry. 
   
Because it was noted that SSEA4+/TRA-1-81-  cells were generated at the early phase 
of neural differentiation, pluripotent markers; OCT4, nanog and REX1, and the neural 
lineage marker, PAX6, were selected for the gene expression study.  SOX2, known to 
be expressed in both hESCs and neural progenitor cells, was also included for the 
analysis. In addition, as it is well known that FGF5 expression is upregulated on the 
formation of the primitive ectoderm from the ICM (Haub & Goldfarb, 1991), FGF5 was 
chosen for the gene expression analysis. I also included markers of other lineages, 
such as GATA6 and Brachyury, to confirm lineage segregation.  qRT-PCR showed the 
OCT4, nanog and REX1 in SSEA4+/TRA-1-81- cells were expressed but at a lower 
level (~50%) in comparing to that in the hESCs, while in neural progenitor cells the 
expression of these genes was undetectable (Figure 3.4 A).  On the other hand, the 
homeodomain transcription factor SOX2 maintained its expression at a comparable 
expression level to that of hESCs but evidently lower than that in neural progenitor cells 
(Figure 3.4 A). Neural marker PAX6 was upregulated in SSEA4+/TRA-1-81- cells in 
compare to hESCs but the expression level was not as high as that in neural progenitor 
cells. Interestingly, the mRNA expression of FGF5 was only detected in SSEA4+/TRA-
1-81- cells, but not in hESCs or neural progenitor cells. Other lineage markers, GATA6 
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and Brachyury, could not be observed in all three cell stages (data not shown). The 
expression of OCT4 and nanog was confirmed by Western blot (Figure 3.4 B & C) 
which showed their protein expression is correspondent to the mRNA expression.  
 
 
 
 
 
Figure 3.4: Comparison of gene expression profile in hESCs, SSEA4+/TRA-1-81- 
and neural progenitor cells.  (A): mRNA expression by qRT-PCR. Error bars show 
the standard deviation of three independent experiments.  (B): Western blot of OCT4 
and nanog showing similar results to q-RT-PCR. (C): Histogram showed relative 
expression of OCT4 and nanog, quantified from band intensity of Western result. 
SSEA4+/TRA-1-81- cells were purified by magnetic-activated cell sorting technique.  
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To validate that the reduced expression of OCT4 and nanog, and the increased of 
PAX6 were not due to population discrepancies, immunocytochemistry and flow 
cytometry were carried out.  Immunocytochemistry result revealed that the majority of 
SSEA4+/TRA-1-81- cells expressed both hESC and neural lineage markers; OCT4 and 
PAX6, respectively, while hESCs and neural progenitor cells expressed only a cell type 
specific marker (Figure 3.5 A-C).  This was consistent with flow cytometry data (Figure 
3.5 D).  Flow cytometry analysis showed that the OCT4 staining pattern was similar 
between hESCs and SSEA4+/TRA-1-81- cells but the intensity was lower in the latter 
while OCT4 was negative in neural progenitor cells (Figure 3.5D).  PAX6 was 
upregulated in SSEA4+/TRA-1-81- cells when compared to hESCs (Figure 3.5 D.1&2).  
However, the intensity of PAX6 expression in this specific population was still much 
lower than that in neural progenitor cells (~100; Figure 3.5 D3).  These results 
suggested that the low expression of hESC markers and the upregulation of neural 
lineage gene appeared in the same population rather than in different cells.  It was 
interesting of the detection of co-expression of hESC and neural lineage markers in 
SSEA4+/TRA-1-81- cells.  This supported the initial hypothesis that SSEA4+/TRA-1-81- 
cells represented intermediate phenotypes of hESCs and neural progenitor cells during 
the early neural differentiation.  As it is known that primitive ectoderm serves as a 
transitional phase during the developmental program of the ICM and embryonic germ 
layers, it was possible that SSEA4+/TRA-1-81- cells may be equivalent to the primitive 
ectoderm.  Indeed, these cells do express FGF5, a well-known primitive ectoderm 
marker.  However, to satisfy the criteria of being similar to the primitive ectoderm, 
SSEA4+/TRA-1-81- cells have to be able to contribute three embryonic germ layers; 
endoderm, mesoderm and ectoderm.  The detection of pluripotent cell marker genes in 
SSEA4+/TRA-1-81- cells suggested that these cells could be pluripotent. To address 
this, more experiments were demanded to be performed. 
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Figure 3.5: Expression of hESC and neural progenitor genes. (A-C): 
Immunocytochemistry showed modulation of OCT4 and PAX6 expression at different 
cell stages. Scale bar represented 50 μm for all images. (D): Flow cytometry analysis 
of cell type-specific transcription factors at various stages of cells.  
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3.4. SSEA4+/TRA-1-81- cells are able to generate cells of three germ 
layers via embryoid body formation  
Since OCT4 has been well documented as a gene for pluripotency and SSEA4+/TRA1-
81- cells still express OCT4, it is essential to address the question whether the 
SSEA4+/TRA1-81- cells are able to produce cells of non-neural lineages.  Embryoid 
body (EB) formation is one of the widely used methods to examine differentiation 
potential of cells (Itskovitz-Eldor et al., 2000).  EBs are aggregates of cells that could 
initiate spontaneous differentiation which recapitulates embryonic development at 
certain extent.  All three embryonic germ layers could be differentiated via embryoid 
body formation of pluripotent cells (Itskovitz-Eldor et al., 2000).  Thus to answer 
whether SSEA4+/TRA1-81- cells could produce other cell lineages than neurons; I 
carried out experiments to differentiate these cells via embryoid body formation.  In 
order to exclude the possibility of hESC contamination, SSEA4+/TRA1-81- cells were 
purified by magnetic-activated cell sorting (see materials and methods).  However, 
purified cells were in single cell suspensions and, like hESCs, could not aggregate 
themselves spontaneously. Therefore, they were forced to be aggregated by 
centrifugation in 96-well v-shape plate as described previously (Burridge et al., 2007) 
before cultured in suspension with EB medium (see materials and methods).  
 
Initially, at day 3 of the aggregation, these aggregates were largely composed of 
densely packed cells, creating simple EBs (Figure 3.6 A). Soon after, the centre of EBs 
became cavitated, noticed by dark shadow (Figure 3.6 B), and certain structures 
appeared within the EBs after 7 days in EB condition. To examine the differentiation 
status of the cultured EBs, they were subsequently disassociated and plated as a 
monolayer in EB medium for another 7 days (Figure 3.6 C).  Cells of various 
morphologies were recognized, among them neural-like fibers (Figure 3.6 C, blue 
arrow) and endoderm-like flatted cells (Figure 3.6 C, black arrow). To characterize 
these differentiating cells from EBs, I examined the expression of molecular markers 
specific to three embryonic germ layers by qRT-PCR and immunocytochemistry. The 
mRNA expression of ectoderm markers, (SOX1 and PAX6), mesoderm markers, (GSC 
and MEOX1), and endoderm markers (GATA6 and albumin) were all upregulated in 
embryoid body-differentiated SSEA4+/TRA-1-81- cells, compared to original purified 
SSEA4+/TRA1-81- cells and undifferentiated hESCs (Figure 3.6 D).  By contrast, OCT4 
and nanog expression was significantly downregulated to the background levels. 
Immunocytochemistry confirmed the expression of three germ cell markers in the 
differentiated cells.  It showed that differentiated SSEA4+/TRA-1-81- cells stained 
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positive for endoderm markers; AFP, HNF-4α and GATA6 (Figure 3.5 E-G), mesoderm 
marker; muscle actin (Figure 3.5 H), and ectoderm marker; nestin and PAX6 (Figure 
3.6 I & J).  These results indicated that SSEA4+/TRA-1-81- cells are pluripotent, which 
suggested the equivalent of these cells to the primitive ectoderm. 
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Figure 3.6: SSEA4+/TRA-1-81- cells are able to produce cells of three germ layers. 
(A-C): Phase contrast images of embryoid body formation from SSEA4+/TRA-1-81- 
cells. (D): qRT-PCR analysis of pluripotent and differentiated genes as indicated with 
standard deviation bars. (E-J): Immunocytochemistry images of three embryonic layer 
markers staining.  
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3.5. SSEA4+/TRA-1-81- cells cannot be reversed to hESC state in CM-
self renewal condition  
Since SSEA4+/TRA-1-81- cells exhibited certain characteristics of primitive ectoderm 
cells and the mESC-derived primitive ectoderm-like cells were capable of reversing 
back to ESC state when culture was changed to mESC self-renewal condition (Rathjen 
et al., 1999), the next question to be addressed is whether SSEA4+/TRA-1-81- cells are 
able to be reversed back to their original hESC state if cultured in self-renewal 
condition. Therefore, magnetically purified SSEA4+/TRA-1-81- cells were re-plated into 
hESC self-renewal culture condition.  Cells were seeded onto matrigel-coated plates 
supplied with MEF-CM with FGF2 (see materials and methods). Colonies of 
SSEA4+/TRA-1-81- cells were visible after 3 days and expanded within a week in 
culture (Figure 3.7 B).  The cell colonies exhibited similar structures to that of hESC 
after cultured for 7days with compact and clear-edged colonies (Figure 3.7 B & C, first 
panel).  It is unlikely that these came from the residual undifferentiated hESCs as the 
magnetic-sorted cells were verified their purity by flow cytometry of SSEA4+ and TRA-
1-81- identity (Figure 3.7 A).  However, hESC surface markers, SSEA4 and TRA-1-81, 
could not be reactivated nor maintained in the culture (Figure 3.7B). Instead, the 
expression of SSEA4 was downregulated while SSEA1, a differentiated marker of 
hESCs, was upregulated (Figure 3.7 B, second panel). After 14 days in hESC self-
renewal culture condition, the cells started to exhibit differentiated cell morphology. 
Consistent with this, the cells lost SSEA4 expression. These results indicate that 
SSEA4+/TRA-1-81- cells are no longer hESCs and cannot be reversed to their original 
hESC state by simply reintroduced into hESC self-renewal culture condition. Neither 
can they be maintained in their SSEA4+/TRA-1-81- state in these conditions.  The 
optimal conditions, for example primitive ectoderm culture (Rathjen et al., 1999), may 
be able to maintain SSEA4+/TRA-1-81- cell identity in long term culture which will need 
to be explored in the future.  
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Figure 3.7: SSEA4+/TRA-1-81- cells cannot be reversed to hESC state in CM-self 
renewal condition.  Purified SSEA4+/TRA-1-81- cells re-plated into self-renewal 
culture.  (A-C): Phase contrast images and cell surface antigen profile of purified cells 
after reintroduction to hESC self renewal condition.  Days of culture were specified. 
Scale bar represented 50 μm for all images. 
 
 
Due to the facts that SSEA4+/TRA-1-81- cells could not be maintained by hESC self-
renewal culture condition and seemed continually differentiated, there was a question 
what cell types they would become in that condition. Gene expression profile of the 
SSEA4+/TRA-1-81- cells was examined by qRT-PCR after they were cultured in hESC 
self-renewal medium for 1 and 2 weeks (Figure 3.8). The expression of pluripotent 
markers, OCT4 and nanog, were clearly downregulated with the time in culture and 
significantly lower than both undifferentiated hESCs and the purified SSEA4+/TRA-1-
81- cells (Figure 3.8 A & B). This further confirmed the inability to retain the 
characteristics of either hESC or SSEA4+/TRA-1-81- cells. Neural lineage genes; 
SOX1, SOX2 and PAX6, were also gradually reduced in culture although not as 
dramatically as undifferentiated markers (Figure 3.8 C-E). In contrast, mesoderm and 
endoderm markers; meox1, α-foetoprotein (AFP), GATA6 and albumin, were 
significantly increased in time-dependent manner (Figure 3.8 F-I), implying the 
progression of cells toward mesendoderm lineages.  These results are, to a certain 
degree, in correspondence with those in Figure 3.6 D and showed that the 
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SSEA4+/TRA-1-81- cells were differentiated into three germ layers in this condition, 
which further demonstrated the pluripotency of these cells.  
 
 
 
 
Figure 3.8: Self-renewal condition could not reverse SSEA4+/TRA-1-81- cells to 
the hESC state.  Expression of pluripotent and lineage genes were measure by qRT-
PCR as indicated. Tested samples are undifferentiated hESCs (hESCs), SSEA4+/TRA-
1-81- cell (S4+/TR-), SSEA4+/TRA-1-81- cell cultured in self renewal condition for 7 
(S4+/TR- CM D7) and 14 days (S4+/TR- CM D14). Three independent experiments 
were performed with a standard deviation bar.  
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3.6. Discussion 
hESCs express a number of specific surface antigens, including SSEA3, SSEA4, TRA-
1-60 and TRA-1-81 (Drapper et al., 2002).  These surface markers, along with the 
availability of their antibodies, provide an invaluable tool for monitoring the progress of 
hESC differentiation.  In this study, it was demonstrated that the loss of TRA-1-81 is an 
early event during the neural differentiation of hESCs when SSEA4 is still expressed in 
these cells.  This enabled us to isolate a distinct cell population and characterize them 
for their gene expression and differentiation potential.  The finding of loss of TRA-1-81 
as one the first events of lineage commitment in hESCs in our system is consistent with 
that reported by Enver et al (Enver et al, 2009).  Although they are pluripotent, 
SSEA4+/TRA-1-81- cells are no longer hESCs because of their inability to self renew 
when reintroduced to hESC culture conditions. Noteworthy, the progression of hESCs 
to SSEA4+/TRA-1-81- cells may entail the progressive formation of a temporally distinct 
second pluripotent cell population in vivo, the primitive ectoderm.  
 
Conversion from hESCs into SSEA4+/TRA-1-81- cells was found to be accompanied by 
the mutual expression of hESC and neural progenitor genes. This suggests that 
SSEA4+/TRA-1-81- cells represent a cell type of intermediate state for those two cells. 
The expression of FGF5 indicates the primitive ectoderm-like identity of this population 
as FGF5 is highly expressed within cells of the primitive ectoderm where it persists until 
further differentiation (Hebert et al., 1991).  The alteration of this gene may correlate to 
a key developmental event of hESCs. The similarity of SSEA4+/TRA-1-81- cells and 
primitive ectoderm cells is further supported by the expression of pluripotent markers in 
these cells and their ability to contribute to three embryonic germ layers.  A similar 
initial progression of hESCs toward primitive ectoderm was also reported by other 
groups using different differentiation protocols (Bajpai et al., 2009)  as well as those 
found in mESCs (Stavridis et al., 2007).  
 
Recently, there have been reported for the establishment of mouse epiblast stem cells 
(mEpiSCs) which share certain features with hESCs, for example, they exhibit similar 
flattened colony morphology and their self-renewal is dependent on activin/Nodal 
signaling (Brons et al., 2007; Tesar et al., 2007).  In addition, both hESCs and 
mEpiSCs are able to differentiate in vitro into extra-embryonic tissues in the presence 
of BMP4 (Brons et al., 2007; Xu et al., 2004).  Therefore, it has been suggested that 
hESCs are more close to mEpiSCs than mESCs, and this could reflect the similarity of 
their origins.  Intriguingly, there also several lines of evidence that do not support this.  
For example, hESCs express REX1 but not FGF5, while mEpiSCs exhibit in an 
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opposite way.  Alkaline phosphatase activity, which generally marks pluripotent hESCs, 
is undetectable in mEpiSCs. The establishment of SSEA4+/TRA-1-81- cells in this study 
could add a strategically important system for understanding the relationship between 
hESCs and their developmental counterparts. The inability to maintain SSEA4+/TRA-1-
81- cells may result from an unsuitable culture conditions that promotes the 
differentiation progression.  In order to maintain cells at primitive ectoderm-like state, 
multiple signaling pathways have to be activated, especially Nodal/Activin and gp130 
(Rathjen et al., 1999; Tesar et al., 2007).  
 
Gene expression analysis of SSEA4+/TRA-1-81- cells has showed that OCT4 and 
nanog were still expressed though at a lower level than hESCs.  The sustained 
expression of these genes may contribute to the pluripotency of the cells. It has 
previously been reported that OCT4 has important roles in the maintenance of 
pluripotency of mESCs (Nichols et al., 1998).  When OCT4 expression level goes 
beyond ± 50% of the ESC level by genetic interference, mESCs lose the pluripotency 
in the self-renewal culture condition and became trophoblast and primitive endoderm 
cells, respectively (Niwa et al., 2000).  Similar finding has been reported in hESCs as 
well that specific knockdown of OCT4 resulted in extra-embryonic endoderm 
differentiation (Hay et al., 2004).  Sustained OCT4 expression may also play a role in 
the induction of neural differentiation from hESCs. It was demonstrated that the 
sustained expression of OCT4 in mESCs during their neural differentiation leads to 
efficient neuroectoderm formation and subsequent neuronal differentiation (Shimozaki 
et al., 2003).  As shown in this study, OCT4 was still expressed in the SSEA4+/TRA-1-
81- cells. This gradual reduction of OCT4 may be critical for neural progression of 
hESCs (Akamatsu et al., 2009).  It is interesting to further explore the roles of OCT4 in 
the regulation of neural differentiation of hESCs since it has been reported that OCT4 
interacts with unique repression complexes to modulate transcription programmes 
necessary for determining mESC fate (Liang et al., 2008).  
 
In this study, in vitro differentiation, to a certain extent, recapitulates the in vivo 
development. The formation of primitive ectoderm appears to be an obligatory process 
in the differentiation of hESCs.  This is consistent with the finding in mESCs which also 
show an intermediate cell status as primitive ectoderm-like cells (Rathjen et al., 1999).  
It is important to note that the current differentiation condition may provide a suitable 
system mimicking in vivo environmental cues for early pluripotent cell development.  
The generation of SSEA4+/TRA-1-81- cells here is the first line of evidence showing 
that hESC differentiate toward primitive ectoderm stage prior to the progression of 
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tissue-specific lineages. If SSEA4+/TRA-1-81- cells can be further manipulated and 
studied, they will allow more precise system to model process of early human 
embryogenesis, in particular the processes of pluripotent cell development and the 
subsequent events of gastrulation. Characterization of SSEA4+/TRA-1-81- cells 
supports the hESC-primitive ectoderm transition as a model for the ICM to the primitive 
ectoderm development in vivo.  The ability to generate a homogeneous population in 
culture may also provide a starting point for the development of procedures for directed 
cell differentiation and production of cell populations with therapeutic applications from 
pluripotent cells.   
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Chapter 4: Characterization of neural progenitor and 
progenitor/stem cells derived from hESCs 
 
4.1. Introduction   
Neural stem cells are defined by their ability to clonally give rise to the three major CNS 
lineages; neurons, astrocytes and oligodendrocytes.  In the developing CNS, distinct 
neural stem cells with different temporal identities are generated depending on the 
developmental stages.  The earliest are neural stem cells have the potential to 
generate early-born neurons; the latest are neural stem cells with gliogenic potential 
that cannot generate early-born neurons (Temple, 2001).  The current knowledge of 
mechanisms involved in neural stem cell formation as well as its cell fate determination 
is obtained mostly from studying neurogenesis in developing embryos of animal 
models.  Although undoubtedly similar in many aspects between human development 
and other species, critical differences are clearly present.  hESCs may play major roles 
in confirming the biological principles learned from studies of other animals and 
identifying novel rules governing the development of human primates.  They are 
relatively easy to access in large number, which will facilitate the study (Gerrard et al., 
2005; Schwartz et al., 2008; Ying et al., 2003).   By analyzing hESCs at different stages 
during their in vitro neural differentiation, we may have a better understanding of 
human neurogenesis in vivo since neural differentiation of mESCs have been 
demonstrated a good in vitro model for studying murine neural development (Okada et 
al., 2008).  
 
The neural differentiation of hESCs can be induced and enhanced under several in 
vitro conditions, and this can be achieved by adding growth factors, growth factor 
antagonists and morphogens (Carpenter et al., 2001; Trounson, 2006).  Similar to 
mESCs, during neural differentiation, hESCs undergo morphogenetic events mimicking 
the step identified during embryogenesis for neural specification; however, to date, the 
mechanisms regulating these temporal characteristics of neural progenitor/stem cells 
derived from hESCs have not been addressed. It is well known that Notch signaling 
has a role in deciding cell fates during development (Artivanis-Tsakonas et al., 1999). 
With regard to neurodevelopment, Notch signaling also has an important role in the 
maintenance of neural stem cell features (Yoon and Gaiano, 2005).  Notch signaling is 
dependent on cell-cell interaction. Binding of the Notch receptor to a ligand of the 
Delta/Serrate/Lag2 (DSL) family on an adjacent cell triggers a series of proteolytic 
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cleavages.  As a result, the Notch intracellular domain is released and enters the 
nucleus where it associates with the DNA-binding protein, C-promoter binding factor 
(CBF1), to assemble a transcriptional complex that activates downstream targets 
(Kopan & Ilagan, 2009).  It has been reported that the differential Notch signaling can 
distinguish neural stem cells from neural progenitor cells and may have a role in cell 
development (Mizutani et al., 2007).  Thus, the objective of this study is to investigate 
the temporal changes; differentiation potential and gene expression, and the 
implication of Notch signaling during neural differentiation of hESCs. This study may 
provide the useful information of mechanisms underlying the human CNS development 
and, ultimately, the pathogenesis of neurological disorders. 
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Results  
 
4.2. hESC-derived neural progenitor cells can be maintained in 
prolonged culture 
4.2.1. Morphological changes during the differentiation process 
Different factors or signaling molecules have been used to differentiate hESCs into 
neural lineage (Dhara et al., 2008).  We have differentiated hESCs efficiently into 
neural lineage cells by blocking BMP signaling pathway with its antagonist noggin at 
the initial stage of the differentiation (see materials and methods; Gerrard et al 2005).  
The sequence of neural differentiation process in our system could be divided into 5 
stages as illustrated in Figure 4.1 A.  After several days in differentiation, majority of 
hESCs lost their specific cell surface antigen TRA-1-81 but sustained expression of 
SSEA4.  We named the cells at this stage as N1 neural initiation stage cells (see 
chapter 3 for details, Figure 4.1 C).  The cells then patterned to form neural tube-like 
structures (day 15; Figure 4.1 D), in which cell morphology is similar to that of 
neuroepithelium.  It is noted that the timing of neural initiation from hESCs was similar 
to that of early neurodevelopment in vivo.  During this initiation stage, BMP antagonist, 
noggin is required to block extraembryonic endoderm differentiation. After 
neuroepithelium formation, noggin was replaced by FGF2 and EGF in the N2B27 
neural differentiation medium and the cells showed typical bipolar neural progenitor 
morphology (Figure 4.1 E) in the first three months, and were defined as N2 stage 
neural progenitor cells (NPCs).  The morphology of these cells started to change with 
continuous culture in these condition from bipolar to triangle shape and after 15 weeks 
of differentiation (about passage 15 (p15)), almost all cells exhibited triangle cell shape 
(Figure 4.1 F) and named N3 stage cells.  From then, cell morphology stayed similar 
without significant change.  
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Figure 4.1: Morphological changes during neural lineage differentiation of 
hESCs. (A): Schematic representation of neural differentiation procedure and different 
stages of cells.  (B-F): Phase contrast images showed morphology of neural 
derivatives of hESCs at various stages. (B) hESC colonies; (C) day 9 after 
differentiation (N1); (D) neural tube-like structure formation around 2 weeks of 
differentiation; (E) Bipolar N2 stage neural progenitor cells; (F) N3 stage cells.  Scale 
bar represents to 50 μm for all images. 
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4.2.2. Differentiation potential of hESC-neural derivatives of various 
stages  
Neural progenitor/stem cells are self-renewing and multipotent cells that can 
differentiate into neurons, oligodendrocytes and astrocytes (Kalyani et al., 1997). 
However, their fate determination is generally regulated spatially and temporally.  For 
example, neural progenitor cells during early embryogenesis generate neurons but not 
glial cells, whereas later and adult neural progenitor/stem cells generate both neurons 
and glial cells. These late neural progenitor/stem cell, however, do not normally 
produce early-born neurons, such as forebrain cholinergic and midbrain dopaminergic 
neurons (Temple, 2001).  
 
In our neural differentiation system, it has been demonstrated that the cells during 
initial neural differentiation (N1 stage) are still capable of differentiation into cells of 
three germ layers (see Chapter 3).   Due to the heterogeneity and difficulty of isolation, 
I did not carry on experiments at neural rosette stage and this chapter focused on N2 
and N3 cell stages.  To further understand the differentiation potential of both N2 and 
N3 cells, I further differentiated these cells by simply withdrawing growth factors FGF2 
and EGF from the culture media 7 days and stained them with various antibodies.  It is 
noted that, upon growth factor withdrawal, the proliferative capacity of N2 and N3 cells 
was significantly reduced; from 60.4% ± 2.2% to 13.6% ± 0.7% and 69.8% ± 2.4% to 
32.1% ± 1.8%, respectively (Figure 4.2 A).  This implied that FGF2/EGF are required 
for the maintenance of proliferation and inhibition of differentiation for both N2 and N3 
cells. However, there was a differentiation discrepancy between them. The results 
showed that cells at N2 stage (represented by passage9) exclusively generated Tuj1-
positive neurons while N3 cells (passage 22) preferred to produce GFAP-positive glia 
(Figure 4.2 B). The results indicated that there was the transition from a predominantly 
neuronal nature to one which increased gliogenic potential. To confirm that cell fate 
preference of these cells is not an effect of early application of noggin, I also applied 
another approach to replace growth factors with fetal bovine serum (FBS, see materials 
and methods) and quantitatively analyzed the outcome from cells of three different 
passages. The results showed that by simply withdrawing FGF2 and EGF from culture 
media for 7 days, N3 stage cells showed 9.21% ± 1.64% cells of Tuj1-positive neurons 
and 47.36% ± 2.32% cells of GFAP-positive astrocytes (Figure 4.2 C). However, there 
were a number of cells that did not express either neuron or glial markers. This might 
due to remaining of uncommitted cells as a small proportion of cells were still BrdU 
positive (Figure 4.2 A). The high proportion of glia cells generated by long-term N3 
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cells was in contrast to the absence of GFAP-positive cells in an early derived N2 cells 
(passage 5); only 31.75% Tuj1-positive neurons were generated.  However, when 1% 
FBS added into medium, the number of neurons, generated from N3 cells passage 22, 
was reduced to 7.19% ± 0.62% while glia cells were maintained at 41.92% ±1.46% 
(Figure 4.2 C).  Although the addition of FBS to N2 passage 5 cells increased the 
generation of GFAP-positive astrocytes (0.93%) and reduced the proportion of Tuj1-
positive neurons (15.80%), it did not change the overall outcome that the cell fate 
preference has been shifted from neuronal competence to glial competence with time 
in the neural culture. The data were obtained from three independent differentiation 
experiments. The reason for FBS increasing gliogenesis in the early passage cells 
could be resulted from higher  levels of BMPs in the serum (D‟Alessandro et al., 1994).  
 
These discrepancies of differentiation observed in vitro are reminiscent of in vivo 
neurodevelopment, in which neurogenesis occurs before the onset of gliogenesis 
(Temple, 2001). Perhaps developmental changes in neural stem cells are 
accomplished by environmental input and intrinsic timing mechanisms. Since neural 
stem cells are defined as multipotent, therefore, we named the stage N2 as neural 
progenitor cells (NPCs) and N3 as neural progenitor/stem cells (NPSCs). 
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Figure 4.2: Differentiation of neural derivatives from hESCs at different passages. 
(A): BrdU proliferation assay. Immunocytochemistry against BrdU labeled proliferating 
cells in both N2 and N3 cells. Histograms showed percentage of BrdU-positive cells 
under with/without the supplement of growth factors. (B-C): Immunocytochemistry with 
indicated antibodies showed differentiated Tuj1-positive neuron or GFAP-positive glial 
cells at N2 (passage 9) and N3 (passage 22) stages. Scale bar represents 30 μm for all 
images. (C): Histograms showing numbers of neuron/glial cells at different passages 
numbers, representing cells at distinct stages. Three independent samples were 
counted with standard deviation bars. 
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4.2.3. Gene expression of hESCs and their neural derivatives at various 
stages  
To begin the investigation of gene expression, I carried out qRT-PCR analysis of key 
neural stem cell genes and signaling molecules in hESCs and cells of N1-N3 stages of 
the neural differentiation. The data showed that after the neural differentiation 
commenced, all the pluripotent markers, OCT4 and nanog, were dramatically 
downregulated (Figure 4.3 A) while neural lineage genes started to express at neural 
initiation stage (Figure 4.3 B).  However, there was variation of the expression levels 
among these neural derivatives.  The key neural markers, PAX6, SOX1 and Musashi1, 
were not expressed in hESCs but were upregulated after differentiation and peaked at 
N2 stage of the differentiation, then reduced their expression when cells were in the N3 
stage, whereas, the proneural gene Mash1 showed continuous increase in the 
expression after differentiation (Figure 4.13 B).  Nuclear factor (NF) I genes, a member 
of CCAAT box element-binding transcription factors (Gronostajski, 2000) and playing a 
role in gliogenesis, were upregulated after the differentiation began (Figure 4.3 C), but 
slightly down at N2 cell stage prior to a dramatic increase when cells became N3 cells.  
In addition, some other neuronal/glial markers were found to be differentially expressed 
(Figure 4.3 D).  For example, MAP2, Olig2 and DCX were markedly upregulated in the 
N2 stage NPCs, while glial marker, GFAP, was highly expressed in the N3 stage of 
NPSCs.  These results support the phenotypes observed in the previous section 
(section 4.2.2).  Furthermore, in collaboration with scientists at the Yale University, 
USA, we have carried out genome-wide analysis of gene expression profile in these 
cells by next generation deep sequencing technology (Wu et al., 2010).  The qRT-PCR 
results here corresponded well with the genome wide data.  
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Figure 4.3: mRNA expression of hESCs and their neural derivatives at various 
stages.   Histograms showing relative expression levels of indicated genes by qRT-
PCR.  The expression levels were calculated from three independent experiments with 
the standard deviation bars.  Abbreviations: ES, undifferentiated hESCs; N1-N3, three 
stages of neural differentiation (see section 4.2.1). 
 
 
To further validate gene expression in these cells and better understand their 
properties, I performed immunocytochemistry because this technique could detail not 
only cell morphology, but also protein localization.  Since N1 stage cells have been 
described in Chapter 3, here will focus on N2 and N3 stages.  A group of transcription 
factors and filament proteins (Garcia et al., 2004; Lendahl et al., 1990; Suh et al., 2007) 
were chosen for the experiments.  The result showed a certain similarity of gene 
expression pattern between N2 and N3 cells as they both exhibited robust staining for 
neural progenitor cell markers, SOX1, SOX2, PAX6 and nestin (Figure 4.4/4.5 A-D), 
and some astroglial markers, S100β and 3CB2 (Figure 4.4/4.5 G & H).  However, only 
N2 cells could be detected the expression of PSA-NCAM, a nature of an intermediate 
neural progenitor cell (Figure 4.4 E).  This set of markers is considered diagnostic for 
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neurogenic radial glial, precursors of both neurons and astrocytes during development 
of the embryonic nervous system (Merkle and Alvarez-Buylla, 2006).  On the other 
hand, the additional astroglial markers, including vimentin and GFAP, were expressed 
in N3 cells (Figure 4.5 E & F).  The low expression level of GFAP at this stage of cells 
highlighted the similarity between them and adult neural stem cells (Doetsch et al., 
1999).  This result suggested the comparable properties of hESC-NPSCs cells with 
endogenous adult neural stem cells.   
 
 
 
 
 
Figure 4.4: Gene expression of N2 stage hESC-NPCs by immunocytochemistry.  
(A-D): Immunocytochemistry against the key transcription factors of neural stem cells 
as indicated.  Co-staining with DAPI represented nuclear localization of those markers.   
(E-F): Immunocytochemistry for intermediate filament proteins as indicated. Scale bar 
represented 50 µm for all images. 
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Figure 4.5: Gene expression of N3 stage hESC-NPSCs by immunocytochemistry.  
(A-D): Immunocytochemistry against the key transcription factors of neural stem cells 
as indicated.  Co-staining with DAPI represented nuclear localization of those markers.   
(E-F): Immunocytochemistry for intermediate filament proteins as indicated. Scale bar 
represented 50 µm for all images. 
 
 
From the immunocytochemistry results, it was observed that neural stem cell markers 
were expressed in every single cell in the populations.  It was possible that cells may 
contain distinct sub-populations which differently expressed these genes. Flow 
cytometry would provide good tool for detecting not only proportion of cell population 
expressing particular gene, but also the expression levels.  It was found that the high 
proportion cells expressed SOX1 and Musashi1 in both cell stages, over 80% and 90% 
respectively (Figure 4.6 A & B).  In addition, the fluorescence intensity, representing the 
level of gene expression, displayed no significant difference between them (Figure 4.6 
A&B) although their mRNA levels showed some differences by qRT-PCR.  In addition 
to neural progenitor markers, neural cell adhesion molecule (NCAM) was also analyzed 
here. It is known that NCAM is widely expressed in the brain and has been implicated 
in a variety of process, including promoting neurogenesis (Boutin et al., 2009).  Flow 
cytometry result showed that NCAM was restricted to a small population (~20%) for 
both hESC-NPCs and hESC-NPSCs (Figure 4.6 A & B).  It was possible that these 
NCAM positive cells may represent proliferating cells at the time of investigation 
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(Boutin et al., 2009).  A major population of these two cell types was also positive for 
SSEA-1 which marked differentiated hESCs.  
 
Among the neural stem cell genes, CD133 (Prominin-1) has been used as a marker for 
both embryonic and adult neural stem cells (Uchida et al., 2000).  CD133 is a five-
transmembrane protein that was originally identified in mouse neuroepithelial stem 
cells (Weigmann et al., 1997) and was found expressed in several types of stem cells. 
Therefore, it has been widely used as a marker for stem cells (Uchida et al., 2000).  
Western blot showed that CD133 was highly expressed in hESCs and downregulated 
after the differentiation started.  Interestingly, CD133 was reactivated when hESC-
NPCs switched to hESC-NPSCs stage (Figure 4.6 C). This result supported our 
hypothesis that N2 stage cells are mainly neural progenitor cells and N3 stage are 
mainly neural stem cells.  However, the role of CD133 in neural stem cells and brain 
development is not clear and, therefore, its function could be approached by using 
hESC-NPSCs.  This gene expression profile suggested that the discrepancies of neural 
stem cell and lineage genes may be playing a part for cell differentiation which was 
examined later.  
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Figure 4.6: Flow cytometry and Western blot analyzed protein expression of 
neural stem cell markers.  (A, B): Flow cytometry analysis was performed for 
indicated genes. (A): hESC-NPCs and (B): hESC-NPSCs. (C): Western blot showed 
the expression of CD133 at various stages of cells. 
 
 
Taken together, it was clear to state that temporal characteristics have appeared during 
neural differentiation of hESCs and was reminiscent in vivo neurodevelopment at 
certain degree. This emphasized the potential benefits of using hESCs to study 
embryogenesis which could provide information at molecular level. 
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4.3. Clonally derived neural progenitor/stem cells of hESCs are 
multipotent  
Two important properties of a neural stem cell are its ability to produce itself (self-
renewal) and three types of neural progeny, neurons, astrocytes and oligodendrocytes 
(multipotency).  Although our NPSCs derived from hESCs were able to differentiate to 
neurons and glia, one could argue the results as a consequence of a heterogeneous 
population containing both neuronal and glial progenitors. To further validate the neural 
progenitor/stem cell identity of those cells, it is critical to carry out clonal analysis 
because it is a stringent paradigm for testing multipotency at single cell level.  
 
NPSCs derived from hESCs H1 and H7 were split and plated at single cell density in 
96 well plates (see materials and methods, Figure 4.7 A).  In the presence of FGF2 and 
EGF, about 3.1% of H1 origin and 5.2% of H7 origin cells grew and formed colonies in 
approximately a month time (Figure 4.7 B & C).  5 Clones of H7 and 3 clones of H1 
NPSCs were further expanded to become clonal lines. (Figure 4.7 D) Cells of the clonal 
lines showed similar morphology and gene expression pattern to the parental NPSC 
population (data not shown) and were able to form neurospheres when plated into non-
adherent culture dish (Figure 4.7 E), indicating their self-renewal capacity.  To examine 
differentiation potency of these cells, the clonally derived cells were subjected into 
further differentiation procedures by the similar methods in 4.2.2.  After 3 weeks 
differentiation, the cells exhibited more matured neural cell morphology (Figure 4.7 F) 
and contained both GFAP positive (astrocyte marker, Figure 4.7 G) and Tuj1 positive 
(neuron marker, Figure 4.7 H), indicating that the hESC-NPSCs are able to generate 
both neurons and astrocytes.  
 
 97 
 
 
Figure 4.7: Clonally isolated hESC-NPSCs can produce both neurons and glia. 
(A-D): Phase contrast images showed clonal analysis.  (A): A single cell dilution, 
arrowed, was seeded to a 96-well plate. (B): Cells were expanded as a small clump, 
arrowed, and (C): enlarged as colony.  (D): Morphology of clonally derived neural 
progenitor cells which can form neurospheres (E). (F): Differentiated cell morphology 
after the withdrawal of growth factors.  (G-I): Immunocytochemistry of differentiated 
cells for (G): glial marker, GFAP and (H): neuron marker, Tuj1. (I): Colocalization of 
those markers with dapi shown distinct expression. Scale bars represented 50 μm for 
all images. 
 
 
However, No O4 (oligodendrocyte marker) expression could be detected in these 
differentiating conditions. Although there were no O4-positive oligodendrocytes 
observed under differentiating conditions, it was believed that the NPSCs could 
differentiate to oligodendrocytes because they expressed Olig2 (Figure 4.8 C).  Olig 
was reported to function as an inducer for oligodendrocyte differentiation from neural 
progenitor cells (Zhou & Anderson, 2002).  Although several protocols have been 
developed for the production of oligodendrocytes from hESCs (Okamura et al., 2007; 
Zhang et a, 2006), none of them are efficient enough to yield high number of 
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oligodendrocytes.  However, previous studies have shown that tissue- and ESC-
derived oligodendrocyte progenitors can be efficiently proliferated in the presence of 
FGF2 and PDGF (Bogler et al., 1990; Brustle et al., 1999).  Furthermore, T3 and 
ascorbic acid are known to promote the differentiation and survival of oligodendrocytes 
(Glaser et al., 2005).  Combine this knowledge, the protocol for oligodendrocyte 
differentiation has been improved by several groups.  To generate oligodendrocytes in 
this study, the inducing condition was modified from the previous report (Glaser et al., 
2007) and applied to our clonal NPSCs (see materials and methods).  The 
immunocytochemistry showed that although O4-positive cells were still not detected in 
this experimental condition but a substantial number of differentiated cells displayed 
A2B5-positive oligodendrocyte progenitor cells (Figure 4.8 E).  These A2B5-positive 
oligodendrocyte progenitor cells were similar to those present in adult human white 
matter (Scolding et al., 1999).  It was consistent with the others shown that mature 
oligodendrocytes are rarely generated from the differentiation of hESCs as well as from 
neurosphere cultures derived from human fetal CNS tissues (Zhang et al., 2000) and 
took a very long time of differentiation. Nevertheless, it was promising that A2B5-
positive oligodendrocyte progenitor cells could be differentiated from the NPSCs and 
when optimal conditions are applied, cells should be able to generate O4-positive 
mature oligodendrocytes. 
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Figure 4.8: hESC-NPSCs are potent to differentiate toward oligodendrocyte 
progenitors. (A): A schematic picture showed a protocol to differentiate 
oligodendrocyte progenitor cells. (B): A phase contrast image of hESC-NPSCs before 
being induced toward oligodendrocyte lineage. (C): Immunocytochemistry showed 
Olig2 expression of undifferentiated hESC-NPSCs.  (D): A phase contrast image of 
cells after being induced which showed immunoreactive to A2B5 antibody (E).  Scale 
bar represented 50 μm for all images. 
 
 
In addition to neuron/glial differentiation, hESC-NPSCs were examined for their 
differentiation ability toward dopaminergic neurons. This would describe whether 
clonally-derived NPSCs were responsive to distinct environmental clues.  Previous 
studies showed that fibroblast growth factor 8 (FGF8), a morphogen involved in the 
patterning of isthmus, and sonic hedgehog (SHH), a ventralizing molecule, can specify 
a dopaminergic fate from explanted neuroepithelial cells (Ye et al., 1998). The same 
principle was applied to in vitro dopaminergic neuron differentiation from hESC-NPSCs.  
When subjecting the clonal hESC-NPSCs into such differentiation regime (see 
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materials and methods), they showed 8.63% ± 1.28% MAP2-positive neurons which 
contained 79.54% ± 2.14% TH-positive dopaminergic neurons, i.e. 6.85% TH-positive 
dopaminergic neurons of total population (Figure 4.9 B-D). However, it has not yet 
confirmed that TH-positive neurons generated in this experiment were midbrain-origin 
which are promisingly required for the treatment of Parkinson‟ disease.  Genetic 
markers of the midbrain, for example Pitx3 and Lmx1a, will be needed to incorporate in 
order to confirm specific regional cell identity.  These results indicated that hESC-
NPSCs are still responsive to specified environmental cues as here they have the 
potential to terminal differentiate into dopaminergic neurons.  It is believed that hESC-
NPSCs would be able to generate other types of neurons if optimal culture conditions 
for a particular neuronal subtype are provided. 
 
 
 
 
Figure 4.9: hESC-NPSCs are responsive to dopaminergic-inducing signals. (A): 
Schematic diagram shows inducing condition to generate dopaminergic neurons.  (B-
D): Immunocytochemistry images of dopaminergic-neuron marker. (B): 
Immunocytochemistry image for neuron marker, MAP2.  (C): Immunocytochemistry 
image for dopaminergic neuron marker, tyrosine hydroxylase (TH).  (D): Merge both 
markers with dapi. Scale bar represented 50 μm for all images. 
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Taken together, it was noted that NPSCs derived from hESCs were multipotent neural 
stem cells and capable of clonogenicity as well as responding to environmental cues to 
differentiate into multiple types of neurons and astrocytes. 
 
 
4.4. Differential CBF1 responsiveness distinguishes neural stem cells 
from progenitor cells 
Notch signaling is well known to regulate neural lineage initiation, neural stem cell 
maintenance and cell fate determination (Baladron et al., 2005).  The activation of the 
canonical Notch signalling pathway through C-promoter binding factor 1 (CBF1) plays a 
critical role in the signaling transduction (Iso et al., 2003).  Recently, it has been 
demonstrated that differential response to CBF1 is an important feature to distinguish 
neural progenitor cells and neural stem cells, which is independent of activation of 
Notch receptors (Mizutani et al., 2007). To further elucidate the differences between N2 
and N3 stage of neural derivatives from hESCs, I studied CBF1-responsiveness in 
these cells.  CBF1-responsiveness was demonstrated by transient transfection of 
CBF1-responsive reporter plasmids in which the reporter genes, GFP and luciferase, 
are driven by promoter containing 4 CBF1 responsive elements (see materials and 
methods).  The result showed that most of N3 NPSCs (~70%) expressed CBF1-GFP 
while only small population (~20%) of the N2 cells did (Figure 4.10 A-C).  Furthermore, 
luciferase assay displayed a similar pattern that N3 NPSCs exhibited 3 times higher 
CBF1-luciferase activity than did N2 NPCs (Figure 4.10 D).  These results 
demonstrated that N2 stage NPCs do not respond to CBF1 whereas N3 stage NPSCs 
respond to it well.  This further supported our previous data that N2 stage cells are 
mainly neural progenitor cells with predominant neurogenicity, while N3 stage cells are 
neural stem cells with highly gliogenic potential.  The CBF1-responsiveness seemed to 
correspond to cell intrinsic programs, including neuron/glial transition. 
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Figure 4.10: Different CBF1 responses between hESC-NPCs and hESC-NPSCs. 
(A-C): Cells were measured their CBF-1 responsive by transient transfection of GFP-
reporter plasmid.  (A & B): Phase contrast and fluorescence images of hESC-NPCs 
and hESC-NPSCs, respectively. Scale bar represented 50 μm for al images.  (C): 
Histogram showed percentage of CBF-1 responsive cells.  (D): Histogram presented 
luciferase activity controlled by CBF-1. Three independent experiments were 
performed with a standard deviation bar and * represented p<0.005 (student t-test).   
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4.5. Discussion  
In early development, some neural precursors transit from nestin-positive single layer 
neuroepithelial cells to S100β-positive radial glial cells and eventually give rise to 
GFAP-positive adult neural stem cells (Gotz & Barde, 2005).  Studies have reported 
the generation of mouse ESC-derived precursor cells with radial glial properties (Bibel 
et al., 2004) that can be propagated in the presence of FGF2/EGF (Conti et al., 2005).  
In our study, neural differentiation of hESCs is a dynamic and multistage process. 
Neural progenitor/stem cells derived from hESCs can be propagated in the presence of 
FGF2 and/or EGF, liberated from any requirement for a specific cellular niche. Cells 
show multiple distinct characteristics; 1) stability in a long term culture, 2) ability to 
produce neurons and glia and 3) expression of neural stem cell markers, indicating the 
long-term maintenance of pure neural stem cell population in our culture system. 
Importantly, hESC-NPSCs partially retain the capacity to respond to patterning cues. 
This emphasizes the potential use for regenerative medicine. These finding establishes 
that hESC-NPSCs represent a generic phenotypes of neural stem cells (Sun et al., 
2008; Weigmann et al., 1997).  
 
Noteworthy, this system enables the sequential generation of neural progenitor cells 
with early and late temporal identities similar to the neural development in vivo, and it 
recapitulates the temporal transition of the neurogenic feature in the early neural 
progenitor cells to the gliogenic in the late neural progenitor/stem cells.  hESC-NPCs 
were relatively close to radial glial cells because they express markers of radial glial, 
and mainly generate mature neurons (Bibel et al., 2004).  However, these early hESC-
NPCs could not be maintained in vitro as they gradually convert into a later-stage 
hESC-NPSCs which generate both neurons and astrocytes. Therefore, neural 
differentiation of hESCs provides a useful model to investigate signalling pathways and 
factors that are important in regulating neural development and neural cell fate. 
 
The gradual transition from the neurogenic neural progenitor cells to the gliogenic 
neural progenitor/stem cells could be influenced by many mechanisms, both extrinsic 
and intrinsic, including culture conditions, transcription factors and epigenetic 
regulators.  Currently, the most common used culture systems for NPSCs, including 
the one in this study, use FGF2 and EGF as supplements.  The FGF2/EGF may 
selectively amplify the cells responding to them and these responding cells are more 
gliogenic.  The supplements of SHH and Notch receptor agonists may be able to 
maintain cell identity as neuronal progenitor cells in longer passages (Elkabetz et al., 
2008).  It is known that transcription factors, such as PAX6 and SOX1, are essential for 
 104 
controlling fate of neural progenitor/stem cells; increasing PAX6 expression levels 
drives cells toward neuronal differentiation (Samson et al., 2009) and knock-out SOX1 
causes deficiency in neuron production (Kan et al., 2007).  The high expression of 
these genes at hESC-NPC stage is likely to impart cell identity, including maintaining 
progenitor pool and preserving neuronal differentiation.  On the other hand, nuclear 
factor I (NFI) is both necessary and sufficient to promote glial fate specification in vivo 
(Deneen et al., 2006) because GFAP expression is directly regulated by the binding of 
NFI A/B to its promoter (Cebolla & Vallejo, 2006). The high expression of NFI genes 
may cause the pro-gliogenicity of hES-NPSCs cells by means of GFAP promoter 
demethylation (Fan et al., 2005).  NFI can also inhibit neurogenesis, since it can bind to 
and repress transcription of at least one neuron-specific gene (Adams et al., 1995). 
The modulation of NFI gene expression; low to high manner, during neural 
differentiation of hESCs may play roles for the appropriate timing and level of 
astrocytogenesis.  The regulatory network of these neurogenic- and gliogenic factors 
must be tightly controlled in order to determine the timing and number of desired cell 
types. 
 
Notch is important to regulate neural stem cell properties (Taylor et al., 2007). It inhibits 
neurogenesis (Gaiano & Fishell, 2002) and instructively promotes gliogenesis 
(Morrison et al., 2000).  The differential use of Notch signaling, in particular with 
respect to CBF1 activation, is a mechanism used to distinguish the state of cells; neural 
progenitor or stem cells (Mitzutani et al., 2007). In this study, CBF1-responsiveness of 
hESC-NPSCs cells was significantly higher than that of hESC-NPCs cells, supporting 
their neural stem cell features.  Moreover, this result implies that the use or blockade of 
canonical Notch-CBF1 cascade may direct expression of different target genes 
(Martinez Arias et al., 2002) which determine the neural/glial potency.  As NFI genes 
have been identified as a direct targets of canonical Notch pathway (Namihira et al., 
2009); the high CBF1 responsiveness of hESC-NPSCs cells may impact, directly or 
indirectly, NFI expression.  However, the exact mechanism for this is needed to be 
further explored. 
 
Since the molecular mechanisms underlying human neurodevelopment remain largely 
elusive due to the difficulties in obtaining human brain samples, the identification of 
temporal changes here, combined with our previous transcriptome data (Wu et al., 
2010), will enhance our understanding for various aspects of neurodevelopment of 
human system, such as the acquisition of neurogenic potential and the transition of 
gliogenic preference.   This study has illustrated the candidate factors/molecules 
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playing a role for this differentiation transition. The interaction of intrinsic factors, such 
as PAX6 and SOX1, with extrinsic signals like Notch, may integrate their functional 
roles in order to control neural progenitor/stem cell identities (Genethliou et al., 2009).  
In addition, with this differentiation system, we have mapped the genome-wide gene 
expression profile at various stages of neural differentiation from hESCs (Wu et al., 
2010), which will provide more information for further studies. For example, the study 
has identified sets of factors which are differentially expressed in the cells of N2 and N3 
stages, including FGF11/13/14.  The functions of these factors are still largely 
unknown.  Further studies could involve the application of a variety of undefined-
function factors found from our genome-wide study, including non-FGF receptor 
binding FGF11/13/14, to the culture system for investigating their roles in neural 
differentiation. This will ultimately extend our understanding of human neural 
development.  
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Chapter 5: DLK-1 modulates neuronal differentiation through 
multiple pathways 
 
5.1. Introduction 
Delta like1 homolog (DLK-1), also called Pref-1 or FA1, was initially identified and 
further characterized in pre-adipocyte cell lines (Smas et al., 1993). It is a 
transmembrane protein containing 6 EGF-like repeats in the extracellular domain which 
is highly conserved in human and rodent (Jensen et al., 1994), a single transmembrane 
domain, and a short cytoplasmic tail (Laborda, 2000). It is a member of the epidermal 
growth factor (EGF)-like family with homologies to Delta, a family of Notch ligands.  
DLK-1 protein is either membrane-associated or released into the extracellular space 
after cleavage, and appears to participate in extracellular protein-protein interactions 
(Laborda, 2000). However, unlike other delta-family members, DLK-1 lacks the so-
called DSL motif (Delta, Serrate and Lag2, conserved in all Notch ligands) at the DLK-1 
N-terminus, which is the functional binding domain crucial for the interaction between 
Notch receptors and their ligands, suggesting that DLK-1 may exert its activity 
independent of the Notch receptors.  
 
DLK-1 is present in animals from birds to mammals and is an imprinted gene (Schmidt 
et al., 2000).  It is expressed in a variety of murine and human fetal tissues, but is 
present only in a limited number of adult tissues (Floridon et al., 2000). DLK-1 
participates in several differentiation processes including adipogenesis (Garces et al., 
1999), hematopoiesis (Kaneta et al., 2000), and adrenal gland development (Whitworth 
& Vinson, 2000); it is also involved in embryonic growth development (Moon et al., 
2002).  Soluble DLK-1 was found to efficiently block differentiation of pre-adipocytes 
(Smas et al., 1997) and an  induction of pre-adipopcytes and hepatocytes is associated 
with DLK-1 downregulation (Tanimizu et al., 2003). So far, limited reports have 
revealed a consistent molecular mechanism underlying DLK-1 functions. It proposed 
that DLK-1 acts as a negative regulator of Notch1 signaling during several 
differentiation processes regulated by Notch1 activity, including hematopoiesis and 
adipogenesis (Baladron et al., 2005). In addition, DLK-1 directly activates the 
MEK/ERK pathway and that ERK phosphorylation is responsible for the inhibition of 
adipogenesis (Kim et al., 2007).  This suggests that DLK-1 may affect cell 
proliferation/differentiation through interactions with multiple signaling pathways. 
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To date, there are only limited reports regarding DLK-1 functions in the central nervous 
system.  DLK-1 is highly expressed in neuroblastoma and has been suggested to play 
an important role in tumorigenesis of this cell type (Laborda, 2000). Neuroblastoma cell 
lines treated with agents that induced differentiation towards the non-neural chromaffin 
lineage, a derivative of neural crest cells, increased their expression of DLK-1, while 
compounds that induced differentiation towards the neural phenotype decreased DLK-
1 level (Laborda, 2000).  DLK-1 is found to be expressed in early embryonic rodent 
dopaminergic neurons (Jensen et al., 2001).  In the adult rodent and human CNS, 
DLK-1 expression is found in mature dopaminergic neurons of the substantia nigra and 
ventral tegmental area (Jensen et al., 2001).  It participates in the specification of 
ventral midbrain progenitor derived dopaminergic neurons.  This previous study 
suggests the importance of DLK-1 in certain areas of the developing and adult rat and 
human CNS; however, it has not been reported how DLK-1 functions on 
neurodevelopment. Since neural differentiation of hESCs has provided a good model to 
approach this developmental process, it was fascinating to explore the roles and 
possible mechanisms of DLK-1 in neural progenitor/stem cells derived from hESCs.  
The outcome of this study will enhance our understanding, not only the function of 
DLK-1, but also the regulatory network for neural progenitor/stem cells. 
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Results 
 
5.2. Expression pattern of DLK-1 during neural differentiation 
It was found that DLK-1 was transiently upregulated shortly after the neural 
differentiation began (Figure 5.1).  However, DLK-1 was gradually downregulated in a 
prolonged culture, while other neural lineage markers still maintained their expression 
(see chapter 4).  It seemed that this high expression of DLK-1 was confined to neural 
induction (N1) and the early NPC (N2) stages.  
 
 
Figure 5.1: Relative expression level of DLK-1 at various cell stages.  Three 
independent samples were valued with a standard deviation bars. 
 
 
Thus, I hypothesized that this differential expression of DLK-1 may be associated with 
the biological properties of NPSCs, in particular cell proliferation and differentiation.  
Further functional study of DLK-1 may provide evidence for molecular mechanisms 
underlying neural differentiation process as well as the discrepancy of cells at different 
stages along the process. 
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5.3. Generation of DLK-1 overexpressing hESC-NPSCs.  
To examine whether DLK-1 plays any role in cell fate determination of hESC-NPSCs, I 
stably transfected DLK-1 expressing construct (Figure 5.2 A) into the NPSCs derived 
from hESCs (see materials and methods).  Overexpression of DLK-1 was confirmed by 
qRT-PCR (Figure 5.2 B) as well as immunocytochemistry with DLK-1 antibody (Figure 
5.2 C).  However, DLK-1 overexpression did not alter the expression of neural stem 
cells genes; SOX1, SOX2 and Musashi1 (Figure 5.2 B), as well as a neural progenitor 
cell marker, nestin (Figure 5.2 C).  It was surprising to observe that DLK-1 expression 
was localized within the cytoplasm instead of at cell surfaces (Figure 5.2 C). The 
parental and established DLK-1 overexpressing hESC-NPSCs were examined to 
address whether DLK-1 has any effect on cell proliferation and differentiation. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 110 
 
 
Figure 5.2: Establishment of DLK-1 overexpression of neural progenitor/stem 
cells.  (A): Schematic diagram illustrating the structure of DLK-1 overexpressing 
construct.  (B): qRT-PCR results of relative expression levels of DLK-1 and key neural 
stem cell genes between the parental and transfected cells. Error bars represented 
standard deviation of three independent experiments. (C): Immunocytochemistry 
images of indicated antibodies in the parental and DLK-1 overexpressing cells. Scale 
bar represented 50 μm.  
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5.4. The effects of DLK-1 on cell proliferation 
Bromodeoxyuridine (BrdU) labeling assay was used to quantify the number of 
proliferating cells as BrdU is incorporated into new synthesized DNA, thus marking 
actively dividing cells. In order to eliminate effects from external stimuli, parental and 
DLK-1+ NPSCs were starved by cultured in N2B27 medium only for overnight prior to 
the incubation with BrdU for 2 hours. The cells were then stained using a specific 
antibody against BrdU and counted for the number of BrdU-positive cells (see materials 
and methods).  The result showed no significant difference of the BrdU-positive cells 
between the parental and DLK-1+ NPSCs, 57% ± 3.4% and 60% ± 2.6% respectively 
(Figure 5.3 A).  In addition to BrdU labeling for dividing cells, I also performed cell cycle 
profile analysis.  Propidium Iodide (PI) is an intercalating agent and a fluorescence 
molecule that is commonly used to quantitatively assess DNA content in cells. To 
evaluate cell cycle profile, the parental and DLK-1+ NPSCs were analyzed their DNA 
content by PI staining, followed by flow cytometry analysis (see materials and 
methods).  The cell cycle profile of parental cells displayed their cell cycle profile as 
87.18% of cells in G1-phase, 2.54% of cells in S-phase and 10.28% of cells in G2-
phase (Figure 5.3 B, left). This profile was not significant difference to that of DLK-1+ 
hESC-NPSCs in which showed G1-phase 83.45%, S-phase 2.41% and G2-phase 
14.14% (Figure 5.3 B, right).  These cell cycle profiles were consistent to the BrdU 
proliferation assay, and suggested that DLK-1 did not have an effect on cell 
proliferation or division.   
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Figure 5.3: The effect of DLK-1 overexpression on cell proliferation and division.  
(A): Histograms showed the number of BrdU-positive cells for both the parental and 
DLK-1+ cells.  (B): Cell cycle profiles by PI staining revealed similar cell cycle profile 
between those two cell types. 
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5.5. Effects of DLK-1 overexpression on cell differentiation 
Differentiation potential is a key parameter to define whether cells are neural stem 
cells, and, as previously described, NPSCs derived from hESCs are multipotent, 
regarding the ability to generate both neurons and glial cells.  Although DLK-1 was not 
found to impact on cell proliferation, it was interesting to examine the effect on cell 
differentiation.  In the culture condition supplemented with FGF2 and/or EGF, the 
NPSCs can maintain their proliferative capacity without losing multipotentiality. Post-
mitotic differentiation can be induced by either withdrawal of growth factors or by the 
addition of FBS (see materials and methods).  The parental and DLK-1+ NPSCs were 
further differentiated in those two conditions for 7 days prior to performing quantitative 
immunostaining for neuron and glial markers, Tuj1 and GFAP respectively. Comparing 
the number of glial cells between these two cell populations, there was no significant 
difference in the number of GFAP-positive astrocytes in either differentiating condition 
(Figure 5.4 B). On the other hand, the number of Tuj1-positive neurons showed 
different results. After withdrawing the growth factors, both cell types produced similar 
number of Tuj1-positive neurons, 6.6% ± 1.3% for parental and 7.2% ± 1.2% for DLK-
1+ NPSCs (Figure 5.4 C). However, the addition of 1% FBS caused a dramatic 
reduction of neuron differentiation from the parental cells (<1%), but not in the DLK-1+ 
NPSCs which produced similar percentage neurons as that in the absence of serum 
(7.1% ± 09%, Figure 5.4 C). This result revealed that the FBS inhibits neurogenesis 
from parental hESC-NPSCs but not in the DLK-1+ NPSCs, indicating that DLK-1 
seems able to modulate the factors or signalling pathways that FBS provides to inhibit 
neuron differentiation.  
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Figure 5.4: Neuron/glial differentiation of neural progenitor/stem cells under 
different conditions.   (A): Immunocytochemistry images showed the expression of 
neuron/glial markers in different differentiating conditions.  (B): Histograms of the 
percentage of GFAP-positive glial and (C): the Tuj-1-positive neurons. The 
percentages were calculated from three independent experiments with the standard 
deviation bars, * represented p-value < 0.001 (student t-test). 
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5.6. DLK-1 inhibit BMP signalling 
BMPs have been reported as a well-known anti-neurogenic factor and mediate this 
effect partly through induction of gene expression for Id1, Id3 and HES5 in the 
neuroepithelium cells (Di-Gregorio et al., 2007). The reduced ability of parental NPSCs 
to produce neurons in the presence of FBS could be due to the higher levels of BMPs 
in the serum (D‟Alessandro et al., 1994).  It is possible that the distinct difference 
between the parental and DLK-1+ NPSCs to generate neurons in the presence of 1% 
FBS is a result of different response to BMPs.  
  
To investigate the effect of DLK-1 on BMP signaling pathway, the phosphorylation of 
SMAD1/5/8, a mediator for BMP signalling, was examined by western blotting in the 
two cells (see materials and methods). The result showed that SMAD1/5/8 
phosphorylation of parental cells were fully activated in the low concentration of BMP2 
(e.g. 5ng/ml) and did not increase with more BMP2 added (Figure 5.5 A).  In contrast, 
SMAD 1/5/8 phosphorylation was gradually enhanced in a dose-dependent manner for 
DLK-1+ cells (Figure 5.5 A).  At 5 ng/ml, SMAD 1/5/8 phosphorylation showed no 
significant increase compared to the control sample in the DLK-1+ cells when higher 
concentration of BMP2 was applied. The effect of DLK-1 on attenuation of SMAD 1/5/8 
phosphorylation was also found in a time-dependent manner.  Although the longer 
period of BMP2 incubation the higher level of SMAD1/5/8 phosphorylation it caused in 
both cell types, the DLK-1+ cells showed to be retarded for BMP2 activation (Figure 5.5 
B).  This line of evidence suggests that DLK-1 may alter cell fate differentiation through 
the inhibition of BMP signaling pathway. 
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Figure 5.5: Overexpression of DLK-1 inhibits the effect of BMP2 on SMAD1/5/8 
phosphorylation.  (A): Phosphorylation of SMAD1/5/8 in cells 30 minutes after various 
concentrations of BMP2 added.  (B): Phosphorylation of SMAD1/5/8 in response to 10 
ng/ml of BMP2 at various time points. 
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In order to confirm that the inhibition of BMP signaling by DLK-1 resulted in the 
differential differentiation outcome between parental and DLK-1+ NPSCs in the 
presence of 1% FBS, various concentrations of BMP2 were applied to these cells in 
N2B27 medium for 7 days before the examination of differentiated cell types by 
immunocytochemistry. The immunostaining showed that both cell populations 
contained GFAP-positive cells in all treatment conditions but Tuj1-positive cells were 
less obvious in the parental cells when treated with higher concentration BMP2 (e.g. 10 
& 20ng/ml) (Figure 5.6 A).  After counting the cell numbers, it was found that the 
number of GFAP-positive astrocytes was increased in a BMP2 dose-dependent 
manner in both cell populations and there was no significant difference between the 
parental and DLK-1 cells (Figure 5.6 B).  By contrast, Tuj1-positive cells showed 
significant difference in response to BMP2 between the two cell populations.  When no 
BMP2 or 1ng/ml BMP2 was applied, the two cell populations showed no significant 
difference in percentage neurons produced.  However, at 10ng/ml of BMP2, parental 
hESC-NPSCs could only produce 2.1% ± 0.2% Tuj1-positive neurons, while the DLK-1 
overexpressing cells could generate 7.4% ± 0.3%, a comparable number of neurons as 
those generated by simply withdrawing growth factor condition. Furthermore, parental 
hESC-NPSCs were almost unable to generate Tuj1-positive neurons at 20ng/ml BMP2, 
but DLK-1-positive cells still produced substantial number of Tuj1-positive neurons 
(3.2% ± 0.4%; Figure 5.6 C).  These results suggest that DLK-1 is able to inhibit BMP 
signaling pathway in hESC-NPSCs which leads to the sustaining of neuron production 
in the presence of BMP2.  
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Figure 5.6: Overexpression of DLK-1 sustained neuron production. (A): 
Immunocytochemistry images of differentiated neuron/glial cells produced at various 
BMP2 concentrations. A standard bar represented 50 μm for all images. (B): 
Histograms presented percentage of glial cells and (C): neurons. Three independent 
experiments were conducted with the standard deviation bars and * represented p-
value < 0.001 (student t-test). 
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5.7. DLK-1 attenuates Notch signalling 
Although it showed here that DLK-1 play an important role for neuronal differentiation 
by inhibiting BMP pathway, other signaling, for example Notch, are also critical for 
neuron/glial differentiation of neural stem cells, thus; it was interesting to investigate the 
interaction between them in our system.  It is known that Notch has an instructive role 
in gliogenesis for neural stem cells (Gaiano & Fishell, 2002) and its inhibition promoted 
the neuronal differentiation of hESC-derived neural stem cells (Borghese et al., 2010). 
Since DLK-1 was previously reported as a negative regulator of Notch (Baladron et al., 
2005), it is possible that DLK-1 may modulate neuron/glial differentiation of neural 
progenitor/stem cells through the modulation of Notch signaling.  
 
To test this hypothesis, luciferase reporter assays were performed in parental hESC-
NPSCs (see materials and methods). In these experiments, the luciferase expression 
was controlled by either the HES1 or the CSL promoters, which are the effectors of 
Notch signalling.   The luciferase reporter constructs were co-transfected with either 
DLK-1 expressing plasmid or activated Notch plasmid (NICD plasmid) or both.  It was 
noted that luciferase activity of both reporter systems did not alter when only DLK-1 
was transfected to the cells (Figure 5.7 A & B 1st and 2nd column).  The introduction of 
active form of Notch (NICD) caused dramatic increase of luciferase activity in both 
reporter systems and this increase was markedly suppressed by DLK-1 expression 
(Figure 5.7 A & B 3rd and 4th columns). This evidence, together with the previous report, 
suggested that DLK-1 functions as an inhibitor of Notch signaling in neural 
progenitor/stem cells. 
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Figure 5.7: DLK-1 interferes with the function of active NICD.  (A): HES1 promoter-
luciferase reporter and (B): CSL promoter-luciferase reporter. Three independent 
experiments were performed with a standard deviation bar.  * and ** represented p-
value <0.005 and <0.001, respectively (student t-test).  
 
 
In order to verify the effects of DLK-1, direct target genes of Notch and BMP signaling 
pathways were investigated after transient transfection of DLK-1 expressing plasmid 
(see materials and methods). Compared to the GFP transfected control, DLK-1-
transfected hESC-NPSCs showed significant downregulation (over 50%) for the Notch 
target genes; HES1 and HES5 (Figure 5.8 top panel). Similarly, BMP effectors, ID2 and 
ID3, were also downregulated when DLK-1 was transiently expressed in the cells 
(Figure 5.8 low panel).  This evidence supported the previous findings that DLK-1 
inhibits Notch and BMP signaling pathways. This signaling modulation by DLK-1 in 
neural progenitor/stem cells seems responsible for the changes in cell fate. However, it 
is still unknown whether there is a cross talk between Notch and BMP pathways 
contributed by DLK-1 and if there is, how the cross talk takes place.  This will need 
further investigations.   
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Figure 5.8: Effect on mRNA expression of Notch and BMP effector genes by DLK 
expression.   qRT-PCR was performed 48hours post transfection of DLK-1 expressing 
plasmid.  GFP expressing plasmid was used as control. Error bars represented 
standard deviation of three independent experiments. 
 
 
 
 
 
 
 
 122 
5.8. Discussion 
We have previously found that DLK-1 is differentially expressed during neural 
differentiation, being highly expressed at early stage of neural differentiation but 
becoming undetectable at N3 stage of the differentiation.  In this chapter, I have 
investigated effect of DLK-1 expression in the N3 neural stem cells and found that 
overexpression of DLK-1 did not affect the proliferation of these cells but reversed the 
inhibiting effect by serum on neuronal differentiation. 
 
One principal characteristic of neural stem cells is the ability to self-renew and 
proliferate which is known to be regulated by MEK/ERK transduction pathway (Wang et 
al., 2009).  It is reported that DLK-1 can activate MEK/ERK pathway (Kim et al., 2007).  
However, its overexpression in the N3 NPSCs does not affect cell proliferation. This 
may due to the fact that, under routine culture condition supplemented with FGF2 
and/or EGF, hESC-NPSCs already have a high level of phosphorylated MEK/ERK.  
Accordingly, overexpression of DLK-1 may not be able to dominate the cell intrinsic 
programs and external stimuli.  
 
The effect of DLK-1 on the neuronal differentiation is thought to be through the 
inhibition of multiple signaling pathways, including BMP and Notch.  DLK-1 inhibits 
BMP signaling through the canonical SMAD/ID pathway (Derynck and Zhang, 2003).  
Although the interaction of DLK-1 to BMP signal cascade is still unclear, it has shown 
here that DLK-1 acts through the inhibition of SMAD1/5/8 phosphorylation which is 
supported by the reduction of ID2/3 expression.  It has been reported that BMP2 can 
inhibit neurogenesis in cultured olfactory cells through enhanced degradation of 
MASH1 via the activation of ID gene expression (Shou et al., 1999; Vinals et al., 2004). 
This is a possible explanation as DLK-1 could inhibit BMP signaling. The retention of 
neuronal differentiation within DLK-1+ cells may due to the suppression of ID2/3 
expression, permitting neurogenic bHLH, such as MASH1, to further function. The 
results, together, indicate that DLK-1 might be involved in the maintenance of neuronal 
competence through the inhibition of BMP signaling and its downstream cascade. 
 
DLK-1 has previously reported as a negative regulator for Notch signaling during 
several differentiation processes (Baladron et al., 2005). The high homology 
encountered between DLK, and Delta proteins prompted the investigation of the 
possibility that DLK-1 may modulate Notch activity.  The implication of Notch proteins 
and their ligands in cell fate determination is widely demonstrated. Interestingly, several 
of the differentiation processes in which Notch proteins play a role are those in which 
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DLK-1 also participates.  For example, both proteins play an important role in the 
differentiation of hematopoietic precursors (Deftos and Bevan, 2000), adipogenic 
differentiation (Smas & Sul, 1997) or differentiation of tissue of neural origin (Costaglioli 
et al., 2001; Jensen et al., 2001).  In this study, the results suggest the existence of 
inhibition relationship of DLK-1 on Notch signaling in neural progenitor/stem cells.  
However, our results showed different mechanisms on how DLK-1 interfering the Notch 
signalling pathway.  It is considered that DLK-1 inhibits Notch signalling by interfering 
with the ligand-receptor interaction which consequently affects Notch activation and 
cleavage as DLK-1 shares similar extracellular domain with Notch ligand Dll (Artavanis-
Tsakonas et al., 1999).  By contrast, the results here showed that DLK-1 seems 
inhibiting the Notch signalling downstream of the Notch receptor activation and 
cleavage, not acting on the ligand-receptor level because DLK-1 is able to attenuate 
the effect of NICD, a cleavage-active form of the Notch receptors. It was previously 
reported that endocytosis plays a key role in Notch signaling (Furthauer & Gonzalez-
Gaitan, 2009; Le Borgne & Schweisguth, 2003). This mechanism may be required for 
signal transduction of DLK-1, possibly by bringing internalized DLK-1 to a specific 
intracellular compartment. Then internalized DLK-1 could associate with a signaling 
machinery, such as NICD, and regulate downstream signaling. The existence of DLK-1 
internalization is supported by immunocytochemistry result (Figure 5.2 C).  However, 
the exact mechanisms remain to be elucidated.  The decrease of HES1 and HES5 
gene expression in hESC-NPSCs transfected with full length DLK-1 expressing 
construct adds extra evidence to the negative effects of DLK-1 on Notch activation. 
These results strongly suggest that DLK-1 functions as an inhibitor to Notch signaling 
in neural progenitor/stem cell models.  
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Figure 5.9: Model for the inhibitory effect of DLK-1 on Notch and BMP signaling 
pathways.  
 
 
In summary, our results suggest that DLK-1, a protein only present in higher animals 
(Laborda et al., 1993), functions to enhance neuronal differentiation by modulating at 
least two signaling pathways, Notch and BMP (Figure 5.9).  Notch signaling could be 
inhibited by DLK-1 and this happens through the attenuation of NICD activity. The 
blockade of Notch leads to the downregulation of its target genes, HES1/5, which are 
anti-neuronal differentiation factors. Similarly, DLK-1 could inhibit BMP signaling by the 
prevention of SMAD1/5/8 phosphorylation and further repress ID gene expression. This 
inhibition maintains neuronal production by neural progenitor/stem cells even when 
they are under glial-inducing conditions. It has been reported that Notch and BMP 
pathways could cooperatively inhibit neuronal differentiation by enhancing HES5 
expression (Takizawa et al., 2003).  It is interesting to further investigate their crosstalk 
in our system in which DLK-1 may involve in this interaction. 
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Chapter 6: Characterization of neural lineage reporter human 
embryonic stem cell lines 
 
6.1. Introduction 
The pluripotent differentiation and indefinite self-renewal capacity of hESCs make them 
not only a great cell source for biomedical and clinical applications but also a valuable 
in vitro model to study early human development (Dvash & Benvensity, 2004), 
particularly for elucidating molecular mechanisms controlling lineage differentiation. 
The formation of neuroepithelium structure, resulted from the process called “neural 
induction”, is probably one of the earliest events of the embryogenesis.  Although 
considerable information has been obtained on signaling pathways regulating this 
event, current information is mainly based on studies of animal embryos.  However, the 
whole picture of neurodevelopment is still incomplete, especially regarding to that in 
human.  hESCs may serve as a suitable model system for the investigation of 
molecular mechanisms regulating early human neural development as it has been 
demonstrated that neural differentiation of mESCs recapitulates the CNS development 
in mice (Okada et al., 2008).  However, like mESCs, it is very difficult to assess the 
production of specific lineage from hESCs, especially in the live cells because of their 
pluripotent property.  Therefore, there is a need for the generation of a neural 
progenitor specific hESC reporter lines which will not only facilitate to assess factors 
required for neural differentiation in live cells but also enable to obtain an enriched 
neural cell population by fluorescence-activated cell sorting for further analysis.  
 
Among many genes that have been considered as neural progenitor markers, the 
intermediate filament protein, nestin, is one of the most commonly used and best 
characterized markers for neural progenitor stem cells (Lendahl et al., 1990).  Nestin is 
expressed in the majority of mitotically active progenitor cells in the CNS and PNS 
(Mujtaba et al., 1998) and is downregulated upon postmitotic differentiation (Lothian & 
Lendahl, 1997). Thus, the cells expressing nestin in the CNS show all characteristics of 
neural stem cells such as multipotency, self-renewal and regeneration. Previous 
studies have mapped the regulatory elements in the nestin gene that control its specific 
expression in the CNS onto the second intron of the nestin gene, which contains the 
necessary cis-acting motifs for neural lineage specific expression.  Transgenic mice 
carrying the lacZ reporter gene driven by the human nestin second intron enhancer 
showed specific expression in the developing CNS (Lothian et al., 1999; Zimmerman et 
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al., 1994).  Hence, nestin second intron could serve as an efficient enhancer for driving 
reporter gene expression specifically in the neural progenitors.  
 
In our laboratory, nestin-GFP expression construct has been stably transfected into H1 
hESC line by lipofectamine 2000 (Figure 6.1).  7 clones have been expanded and 
confirmed by Southern blotting to have the intact nestin-GFP transgene integrated into 
their genome.  The objective of this study is to characterize these 7 clones for their 
maintenance of hESCs properties and the GFP expression pattern during 
differentiation, particularly in the neural differentiation. 
 
 
 
 
Figure 6.1: Schematic diagram of the nestin-GFP transgene.  GFP expression is 
driven by the 2nd intron of nestin gene and tk-mini promoter.  Transfected cells were 
selected by their resistance to an antibiotic, G418.  
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Results 
 
6.2. Variability of GFP expression of nestin-GFP hESC clones  
The 7 clones of nestin-GFP hESCs which contained the intact transgene were cultured 
in hESC self-renewal condition and visualized under the fluorescence microscope.  It 
was noted that 2 of 7 clones (clones 1-10 and 2-10) showed no visible green 
fluorescence in both hESCs colonies and surrounding spontaneously differentiated 
stromal cells (Figure. 6.2 A & B).  In contrast, the other 5 clones (1-1, 1-6, 1-12, 2-1 
and 2-14) exhibited GFP expression in the hESC colonies but not in the surrounding 
stromal cells (Figure 6.2 C & D).  As known that the 2nd intron of nestin gene is 
specifically active in neural lineage (Lothian et al., 1999), 4 clones (1-10, 2-10, 1-1 and 
2-14) were induced to differentiate toward neural progenitor cells using an established 
method in our laboratory (Gerrard et al., 2005). It was found that the 2 clones (1-10 and 
2-10), which did not express GFP in undifferentiated hESC colonies, maintained the 
absence of GFP expression in their neural derivatives. These lacks of GFP expression 
are more likely due to position silencing effect of transgene integration, which has been 
well documented in many literatures (Kioussis & Festenstein, 1997). Therefore, the 
subsequent detail characterizations were focused on the clone 1-1 and 2-14 that 
showed increased GFP expression after neural differentiation.  
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Figure 6.2:  Fluorescence imaging of nestin-GFP hESC clones.  (A & B): GFP-
negative of nestin-GFP hESC clones (clone 1-10). No GFP detection throughout the 
colony.  (C & D): GFP was detected within hESC colony (clone 2-14), but not 
spontaneously differentiated cells (asterisk). Scale bar represented 50 µm for all 
microscopic images. 
 
 
 
 
 
 
 
 
 
 129 
6.3. Nestin-GFP hESC clones maintain normal characteristics as their 
parental line 
One of the critical considerations for generating hESC reporter lines is that a transgene 
does not affect the properties of hESCs.  Because if the fundamental characteristics of 
genetic-modified hESCs are altered, these cells will be devalued for downstream 
applications, such as differentiation study and toxicity test.  To validate that the nestin-
GFP hESC clones maintained the characteristics of hESCs, immunocytochemistry and 
flow cytometry analysis were performed to investigate the expression of hESC 
markers. Antibody staining against hESC markers showed that the nestin-GFP clones 
expressed key transcription factors: OCT4, nanog and SOX2 (Figure 6.3 A).  In 
addition, flow cytometry analysis results showed that nestin-GFP hESCs were stained 
positive for hESC-specific cell surface antigens SSEA-4 (84.7%) and TRA-1-81 
(77.1%), but negative for differentiated marker SSEA-1 (Figure 6.3 B).  These results 
indicate that the nestin-GFP clones maintained expression of key hESC transcription 
factors and surface markers.  
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Figure 6.3:  Nestin-GFP hESCs maintain the characteristics of parental hESCs.  
(A): Immunostaining of OCT4, nanog, SOX2 and GFP in the nestin-GFP hESCs.  
Weak GFP staining is co-localized with Oct4 staining in the cells. Scale bar 
represented 20 μm for all images. (B): Flow cytometry analysis showed that the cells 
also express surface antigen markers, SSEA4 and TRA-1-81, but not SSEA1.  
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To further confirm the hESC properties of the nestin-GFP clones, they were examined 
for the pluripotency upon differentiation via embryoid body formation (see materials and 
methods).  After 2 weeks of differentiation, they were stained with antibodies against 
markers representing embryonic three germ layers.  The results showed that clonal 
derived nestin-GFP hESCs are able to form embryoid bodies (Figure 6.4 A) and that 
the differentiated progenies contained cells of all three germ layers, represented by 
positive staining for GATA6 (Figure 6.4 D), an endoderm marker, muscle actin (Figure 
6.4 E), a mesoderm marker and nestin (Figure 6.4 F), a neuroectoderm marker.  It was 
also evident that GFP expression was restricted only in cells exhibiting neural 
progenitor cell morphology (Figure 6.4 B & C).  Immunocytochemistry confirmed that 
GFP staining was only co-localized with nestin (Figure 6.4 F), but not in cells positive 
for muscle actin (Figure 6.4 E) or GATA6 (Figure 6.4 D).  Together, it suggests that the 
nestin-GFP hESC lines maintain the normal characteristics of hESCs, being able to 
self-renewal and differentiation into cells of three germ layers. 
 
 
 
 
Figure 6.4:  The nestin-GFP hESCs are pluripotent.  (A-C): Differentiation of hESC 
clones via EB formation, produced progenies of three germ layers represented by 
positive staining with GATA6 (endoderm, D), muscle actin (M-Actin, mesoderm, E) and 
nestin (ectoderm, F).  Transgenic GFP is expressed only in neural progenitors (B-C) 
and co-localized with endogenous nestin (F). Scale bar represents 25µm in D-F and 50 
µm in A-C. 
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6.4. Nestin-GFP is restrictively expressed in the neural progenitor cells 
after differentiation  
To validate the specificity of nestin-GFP expression after differentiation, the nestin-GFP 
hESC clones were subjected to differentiation by various methods. In human ES cell 
culture condition, over 65% of cells showed GFP expression at the level of 100 units, 
and after 2 weeks in neural differentiation medium, the GFP expressing cells increased 
to almost 80% with intensity of 1000 units, 10 fold higher than that in hESCs (Figure 
6.5 A). These results demonstrated that nestin-GFP transgene is expressed in 
undifferentiated hESCs but the expression levels are significantly increased in neural 
progenitor cells.  These results are similar to the data published in mESCs (Lenka et 
al., 2002).  In contrast, 2 weeks treatment with BMP2, a growth factor leading to extra-
embryonic endoderm differentiation (Pera et al., 2004; Xu et al., 2002), resulted in 
flattened morphology of cells and dramatic downregulation of GFP expression which 
was hardly visible under fluorescent microscope and the negativity was then further 
verified by flow cytometry analysis (Figure 6.5 A).  These data suggest that in 
differentiated hESCs, nestin-GFP is restricted exclusively in neural lineages.  qRT-PCR 
confirmed that the cells derived from nestin-GFP hESCs clones after neural 
differentiation significantly upregulated expression of SOX2 and PAX6, meanwhile, 
downregulated expression of pluripotent genes, e.g. OCT4 and Nanog (Figure 6.5 B).  
Non-neural lineage markers, such as GATA6 and CG-α showed no significant change 
in expression between undifferentiated hESCs and after neural differentiation (Figure 
6.5 B).  In BMP2 treated cells, gene expression analysis by qRT-PCR proved their 
extra-embryonic endoderm identity with high levels of GATA6 and human chorionic 
gonadotropin (hCG) (Figure 6.5 B).   
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Figure 6.5:  Nestin-GFP transgene expression in hESCs and their neural or 
extraembryonic endoderm derivatives.  (A): Nestin-GFP transgene expression is 
increased after neural differentiation but reduced after BMP treatment into 
extraembryonic endoderm cells, which are evident under fluorescent microscope (left) 
as well as by flow cytometry analysis (right).  Arrows point neural rosette structure.  
Scale bar represents 50 µm in all microscopic images.  (B): Gene expression by qRT-
PCR of the nestin-GFP hESC clones in hESC culture conditions (ES), or neural 
differentiation conditions (Neurodif) or treated with BMP2 (BMP2 treated).   Error bars 
are standard derivation of at least three experiments.  
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6.5. Nestin-GFP expression is confined in neural progenitor cells but 
not terminally differentiated cells 
Immunocytochemistry results showed that differentiated GFP positive neural progenitor 
cells expressed not only endogenous nestin (Figure 6.6 C, upper panel) but PAX6 
protein, another neural progenitor marker (Figure 6.6 A). It is well documented that 
nestin is expressed in most of the mitotically active CNS progenitors (Mujtaba et al, 
1998) and depleted upon terminal differentiation (Lothian et al 1997).  In order to 
characterize the specificity of the nestin-GFP transgene expression, neural progenitor 
cells derived from transgenic hESC clones were further differentiated to postmitotic 
neuron/glial cells by withdrawal of growth factors for 7 days, which reduced proliferation 
significantly. Transgenic GFP expression was shown to be significantly decreased after 
withdrawal of growth factor (Figure 6.6 B-C) and immunostaining revealed that GFP 
staining were much less intense when cells became neurons, expressing Tuj1, or 
astrocytes, expressing GFAP (Figure 6.6 Cb & Cc).  Flow cytometry analysis also 
showed dramatic reduction of GFP intensity in post-mitotic differentiated cells; 
~1000unit in neural progenitor cells compared to ~10unit in post-mitotic differentiated 
cells (Figure 6.6 B). These results demonstrated that nestin-GFP is predominantly 
expressed in neural progenitor cells but not in postmitotic neurons and astrocytes.  
Thus, the use of live reporter GFP under the regulatory control of the neural specific-
enhancer nestin has provided the means to investigate not only its expression, but also 
quantitative- and functional characteristics of neurogenesis during early stage of 
development.  This system would help to increase the purity of self-renewing and 
multipotent neural progenitor cells by using fluorescence-activated cell sorting and, 
consequently, allow their use in experimental transplantation propose. 
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Figure 6.6:  Transgenic nestin-GFP expression is confined in neural progenitor 
cells.  (A): Immunostaining showing co-localization of GFP and Pax6 expression in 
neural progenitors derived from nestin-GFP hESC clones.  (B): Live images and flow 
cytometry showing decrease of GFP expression after withdrawal of growth factors.  
(C): Immunocytochemistry showing evident reduction of GFP expression in postmitotic 
neurons (middle, Tuj1 positive) and astrocytes (lower, GFAP positive) in compare with 
proliferative neural progenitor cells (upper, nestin positive).  Scale bar represents 50 
µm in all images. 
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6.6. OCT/SOX binding sites are required for nestin enhancer activity  
It has been demonstrated that expression of nestin gene in rat and mouse neural tube 
is determined by its 2nd intron enhancer whose activity is dependent on a small 
segment of sequences containing binding sites of both POU and SOX transcription 
factors (Jin et al., 2009; Tanaka et al., 2004) and these sites are conserved in the 
human nestin enhancer as well.  Class III POU factor (Brn2) together with SoxB1 
transcription factors (e.g. SOX2), that all are expressed at high levels in neural 
progenitor/stem cells, bind to these sites to control nestin expression (Tanaka et al., 
2004).  However, same binding sites could also recruit class V POU factor (OCT4) and 
SOX2 complex to regulate gene expression in undifferentiated pluripotent cells (Jin et 
al., 2009) .  To investigate if these factors are responsible for the low and high levels of 
nestin-GFP transgene expression in hESCs and their neural derivatives, respectively, 
nestin-luciferase constructs were generated which contains either wild type POU and 
SOX binding sites or depleted POU or SOX binding site. pGL4.10 promoterless 
luciferase reporter plasmid was used for measuring the activity of the 2nd intron 
enhancer of nestin gene for both wild type and mutant forms (Figure 6.7 A & B). The 
constructs were validated by polynucleotide sequencing and restriction endonuclease 
analysis (see materials and methods; Figure 6.7 A & B), and showed the expected 
regulatory sequences.  Transfection of the wild type construct into hESCs, their neural 
derivatives and non-neural HepG2 cells exhibited a 3-fold increase of luciferase in 
hESCs compared with that in HepG2 cells and a further over 4-fold augmentation in 
neural progenitor cells (Figure 6.7 C) and these results further confirmed the 
expression pattern observed with nestin-GFP construct. Depletion of either POU or 
SOX binding site dramatically reduced the activity levels of luciferase in both hESCs (5-
fold decrease, Figure 6.7 D) and their neural derivatives (> 7 fold decrease, Figure 6.7 
E).  These results indicate that expression patterns of nestin 2nd intron enhancer in both 
hESCs and neural progenitor cells are controlled by cis-elements for POU and SOX 
family transcription factors. 
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Figure 6.7: Evaluation of the importance of SOX/POU binding motifs for the 
activity of the 2nd intron nestin enhancer.  (A): A plasmid construct of pGL4.10 
luciferase reporter plasmid and endonuclease restriction analysis of the recombinant 
plasmids. (B): A schematic diagram of luciferase reporter constructs. SOX and POU 
binding segments in the nestin enhancer are marked by grey and shaded boxes, 
respectively.  Sequences of both POU and SOX binding motifs are indicated and the 
deleted sequences are underlined.  (C): Relative luciferase activity of wild-type nestin 
enhancer in hESCs, hESC cell-derived neural progenitor cells and hepatocytes 
carcinoma cell line HepG2.  (D & E): Depletion of either POU or SOX binding motifs in 
the nestin enhancer significantly reduced the luciferase activity in both human ES cells 
(D) and their neural derivatives (E).  Error bars are standard deviation of four 
experiments and * and ** represent p<0.0001 and p<0.0005, respectively (student t-
test). 
 
 138 
6.7. Discussion 
Recently, it has been reported a comprehensive analysis on the applicability of surface 
epitope-mediated selection of hESC-derived neural lineage (Pruszak et al., 2007). 
Although selection based on surface markers bypasses genetic modification and can 
thus be applied to a variety of cell sources, it is often hampered by costs for large-scale 
applications, lack of specificity of individual antibodies, and heterotopic expression of 
the target epitopes in unwanted cell types.  For example, expression of the widely used 
neural selection epitopes neural cell adhesion molecule (CD56), NG2 and CD133 has 
also been observed in lymphocytes, melanocytes, and hematopoietic cells, respectively 
(Kobari et al., 2001; Real et al., 1985; Seldeslagh et al., 1997;. 
 
Genetic lineage selection using genes encoding fluorescence proteins or antibiotic 
resistance is another widely used method.  Transgenic mESCs harbouring a marker 
gene have been successfully used to monitor and isolate multiple cell types including 
neurons (Wernig et al., 2002) and even neuronal subtypes (Thompson et al., 2006).  
Although these approaches have the disadvantage that the selected cells carry a 
genetic modification, the benefits of this system lie in its reliability and simplicity once 
established. Generation of lineage specific fluorescent protein reporter hESC lines will 
significantly benefit investigators to monitor specific cell lineages in a live, simple and 
timely manner, and facilitate high throughput screenings in order to identify molecules 
important in regulating specific cell fate commitment.  In addition, specific cell 
population derived from hESCs could be enriched for downstream analysis and 
applications. 
 
Studies in transgenic mice showed that the CNS-specific enhancer of the human and 
rat nestin genes reside in the 2nd intron (Lothian & Lendahl, 1997; Zimmerman et al., 
1994) and this element  is found to control nestin expression in the CNS in both mouse 
embryo in vivo (Lothian & Lendahl, 1997) and neural stem cells in vitro culture 
(Johansson et al., 2002).  This study reported the characterization of the clonally 
derived nestin-GFP hESC reporter lines in which the GFP expression is under the 
control of 2nd intron of nestin enhancer.  Transgenic mice generated with a similar 
reporter construct showed restricted expression of the reporter gene in the developing 
CNS (Mignon et al., 2004) and isolation of reporter expressing cells showed neural 
stem cells characteristics (Kawaguchi et al., 2001).  Although, nestin-GFP expression 
was visible in undifferentiated hESCs under fluorescence microscope, upon neural 
differentiation, the GFP expression was significantly increased (Figure 6.2) and, even 
more important, the expression was confined specifically to neural progenitor cells but 
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not in other cell types.  Combining with GFP expression, undifferentiated hESCs could 
be excluded from neural progenitor culture by their specific surface marker staining, 
such as TRA-1-81, prior to conduction downstream analysis and applications.  
Noteworthy, neural progenitor cells derived from these reporter lines reduced GFP 
expression upon further differentiation to postmitotic neurons and astrocytes (Figure 
6.6 C). This is corresponding to the data previously reported in mESCs (Lenka et al., 
2002) and supports the notion that nestin is a neural progenitor cell-specific marker.  
Therefore, the nestin-GFP hESC reporter lines exhibited prominent GFP expression in 
neural progenitor cells and could be used as a tool to study the process of neural 
differentiation from uncommitted hESCs as well as to enrich neural progenitor cells 
from other lineages.   
 
The 2nd intron of nestin is found to contain SOX and POU binding motifs which are 
important for the activity of this enhancer (Josephson et al., 1998).  In this study, we 
found that the cooperation of the SOX and POU binding sites are significantly important 
for the activity of this element since the deletion either of them abolishes the activity of 
this enhancer. Although the transcription factors regulating GFP reporter expression in 
hESCs may differ from those in neural progenitor cells, it is conceivable that there are 
various combinations between SOX and POU proteins to elicit gene expression 
synergistically. In neural progenitor cells, it has been reported that class III POU family 
member, Brn2, and SOX B1 family members (SOX1/2/3), bind to the sites 
collaboratively and stimulate the enhancer activity (Jin et al., 2009; Tanaka et al., 
2004). Whereas in ESCs, POU5F1 protein OCT4, together with SOX2, have been well 
studied for their regulation of pluripotent gene expression (Boyer et al., 2005).  
However, the orientation of SOX and POU binding site sequences in the nestin 2nd 
enhancer are different from that they are in the pluripotent genes (e.g. OCT4, nanog). 
This arrangement may account for the low expression of the transgene in hESCs as 
the order of these two binding sites are important (Chambers & Tomlinson, 2009; 
Kondo & Kamachi, 2010).  
 
To date, there are two main strategic approaches for the generation of lineage reporter 
cell lines; 1) promoter/enhancer-driven reporter and 2) homologous recombination 
knock-in, which have their own pros and cons. There are several advantages of 
promoter/enhancer-driven expression that facilitate the establishment of cells (Giudice 
& Trounson, 2008) .  It is technically less demanding than knock-in strategy as routine 
transfection methods, such as electroporation or chemical transfection, could be 
employed.  Moreover, it may be more efficient to obtain targeted cells depending on 
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transfection proficiency. However, transgenic method has a few issues to be 
considered. First, the transgene could be truncated or rearranged during integration 
into the genome, which may impair its expression pattern.  Besides, transgene is 
randomly integrated into the genome and surrounding by the host DNA/chromatin 
structures which may significantly alter a transgene expression (Alami et al., 2000).  
This positional influence suggests that an expression pattern of only one clone of cells 
does not essentially represent the activity of a promoter/enhancer.  Therefore, it is 
important to characterize multiple transfected clones independently to validate that 
reporter gene expression reflects endogenous gene expression and is faithfully 
regulated by the promoter/enhancer applied.  In this study, two individual nestin-GFP 
hESC clones have been properly characterized for their ability to maintain hESC 
properties and, importantly, for their truly transgene expression in the neural progenitor 
cells after differentiation.  Therefore, these nestin-GFP hESC clones will be useful for 
future research. 
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Chapter 7: General discussion 
 
Neurogenesis in mammals is a complex process involving many different cell types that 
differentiate asynchronously.  Our understanding about it is far from complete.  In 
addition to the complicated process, the relatively small number of cells that can be 
readily obtained makes the study of the neural development extremely difficult.  ESCs 
could be used as an in vitro model to study neural differentiation as ESCs can be 
produced in a relatively large number and have the potential to generate all the cell 
types in the neural system.  Previous studies have revealed that generation of neurons 
and glia from hESCs is a multistage process (Elkabetz et al., 2008; Gerrard et al 2005; 
Zhang et al 2003).  Characterization of the different stages of neural derivatives of 
hESCs is expected to provide insights into the mechanisms and pathways involved in 
cell fate specification, such as neural initiation, the acquisition of neurogenic potential, 
and the transition to gliogenic phase, which will help us to have a better understanding 
of human neural development. 
 
In this thesis, I have demonstrated that neural differentiation of hESCs is a dynamic 
process, which could be divided into 5 stages; undifferentiated hESCs, neural initiation 
stage (N1), neural epithelium or rosette stage, neural progenitor cells (N2) and neural 
progenitor/stem cells (N3).   Due to the technical contrains, I have mainly focused my 
study on N1, N2 and N3 stages.  My results showed that the initiation of neural lineage 
from hESCs by BMP inhibition (Gerrard et al., 2005) is certainly mimicking the process 
of neural induction found in vivo (Vonica & Brivanlou, 2006).  Cells at the N1 stage 
share similar characteristics as the primitive ectoderm of the early embryos, such as 
gene expression profile and differentiation potential.  The establishment of primitive 
ectoderm-like cells appears to be an obligatory intermediate stage before the 
specification to neural progenitor cell stage both in hESCs and mESC system (Bajpai 
et al., 2009; Cohen et al., 2010; Stavridis et al., 2007).  Cells at the N2 stage (hESC-
NPCs) mainly produce neurons and express a wide variety of neurotrophic receptor 
genes as shown in our genome-wide studies (Wu et al 2010).  This indicates that these 
cells could potentially differentiate into glutaminergic, GABAergic or dopaminergic 
neurons when the proper conditions are applied (Li et al., 2008; Zeng et al., 2004).  
Several observed characteristics of hESC-NPCs suggest the similarities between them 
and radial glial cells which have been long proposed to serve as neural stem cells in 
the developing brain (Alvarez-Buylla et al., 2001).  The high neurogenic early-born 
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neural progenitor cells derived from hESCs could represent the neural stem cells in the 
early embryonic CNS.  Cells of the N3 stage (hESC-NPSCs) can be extensively 
expanded without significant changes and are able to generate both neurons and glia.  
Many lines of evidence from this study support the connection between these cells and 
adult neural stem cells, for example the expression of several astroglial markers and 
the high responsiveness of CBF1.  The finding of the transition from a predominantly 
neuronal state into ones with increased gliogenic potential is consistent with in vivo 
neural stem cell development  (Temple et al., 2000).  CNS stem cells undergo repeated 
asymmetric cell divisions, first producing neurons then glial cells, thus reproducing the 
normal neuron-glial order (Qian et al., 2000).  The neural differentiation process of 
hESCs, to a certain degree, recapitulates the neural development in vivo (Figure 7.1).  
Further studies are required to reveal the actual correlation between our in vitro cells 
and those existing in vivo regarding their physiological relevance. 
 
 
 
 
Figure 7.1: Developmental links between the different stages of neural 
derivatives of hESCs and their in vivo counterparts.  Neural derivatives exhibit 
several similar characteristics to in vivo counterparts. The corresponding in vivo 
developmental stages are indicated and matched with in vitro populations (modified 
from Conti & Cattaneo, 2010). Abbreviations: ESC, embryonic stem cells; RG, radial 
glial cells; NS, neural stem cells. 
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Elucidating the mechanisms that regulate brain development remains one of the most 
challenges in neurobiology.  In this thesis I have shown that neural differentiation of 
hESCs requires highly regulated and tightly controlled transcription of a number of 
genes.  The current evidence, together with our genome wide analysis (Wu et al., 
2010), demonstrates the temporal gene expression pattern along the differentiation 
process, including neural stem cell genes and signaling pathway molecules.  A number 
of genes are expressed at specific stages, implicating their possible role in molecular 
mechanisms underlying developmental progression of cells.  For example, PAX6 
transcripts appear before SOX1, consistent with the immunostaining observation of 
Gerrard et al., (Gerrard et al., 2005).  Thus, PAX6 may have an earlier role in neural 
lineage choice of hESCs than in mESCs (Suter et al., 2008).   The detection of other 
temporally regulated genes may provide a clue for further studies their roles in various 
aspects of neural differentiation.  DLK-1 was demonstrated in this thesis to enhance 
neuronal differentiation by modulating multiple signalling pathways; it is also noticeable 
that DLK-1 is significantly activated at the early phase of neural differentiation. 
However, whether it plays a critical role at this early stage of neural initiation remains to 
be investigated.  The data from this study highlights the integrative networks of intrinsic 
factors and extrinsic signaling pathways in order to regulating the temporal identities of 
neural derivatives of hESCs.  The knowledge of this regulatory network will not only 
enhance the better understanding of neurobiology and improve protocols for neural 
progenitor differentiation, but also facilitate the generation of neural-specific hESC 
reporter lines.  The molecular mechanisms underlying the transition from neuronal to 
glial differentiation preference of cultured NPSCs are still not fully understood.  Our 
genome-wide analysis on gene expression has revealed a set of transcription factors, 
including TLX and myt1l that are upregulated at early neural differentiation and peaked 
at N2 stage, then downregulated in the N3 stage cells. These factors may function to 
promote neuronal differentiation.  Future work is needed to confirm these.   
 
In addition, the study here indicates that neural derivatives of hESCs could also serve 
as a scalable source of neuron and glial cells for genetic and pharmaceutical screening 
and possibly for cell replacement therapy.  It will be important to determine hESC-
NPSC differentiation capacity to generate different neuronal subtypes in vitro and in 
vivo, and whether or how they can contribute functional reconstruction in disease 
models.  In addition, it will be interesting to study the regulatory factors that are needed 
to prevent senescence of hESC-NPSCs as cells can be maintained long-term in 
cultures.  This will provide a framework to the safe, controlled and expandable of these 
neural progenitor/stem cells and other CNS-derivative cells. 
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The concept of differentiation process of hESCs recapitulating the temporal changes 
found in vivo development has become widely accepted, not only for the nervous 
system, but also other lineages (Hay et al., 2008).  However, it should be considered 
that the in vitro differentiation system could not provide a spatial organization which 
exists as precise cell-specific microdomains or niche within the embryo in vivo.  The 
further development of culture systems, combining with tissue engineering technology, 
will offer an improved microenvironment and increase differentiation efficiency of 
hESCs toward desired cell types. This would also provide better modelling systems for 
early human development study.  To this end, this thesis has provided the foundation 
of neural differentiation system that generates significant information for neural 
development and guided the future direction for neural differentiation study.  
 
 
 
 
 
 
 
 
 145 
References 
 
Adams AD, Choate DM, Thompson MA. 1995. NF1-L is the DNA-binding component of 
the protein complex at the peripherin negative regulatory element. J Biol Chem 
270(12):6975-6983. 
Akamatsu W, DeVeale B, Okano H, Cooney AJ, van der Kooy D. 2009. Suppression of 
Oct4 by germ cell nuclear factor restricts pluripotency and promotes neural stem cell 
development in the early neural lineage. J Neurosci 29(7):2113-2124. 
Alami R, Greally JM, Tanimoto K, Hwang S, Feng YQ, Engel JD, Fiering S, Bouhassira 
EE. 2000. Beta-globin YAC transgenes exhibit uniform expression levels but position 
effect variegation in mice. Hum Mol Genet 9(4):631-636.  
Altmann CR, Brivanlou AH. 2001. Neural patterning in the vertebrate embryo. Int Rev 
Cytol 203:447-482. 
Alvarez-Buylla A, Garcia-Verdugo JM. 2002. Neurogenesis in adult subventricular 
zone. J Neurosci 22(3):629-634.  
Anderson DJ. 2001. Stem cells and pattern formation in the nervous system: the 
possible versus the actual. Neuron 30(1):19-35. 
Andrews PW. 1987. Human teratocarcinoma stem cells: glycolipid antigen expression 
and modulation during differentiation. J Cell Biochem 35(4):321-332. 
Andrews PW. 2002. From teratocarcinomas to embryonic stem cells. Philos Trans R 
Soc Lond B Biol Sci 357(1420):405-417. 
Androutsellis-Theotokis A, Leker RR, Soldner F, Hoeppner DJ, Ravin R, Poser SW, 
Rueger MA, Bae SK, Kittappa R, McKay RD. 2006. Notch signalling regulates stem cell 
numbers in vitro and in vivo. Nature 442(7104):823-826. 
Anthony TE, Klein C, Fishell G, Heintz N. 2004. Radial glia serve as neuronal 
progenitors in all regions of the central nervous system. Neuron 41(6):881-890. 
Artavanis-Tsakonas S. 1999. Notch Signaling: Cell Fate Control and Signal Integration 
in Development. Science 284:770. 
Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI. 1995. Embryonic stem cells 
express neuronal properties in vitro. Developmental biology 168(2):342-357. 
Bajpai R, Coppola G, Kaul M, Talantova M, Cimadamore F, Nilbratt M, Geschwind DH, 
Lipton SA, Terskikh AV. 2009. Molecular stages of rapid and uniform neuralization of 
human embryonic stem cells. Cell Death Differ 16(6):807-825. 
Baker JC, Beddington RS, Harland RM. 1999. Wnt signaling in Xenopus embryos 
inhibits bmp4 expression and activates neural development. Genes Dev 13(23):3149-
3159. 
Baladron V, Ruiz-Hidalgo MJ, Nueda ML, Diaz-Guerra MJ, Garcia-Ramirez JJ, Bonvini 
E, Gubina E, Laborda J. 2005. dlk acts as a negative regulator of Notch1 activation 
 146 
through interactions with specific EGF-like repeats. Experimental cell research 
303(2):343-359. 
Beddington RS. 1983. Histogenetic and neoplastic potential of different regions of the 
mouse embryonic egg cylinder. J Embryol Exp Morphol 75:189-204. 
Beddington RS, Robertson EJ. 1989. An assessment of the developmental potential of 
embryonic stem cells in the midgestation mouse embryo. Development 105(4):733-
737.  
Ben-Shushan E, Thompson JR, Gudas LJ, Bergman Y. 1998. Rex-1, a gene encoding 
a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 
binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site. 
Molecular and cellular biology 18(4):1866-1878. 
Bertrand N, Castro DS, Guillemot F. 2002. Proneural genes and the specification of 
neural cell types. Nature reviews 3(7):517-530. 
Bibel M, Richter J, Schrenk K, Tucker KL, Staiger V, Korte M, Goetz M, Barde YA. 
2004. Differentiation of mouse embryonic stem cells into a defined neuronal lineage. 
Nature neuroscience 7(9):1003-1009. 
Bogler O, Wren D, Barnett SC, Land H, Noble M. 1990. Cooperation between two 
growth factors promotes extended self-renewal and inhibits differentiation of 
oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proceedings of the National 
Academy of Sciences of the United States of America 87(16):6368-6372. 
Borghese L, Dolezalova D, Opitz T, Haupt S, Leinhaas A, Steinfarz B, Koch P, 
Edenhofer F, Hampl A, Brustle O. 2010. Inhibition of Notch Signaling in Human 
Embryonic Stem Cell--Derived Neural Stem Cells Delays G1/S Phase Transition and 
Accelerates Neuronal Differentiation In Vitro and In Vivo. Stem Cells. 
Boutin C, Schmitz B, Cremer H, Diestel S. 2009. NCAM expression induces 
neurogenesis in vivo. The European journal of neuroscience 30(7):1209-1218. 
Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, 
Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA. 
2005. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 
122(6):947-956. 
Brandenberger R, Wei H, Zhang S, Lei S, Murage J, Fisk GJ, Li Y, Xu C, Fang R, 
Guegler K, Rao MS, Mandalam R, Lebkowski J, Stanton LW. 2004. Transcriptome 
characterization elucidates signaling networks that control human ES cell growth and 
differentiation. Nature biotechnology 22(6):707-716. 
Bray SJ. 2006. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell 
Biol 7(9):678-689. 
Bremer S, Pellizzer C, Adler S, Paparella M, de Lange J. 2002. Development of a 
testing strategy for detecting embryotoxic hazards of chemicals in vitro by using 
embryonic stem cell models. Altern Lab Anim 30 Suppl 2:107-109. 
Brons IG, Smithers LE, Trotter MW, Rugg-Gunn P, Sun B, Chuva de Sousa Lopes SM, 
Howlett SK, Clarkson A, Ahrlund-Richter L, Pedersen RA, Vallier L. 2007. Derivation of 
pluripotent epiblast stem cells from mammalian embryos. Nature 448(7150):191-195. 
 147 
Brustle O, Jones KN, Learish RD, Karram K, Choudhary K, Wiestler OD, Duncan ID, 
McKay RD. 1999. Embryonic stem cell-derived glial precursors: a source of myelinating 
transplants. Science 285(5428):754-756. 
Burridge PW, Anderson D, Priddle H, Barbadillo Munoz MD, Chamberlain S, Allegrucci 
C, Young LE, Denning C. 2007. Improved human embryonic stem cell embryoid body 
homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation 
system highlights interline variability. Stem cells (Dayton, Ohio) 25(4):929-938. 
Burrows R, Wancio D, Levitt P, Lillien L. 1997. Response diversity and the timing of 
progenitor cell maturation are regulated by developmental changes in EGFR 
expression in the cortex. Neuron 19:251–267. 
Bylund M, Andersson E, Novitch BG, Muhr J. 2003. Vertebrate neurogenesis is 
counteracted by Sox1-3 activity. Nat Neurosci 6(11):1162-1168.  
Cai L, Hayes NL, Nowakowski RS. 1997. Synchrony of clonal cell proliferation and 
contiguity of clonally related cells: production of mosaicism in the ventricular zone of 
developing mouse neocortex. J Neurosci 17(6):2088-2100. 
Campbell K, Gotz M. 2002. Radial glia: multi-purpose cells for vertebrate brain 
development. Trends in neurosciences 25(5):235-238. 
Carpenter MK, Inokuma MS, Denham J, Mujtaba T, Chiu CP, Rao MS. 2001. 
Enrichment of neurons and neural precursors from human embryonic stem cells. 
Experimental neurology 172(2):383-397. 
Cazillis M, Rasika S, Mani S, Gressens P, Lelievre V. 2006. In vitro induction of neural 
differentiation of embryonic stem (ES) cells closely mimics molecular mechanisms of 
embryonic brain development. Pediatr Res 59(4 Pt 2):48R-53R. 
Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A. 2003. 
Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic 
stem cells. Cell 113(5):643-655. 
Chambers I, Tomlinson SR. 2009. The transcriptional foundation of pluripotency. 
Development 136(14):2311-2322.  
Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. 
2009. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of 
SMAD signaling. Nature biotechnology 27(3):275-280. 
Chenn A, McConnell SK. 1995. Cleavage orientation and the asymmetric inheritance of 
Notch1 immunoreactivity in mammalian neurogenesis. Cell 82(4):631-641. 
Chiang C, Litingtung Y, Lee E, Young KE, Corden JL, Westphal H, Beachy PA. 1996. 
Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. 
Nature 383(6599):407-413. 
Chuang PT, McMahon AP. 1999. Vertebrate Hedgehog signalling modulated by 
induction of a Hedgehog-binding protein. Nature 397(6720):617-621. 
Craig CG, Tropepe V, Morshead CM, Reynolds BA, Weiss S, van der Kooy D. 1996. In 
vivo growth factor expansion of endogenous subependymal neural precursor cell 
populations in the adult mouse brain. J Neurosci 16(8):2649-2658. 
 148 
Cui Y, Brown JD, Moon RT, Christian JL. 1995. Xwnt-8b: a maternally expressed 
Xenopus Wnt gene with a potential role in establishing the dorsoventral axis. 
Development (Cambridge, England) 121(7):2177-2186. 
Carpenter MK, Inokuma MS, Denham J, Mujtaba T, Chiu CP, Rao MS. 2001. 
Enrichment of neurons and neural precursors from human embryonic stem cells. 
Experimental neurology 172(2):383-397. 
Cebolla B, Vallejo M. 2006. Nuclear factor-I regulates glial fibrillary acidic protein gene 
expression in astrocytes differentiated from cortical precursor cells. Journal of 
neurochemistry 97(4):1057-1070. 
Conti L, Cattaneo E. Neural stem cell systems: physiological players or in vitro entities? 
Nat Rev Neurosci 11(3):176-187.  
Conti L, Pollard SM, Gorba T, Reitano E, Toselli M, Biella G, Sun Y, Sanzone S, Ying 
QL, Cattaneo E, Smith A. 2005. Niche-independent symmetrical self-renewal of a 
mammalian tissue stem cell. PLoS biology 3(9):e283. 
Costaglioli P, Come C, Knoll-Gellida A, Salles J, Cassagne C, Garbay B. 2001. The 
homeotic protein dlk is expressed during peripheral nerve development. FEBS Lett 
509(3):413-416.  
D'Alessandro JS, Yetz-Aldape J, Wang EA. 1994. Bone morphogenetic proteins induce 
differentiation in astrocyte lineage cells. Growth factors (11):53-69. 
Darr H, Mayshar Y, Benvenisty N. 2006. Overexpression of NANOG in human ES cells 
enables feeder-free growth while inducing primitive ectoderm features. Development 
(Cambridge, England) 133(6):1193-1201. 
Deftos ML, Bevan MJ. 2000. Notch signaling in T cell development. Curr Opin Immunol 
12(2):166-172.  
Deneen B, Ho R, Lukaszewicz A, Hochstim CJ, Gronostajski RM, Anderson DJ. 2006. 
The transcription factor NFIA controls the onset of gliogenesis in the developing spinal 
cord. Neuron 52(6):953-968. 
Derynck R, Zhang YE. 2003. Smad-dependent and Smad-independent pathways in 
TGF-beta family signalling. Nature 425(6958):577-584. 
Dhara SK, Hasneen K, Machacek DW, Boyd NL, Rao RR, Stice SL. 2008. Human 
neural progenitor cells derived from embryonic stem cells in feeder-free cultures. 
Differentiation 76(5):454-464. 
Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A. 1999. 
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 
97(6):703-716. 
Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A. 1999. 
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 
97(6):703-716. 
Di-Gregorio A, Sancho M, Stuckey DW, Crompton LA, Godwin J, Mishina Y, Rodriguez 
TA. 2007. BMP signalling inhibits premature neural differentiation in the mouse 
embryo. Development (Cambridge, England) 134(18):3359-3369. 
 149 
Draper JS, Pigott C, Thomson JA, Andrews PW. 2002. Surface antigens of human 
embryonic stem cells: changes upon differentiation in culture. J Anat 200(Pt 3):249-
258. 
Du ZW, Li XJ, Nguyen GD, Zhang SC. 2006. Induced expression of Olig2 is sufficient 
for oligodendrocyte specification but not for motoneuron specification and astrocyte 
repression. Molecular and cellular neurosciences 33(4):371-380. 
Dvash T, Benvenisty N. 2004. Human embryonic stem cells as a model for early 
human development. Best Pract Res Clin Obstet Gynaecol 18(6):929-940. 
Dvorak P, Hampl A. 2005. Basic fibroblast growth factor and its receptors in human 
embryonic stem cells. Folia Histochem Cytobiol 43(4):203-208. 
Edwards RG. 2002. Personal pathways to embryonic stem cells. Reprod Biomed 
Online 4(3):263-278. 
Einsiedel E, Premji S, Geransar R, Orton NC, Thavaratnam T, Bennett LK. 2009. 
Diversity in public views toward stem cell sources and policies. Stem Cell Rev 
5(2):102-107. 
Elkabetz Y, Studer L. 2008. Human ESC-derived neural rosettes and neural stem cell 
progression. Cold Spring Harbor symposia on quantitative biology 73:377-387. 
Enver T, Pera M, Peterson C, Andrews PW. 2009. Stem cell states, fates, and the rules 
of attraction. Cell Stem Cell 4(5):387-397. 
Erceg S, Ronaghi M, Stojkovic M. 2009. Human embryonic stem cell differentiation 
toward regional specific neural precursors. Stem cells (Dayton, Ohio) 27(1):78-87. 
Ericson J, Morton S, Kawakami A, Roelink H, Jessell TM. 1996. Two critical periods of 
Sonic Hedgehog signaling required for the specification of motor neuron identity. Cell 
87(4):661-673. 
Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, 
Gage FH. 1998. Neurogenesis in the adult human hippocampus. Nature medicine 
4(11):1313-1317. 
Estivill-Torrus G, Pearson H, van Heyningen V, Price DJ, Rashbass P. 2002. Pax6 is 
required to regulate the cell cycle and the rate of progression from symmetrical to 
asymmetrical division in mammalian cortical progenitors. Development 129(2):455-466.  
Evans MJ, Kaufman MH. 1981. Establishment in culture of pluripotential cells from 
mouse embryos. Nature 292(5819):154-156. 
Evans M, Kaufman MH. 1983. Pluripotential cells grown directly from normal mouse 
embryos. Cancer Surveys 2:186-207. 
Fan G, Martinowich K, Chin MH, He F, Fouse SD, Hutnick L, Hattori D, Ge W, Shen Y, 
Wu H, ten Hoeve J, Shuai K, Sun YE. 2005. DNA methylation controls the timing of 
astrogliogenesis through regulation of JAK-STAT signaling. Development (Cambridge, 
England) 132(15):3345-3356. 
Faux CH, Turnley AM, Epa R, Cappai R, Bartlett PF. 2001. Interactions between 
fibroblast growth factors and Notch regulate neuronal differentiation. J Neurosci 
21(15):5587-5596. 
 150 
Fainsod A, Steinbeisser H, De Robertis EM. 1994. On the function of BMP-4 in 
patterning the marginal zone of the Xenopus embryo. The EMBO journal 13(21):5015-
5025. 
Floridon C, Jensen CH, Thorsen P, Nielsen O, Sunde L, Westergaard JG, Thomsen 
SG, Teisner B. 2000. Does fetal antigen 1 (FA1) identify cells with regenerative, 
endocrine and neuroendocrine potentials? A study of FA1 in embryonic, fetal, and 
placental tissue and in maternal circulation. Differentiation 66(1):49-59.  
Fong H, Hohenstein KA, Donovan PJ. 2008. Regulation of self-renewal and 
pluripotency by Sox2 in human embryonic stem cells. Stem cells (Dayton, Ohio) 
26(8):1931-1938. 
French AJ, Wood SH, Trounson AO. 2006. Human therapeutic cloning (NTSC): 
applying research from mammalian reproductive cloning. Stem Cell Rev 2(4):265-276. 
Fukuda S, Abematsu M, Mori H, Yanagisawa M, Kagawa T, Nakashima K, Yoshimura 
A, Taga T. 2007. Potentiation of astrogliogenesis by STAT3-mediated activation of 
bone morphogenetic protein-Smad signaling in neural stem cells. Molecular and 
cellular biology 27(13):4931-4937. 
Fukuda S, Taga T. 2005. Cell fate determination regulated by a transcriptional signal 
network in the developing mouse brain. Anat Sci Int 80(1):12-18. 
Fukuda T, Kawano H, Osumi N, Eto K, Kawamura K. 2000. Histogenesis of the 
cerebral cortex in rat fetuses with a mutation in the Pax-6 gene. Brain Res Dev Brain 
Res 120(1):65-75.  
Furthauer M, Gonzalez-Gaitan M. 2009. Endocytic regulation of notch signalling during 
development. Traffic 10(7):792-802.  
Gage FH. 2000. Mammalian neural stem cells. Science 287(5457):1433-1438. 
Gage F, Coates P, Palmer T, Kuhn H, Fisher L, Suhonen J, Peterson D, Suhr S, Ray J. 
1995. Survival and differentiation of adult neuronal progenitor cells transplanted to the 
adult brain. Proc Natl Acad Sci USA(92):11879–11883. 
Gaiano N, Fishell G. 1998. Transplantation as a tool to study progenitors within the 
vertebrate nervous system. J Neurobiol (36):152–161. 
Gaiano N, Fishell G. 2002. The role of notch in promoting glial and neural stem cell 
fates. Annual review of neuroscience 25:471-490. 
Garces C, Ruiz-Hidalgo MJ, Bonvini E, Goldstein J, Laborda J. 1999. Adipocyte 
differentiation is modulated by secreted delta-like (dlk) variants and requires the 
expression of membrane-associated dlk. Differentiation 64(2):103-114. 
Garcia A, Doan N, Imura T, Bush T, Sofroniew M. 2004. GFAP-expressing progenitors 
are the principal source of constitutive neurogenesis in adult mouse forebrain. Nature 
neuroscience 7:1233–1241. 
Gardner RL. 1985. Clonal analysis of early mammalian development. Philos Trans R 
Soc Lond B Biol Sci 312(1153):163-178. 
Gardner RL, Rossant J. 1979. Investigation of the fate of 4-5 day post-coitum mouse 
inner cell mass cells by blastocyst injection. J Embryol Exp Morphol 52:141-152.  
 151 
Genethliou N, Panayiotou E, Panayi H, Orford M, Mean R, Lapathitis G, Gill H, Raoof 
S, De Gasperi R, Elder G, Kessaris N, Richardson WD, Malas S. 2009. SOX1 links the 
function of neural patterning and Notch signalling in the ventral spinal cord during the 
neuron-glial fate switch. Biochem Biophys Res Commun 390(4):1114-1120. 
Gerrard L, Rodgers L, Cui W. 2005. Differentiation of human embryonic stem cells to 
neural lineages in adherent culture by blocking bone morphogenetic protein signaling. 
Stem Cells 23(9):1234-1241. 
Gerrard L, Zhao D, Clark AJ, Cui W. 2005. Stably transfected human embryonic stem 
cell clones express OCT4-specific green fluorescent protein and maintain self-renewal 
and pluripotency. Stem cells (Dayton, Ohio) 23(1):124-133. 
Ghosh D, Yan X, Tian Q. 2009. Gene regulatory networks in embryonic stem cells and 
brain development. Birth Defects Res C Embryo Today 87(2):182-191. 
Giudice A, Trounson A. 2008. Genetic modification of human embryonic stem cells for 
derivation of target cells. Cell Stem Cell 2(5):422-433.  
Glaser T, Perez-Bouza A, Klein K, Brustle O. 2005. Generation of purified 
oligodendrocyte progenitors from embryonic stem cells. Faseb J 19(1):112-114. 
Glaser T, Pollard SM, Smith A, Brustle O. 2007. Tripotential differentiation of 
adherently expandable neural stem (NS) cells. PloS one 2(3):e298. 
Gotz M, Barde YA. 2005. Radial glial cells defined and major intermediates between 
embryonic stem cells and CNS neurons. Neuron 46(3):369-372. 
Gotz M, Hartfuss E, Malatesta P. 2002. Radial glial cells as neuronal precursors: A new 
perspective on the correlation of morphology and lineage restriction in the developing 
cerebral cortex of mice. Brain research bulletin 57:777–788. 
Graham V, Khudyakov J, Ellis P, Pevny L. 2003. SOX2 functions to maintain neural 
progenitor identity. Neuron 39(5):749-765. 
Grandbarbe L, Bouissac J, Rand M, Hrabe de Angelis M, Artavanis-Tsakonas S, 
Mohier E. 2003. Delta-Notch signaling controls the generation of neurons/glia from 
neural stem cells in a stepwise process. Development (Cambridge, England) 
130(7):1391-1402. 
Gronostajski RM. 2000. Roles of the NFI/CTF gene family in transcription and 
development. Gene 249(1-2):31-45. 
Hamburger V. 1988. The heritage of experimental embryology: Hans Spemann and the 
organizer. Oxford University Press Oxford. 
Hamburger V. 1988. Ontogeny of neuroembryology. J Neurosci 8(10):3535-3540. 
Hanson I, Van Heyningen V. 1995. Pax6: more than meets the eye. Trends Genet 
11(7):268-272.  
Harland R, Gerhart J. 1997. Formation and function of Spemann's organizer. Annu Rev 
Cell Dev Biol 13:611-667. 
Hatakeyama J, Bessho Y, Katoh K, Ookawara S, Fujioka M, Guillemot F, Kageyama R. 
2004. Hes genes regulate size, shape and histogenesis of the nervous system by 
 152 
control of the timing of neural stem cell differentiation. Development (Cambridge, 
England) 131(22):5539-5550. 
Haub O, Goldfarb M. 1991. Expression of the fibroblast growth factor-5 gene in the 
mouse embryo. Development (Cambridge, England) 112(2):397-406. 
Hawley SH, Wunnenberg-Stapleton K, Hashimoto C, Laurent MN, Watabe T, Blumberg 
BW, Cho KW. 1995. Disruption of BMP signals in embryonic Xenopus ectoderm leads 
to direct neural induction. Genes Dev 9(23):2923-2935. 
Hay DC, Sutherland L, Clark J, Burdon T. 2004. Oct-4 knockdown induces similar 
patterns of endoderm and trophoblast differentiation markers in human and mouse 
embryonic stem cells. Stem cells (Dayton, Ohio) 22(2):225-235. 
Hay DC, Zhao D, Fletcher J, Hewitt ZA, McLean D, Urruticoechea-Uriguen A, Black JR, 
Elcombe C, Ross JA, Wolf R, Cui W. 2008. Efficient differentiation of hepatocytes from 
human embryonic stem cells exhibiting markers recapitulating liver development in 
vivo. Stem Cells 26(4):894-902.  
Hebert JM, Boyle M, Martin GR. 1991. mRNA localization studies suggest that murine 
FGF-5 plays a role in gastrulation. Development (Cambridge, England) 112(2):407-
415. 
Hemmati-Brivanlou A, Melton DA. 1994. Inhibition of activin receptor signaling 
promotes neuralization in Xenopus. Cell 77(2):273-281. 
Hemmati-Brivanlou A, Thomsen GH. 1995. Ventral mesodermal patterning in Xenopus 
embryos: expression patterns and activities of BMP-2 and BMP-4. Dev Genet 17(1):78-
89. 
Henderson JK, Draper JS, Baillie HS, Fishel S, Thomson JA, Moore H, Andrews PW. 
2002. Preimplantation human embryos and embryonic stem cells show comparable 
expression of stage-specific embryonic antigens. Stem cells (Dayton, Ohio) 20(4):329-
337. 
Hollnagel A, Oehlmann V, Heymer J, Ruther U, Nordheim A. 1999. Id genes are direct 
targets of bone morphogenetic protein induction in embryonic stem cells. The Journal 
of biological chemistry 274(28):19838-19845. 
Horner PJ, Power AE, Kempermann G, Kuhn HG, Palmer TD, Winkler J, Thal LJ, Gage 
FH. 2000. Proliferation and differentiation of progenitor cells throughout the intact adult 
rat spinal cord. J Neurosci 20(6):2218-2228. 
Imayoshi I, Sakamoto M, Yamaguchi M, Mori K, Kageyama R. Essential roles of notch 
signaling in maintenance of neural stem cells in developing and adult brains. 2010, J 
Neurosci 30(9):3489-3498. 
Ishibashi M, Moriyoshi K, Sasai Y, Shiota K, Nakanishi S, Kageyama R. 1994. 
Persistent expression of helix-loop-helix factor HES-1 prevents mammalian neural 
differentiation in the central nervous system. The EMBO journal 13(8):1799-1805. 
Iso T, Kedes L, Hamamori Y. 2003. HES and HERP families: multiple effectors of the 
Notch signaling pathway. J Cell Physiol 194(3):237-255. 
 153 
Itskovitz-Eldor, J., Schuldiner, M., Karsenti, D., Eden, A., Yanuka, O., Amit, M., Soreq, 
H. & Benvenisty, N. 2000 Differentiation of human embryonic stem cells into embryoid 
bodies compromising the three embryonic germ layers. Mol Med 6, 88-95. 
Jafar-Nejad H, Norga K, Bellen H. 2002. Numb: "Adapting" notch for endocytosis. Dev 
Cell 3(2):155-156. 
Jensen CH, Meyer M, Schroder HD, Kliem A, Zimmer J, Teisner B. 2001. Neurons in 
the monoaminergic nuclei of the rat and human central nervous system express 
FA1/dlk. Neuroreport 12(18):3959-3963.  
Jin Z, Liu L, Bian W, Chen Y, Xu G, Cheng L, Jing N. 2009. Different transcription 
factors regulate nestin gene expression during P19 cell neural differentiation and 
central nervous system development. J Biol Chem 284(12):8160-8173. 
Johansson CB, Lothian C, Molin M, Okano H, Lendahl U. 2002. Nestin enhancer 
requirements for expression in normal and injured adult CNS. Journal of neuroscience 
research 69(6):784-794. 
Kageyama R, Ohtsuka T, Hatakeyama J, Ohsawa R. 2005. Roles of bHLH genes in 
neural stem cell differentiation. Exp Cell Res 306(2):343-348. 
Kalyani A, Hobson K, Rao MS. 1997. Neuroepithelial stem cells from the embryonic 
spinal cord: isolation, characterization, and clonal analysis. Developmental biology 
186(2):202-223. 
Kan L, Jalali A, Zhao LR, Zhou X, McGuire T, Kazanis I, Episkopou V, Bassuk AG, 
Kessler JA. 2007. Dual function of Sox1 in telencephalic progenitor cells. Dev Biol 
310(1):85-98. 
Kawaguchi A, Miyata T, Sawamoto K, Takashita N, Murayama A, Akamatsu W, Ogawa 
M, Okabe M, Tano Y, Goldman SA, Okano H. 2001. Nestin-EGFP transgenic mice: 
visualization of the self-renewal and multipotency of CNS stem cells. Mol Cell Neurosci 
17(2):259-273.  
Kaneta M, Osawa M, Sudo K, Nakauchi H, Farr AG, Takahama Y. 2000. A role for 
pref-1 and HES-1 in thymocyte development. J Immunol 164(1):256-264. 
Kengaku M, Okamoto H. 1995. bFGF as a possible morphogen for the anteroposterior 
axis of the central nervous system in Xenopus. Development 121(9):3121-3130. 
Kim KA, Kim JH, Wang Y, Sul HS. 2007. Pref-1 (preadipocyte factor 1) activates the 
MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation. 
Mol Cell Biol 27(6):2294-2308.  
Kioussis D, Festenstein R. 1997. Locus control regions: overcoming heterochromatin-
induced gene inactivation in mammals. Curr Opin Genet Dev 7(5):614-619. 
Klimanskaya I, Chung Y, Meisner L, Hohnson J, West DM, Lanza R. 2005. Human 
embryonic stem cells derived without feeder cells. The Lancet 365(9471):1636-1641 
Kobari L, Giarratana MC, Pflumio F, Izac B, Coulombel L, Douay L. 2001. CD133+ cell 
selection is an alternative to CD34+ cell selection for ex vivo expansion of 
hematopoietic stem cells. J Hematother Stem Cell Res 10(2):273-281.  
 154 
Kondoh H, Kamachi Y. SOX-partner code for cell specification: Regulatory target 
selection and underlying molecular mechanisms. Int J Biochem Cell Biol 42(3):391-
399.  
Kopan R, Ilagan MX. 2009. The canonical Notch signaling pathway: unfolding the 
activation mechanism. Cell 137(2):216-233. 
Kornblum HI, Hussain RJ, Bronstein JM, Gall CM, Lee DC, Seroogy KB. 1997. 
Prenatal ontogeny of the epidermal growth factor receptor and its ligand, transforming 
growth factor alpha, in the rat brain. The Journal of comparative neurology 380(2):243-
261. 
Krupnick JG, Damjanov I, Damjanov A, Zhu ZM, Fenderson BA. 1994. Globo-series 
carbohydrate antigens are expressed in different forms on human and murine 
teratocarcinoma-derived cells. Int J Cancer 59(5):692-698. 
Kuhl M, Pandur P. 2008. Dorsal axis duplication as a functional readout for Wnt 
activity. Methods in molecular biology (Clifton, NJ 469:467-476. 
Kunath T, Saba-El-Leil MK, Almousailleakh M, Wray J, Meloche S, Smith A. 2007. FGF 
stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic 
stem cells from self-renewal to lineage commitment. Development (Cambridge, 
England) 134(16):2895-2902. 
Kurosawa H. 2007. Methods for inducing embryoid body formation: in vitro 
differentiation system of embryonic stem cells. J Biosci Bioeng 103(5):389-398. 
Laborda J. 2000. The role of the epidermal growth factor-like protein dlk in cell 
differentiation. Histol Histopathol 15(1):119-129.  
Lai K, Kaspar BK, Gage FH, Schaffer DV. 2003. Sonic hedgehog regulates adult neural 
progenitor proliferation in vitro and in vivo. Nature neuroscience 6(1):21-27. 
Lamb TM, Harland RM. 1995. Fibroblast growth factor is a direct neural inducer, which 
combined with noggin generates anterior-posterior neural pattern. Development 
121(11):3627-3636. 
Lamb TM, Knecht AK, Smith WC, Stachel SE, Economides AN, Stahl N, Yancopolous 
GD, Harland RM. 1993. Neural induction by the secreted polypeptide noggin. Science 
262(5134):713-718. 
Lasky JL, Wu H. 2005. Notch signaling, brain development, and human disease. 
Pediatr Res 57(5 Pt 2):104R-109R. 
Launay C, Fromentoux V, Shi DL, Boucaut JC. 1996. A truncated FGF receptor blocks 
neural induction by endogenous Xenopus inducers. Development (Cambridge, 
England) 122(3):869-880. 
Le Borgne R, Schweisguth F. 2003. Notch signaling: endocytosis makes delta signal 
better. Curr Biol 13(7):R273-275.  
Lee KJ, Jessell TM. 1999. The specification of dorsal cell fates in the vertebrate central 
nervous system. Annual review of neuroscience 22:261-294. 
 155 
Lee SH, Lumelsky N, Studer L, Auerbach JM, McKay RD. 2000. Efficient generation of 
midbrain and hindbrain neurons from mouse embryonic stem cells. Nature 
biotechnology 18(6):675-679. 
Lendahl U, Zimmerman LB, McKay RD. 1990. CNS stem cells express a new class of 
intermediate filament protein. Cell 60(4):585-595. 
Lenka N, Lu ZJ, Sasse P, Hescheler J, Fleischmann BK. 2002. Quantitation and 
functional characterization of neural cells derived from ES cells using nestin enhancer-
mediated targeting in vitro. J Cell Sci 115(Pt 7):1471-1485.  
Lensch MW, Schlaeger TM, Zon LI, Daley GQ. 2007. Teratoma formation assays with 
human embryonic stem cells: a rationale for one type of human-animal chimera. Cell 
Stem Cell 1(3):253-258. 
Li L, Baroja ML, Majumdar A, Chadwick K, Rouleau A, Gallacher L, Ferber I, 
Lebkowski J, Martin T, Madrenas J, Bhatia M. 2004. Human embryonic stem cells 
possess immune-privileged properties. Stem cells (Dayton, Ohio) 22(4):448-456. 
Li K, Ramirez MA, Rose E, Beaudet AL. 2002. A gene fusion method to screen for 
regulatory effects on gene expression: application to the LDL receptor. Human 
molecular genetics 11(26):3257-3265.  
Li XJ, Du ZW, Zarnowska ED, Pankratz M, Hansen LO, Pearce RA, Zhang SC. 2005. 
Specification of motoneurons from human embryonic stem cells. Nat Biotechnol 
23(2):215-221.  
Liang J, Wan M, Zhang Y, Gu P, Xin H, Jung SY, Qin J, Wong J, Cooney AJ, Liu D, 
Songyang Z. 2008. Nanog and Oct4 associate with unique transcriptional repression 
complexes in embryonic stem cells. Nat Cell Biol 10(6):731-739. 
Liem KF, Jr., Tremml G, Roelink H, Jessell TM. 1995. Dorsal differentiation of neural 
plate cells induced by BMP-mediated signals from epidermal ectoderm. Cell 82(6):969-
979. 
Liu A, Niswander LA. 2005. Bone morphogenetic protein signalling and vertebrate 
nervous system development. Nature reviews 6(12):945-954.  
Liu L, Roberts RM. 1996. Silencing of the gene for the beta subunit of human chorionic 
gonadotropin by the embryonic transcription factor Oct-3/4. The Journal of biological 
chemistry 271(28):16683-16689. 
Lim DA, Tramontin AD, Trevejo JM, Herrera DG, Garcia-Verdugo JM, Alvarez-Buylla A. 
2000. Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. 
Neuron 28(3):713-726. 
Litingtung Y, Chiang C. 2000. Control of Shh activity and signaling in the neural tube. 
Dev Dyn 219(2):143-154. 
Lobjois V, Benazeraf B, Bertrand N, Medevielle F, Pituello F. 2004. Specific regulation 
of cyclins D1 and D2 by FGF and Shh signaling coordinates cell cycle progression, 
patterning, and differentiation during early steps of spinal cord development. 
Developmental biology 273(2):195-209. 
Lorico A, Rappa G, Flavell RA, Sartorelli AC. 1996. Double knockout of the MRP gene 
leads to increased drug sensitivity in vitro. Cancer Res 56(23):5351-5355. 
 156 
Lothian C, Lendahl U. 1997. An evolutionarily conserved region in the second intron of 
the human nestin gene directs gene expression to CNS progenitor cells and to early 
neural crest cells. Eur J Neurosci 9(3):452-462. 
Lothian C, Prakash N, Lendahl U, Wahlstrom GM. 1999. Identification of both general 
and region-specific embryonic CNS enhancer elements in the nestin promoter. Exp 
Cell Res 248(2):509-519. 
Machold R, Hayashi S, Rutlin M, Muzumdar MD, Nery S, Corbin JG, Gritli-Linde A, 
Dellovade T, Porter JA, Rubin LL, Dudek H, McMahon AP, Fishell G. 2003. Sonic 
hedgehog is required for progenitor cell maintenance in telencephalic stem cell niches. 
Neuron 39(6):937-950. 
Malatesta P, Appolloni I, Calzolari F. 2008. Radial glia and neural stem cells. Cell 
Tissue Res 331(1):165-178. 
Malatesta P, Hack MA, Hartfuss E, Kettenmann H, Klinkert W, Kirchhoff F, Gotz M. 
2003. Neuronal or glial progeny: regional differences in radial glia fate. Neuron 
37(5):751-764. 
Martin GR. 1981. Isolation of a pluripotent cell line from early mouse embryos cultured 
in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 
78(12):7634-7638. 
Martinez Arias A, Zecchini V, Brennan K. 2002. CSL-independent Notch signalling: a 
checkpoint in cell fate decisions during development? Curr Opin Genet Dev 12(5):524-
533. 
Matsuda T, Nakamura T, Nakao K, Arai T, Katsuki M, Heike T, Yokota T. 1999. STAT3 
activation is sufficient to maintain an undifferentiated state of mouse embryonic stem 
cells. Embo J 18(15):4261-4269.  
McDonald JW, Liu XZ, Qu Y, Liu S, Mickey SK, Turetsky D, Gottlieb DI, Choi DW. 
1999. Transplanted embryonic stem cells survive, differentiate and promote recovery in 
injured rat spinal cord. Nature medicine 5(12):1410-1412. 
McConnell SK. 1995. Constructing the cerebral cortex: neurogenesis and fate 
determination. Neuron 15(4):761-768. 
McGrew LL, Hoppler S, Moon RT. 1997. Wnt and FGF pathways cooperatively pattern 
anteroposterior neural ectoderm in Xenopus. Mechanisms of development 69(1-2):105-
114. 
McKay R. 1997. Stem cells in the central nervous system. Science 276(5309):66-71. 
Menendez P, Bueno C, Wang L, Bhatia M. 2005. Human embryonic stem cells: 
potential tool for achieving immunotolerance? Stem Cell Rev 1(2):151-158. 
Merkle FT, Alvarez-Buylla A. 2006. Neural stem cells in mammalian development. 
Current opinion in cell biology 18(6):704-709. 
Merkle FT, Tramontin AD, Garcia-Verdugo JM, Alvarez-Buylla A. 2004. Radial glia give 
rise to adult neural stem cells in the subventricular zone. Proc Natl Acad Sci U S A 
101(50):17528-17532. 
 157 
Mignone JL, Kukekov V, Chiang AS, Steindler D, Enikolopov G. 2004. Neural stem and 
progenitor cells in nestin-GFP transgenic mice. J Comp Neurol 469(3):311-324.  
Mizutani K, Yoon K, Dang L, Tokunaga A, Gaiano N. 2007. Differential Notch signalling 
distinguishes neural stem cells from intermediate progenitors. Nature 449(7160):351-
355. 
Mizuseki K, Sakamoto T, Watanabe K, Muguruma K, Ikeya M, Nishiyama A, Arakawa 
A, Suemori H, Nakatsuji N, Kawasaki H, Murakami F, Sasai Y. 2003. Generation of 
neural crest-derived peripheral neurons and floor plate cells from mouse and primate 
embryonic stem cells. Proceedings of the National Academy of Sciences of the United 
States of America 100(10):5828-5833. 
Molnar Z, Metin C, Stoykova A, Tarabykin V, Price DJ, Francis F, Meyer G, Dehay C, 
Kennedy H. 2006. Comparative aspects of cerebral cortical development. The 
European journal of neuroscience 23(4):921-934. 
Molofsky AV, Slutsky SG, Joseph NM, He S, Pardal R, Krishnamurthy J, Sharpless NE, 
Morrison SJ. 2006. Increasing p16INK4a expression decreases forebrain progenitors 
and neurogenesis during ageing. Nature 443(7110):448-452. 
Moon YS, Smas CM, Lee K, Villena JA, Kim KH, Yun EJ, Sul HS. 2002. Mice lacking 
paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity. 
Mol Cell Biol 22(15):5585-5592. 
Mujtaba T, Mayer-Proschel M, Rao MS. 1998. A common neural progenitor for the 
CNS and PNS. Dev Biol 200(1):1-15.  
Mumm JS, Kopan R. 2000. Notch signaling: from the outside in. Dev Biol 228(2):151-
165.  
Murone M, Rosenthal A, de Sauvage FJ. 1999. Sonic hedgehog signaling by the 
patched-smoothened receptor complex. Curr Biol 9(2):76-84. 
Nagao M, Sugimori M, Nakafuku M. 2007. Cross talk between notch and growth 
factor/cytokine signaling pathways in neural stem cells. Mol Cell Biol 27(11):3982-3994. 
Nakashima K, Yanagisawa M, Arakawa H, Taga T. 1999. Astrocyte differentiation 
mediated by LIF in cooperation with BMP2. FEBS Lett 457(1):43-46. 
Namihira M, Kohyama J, Semi K, Sanosaka T, Deneen B, Taga T, Nakashima K. 2009. 
Committed neuronal precursors confer astrocytic potential on residual neural precursor 
cells. Dev Cell 16(2):245-255. 
Nguyen VH, Trout J, Connors SA, Andermann P, Weinberg E, Mullins MC. 2000. 
Dorsal and intermediate neuronal cell types of the spinal cord are established by a 
BMP signaling pathway. Development (Cambridge, England) 127(6):1209-1220. 
Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Scholer 
H, Smith A. 1998. Formation of pluripotent stem cells in the mammalian embryo 
depends on the POU transcription factor Oct4. Cell 95(3):379-391. 
Nieto M, Schuurmans C, Britz O, Guillemot F. 2001. Neural bHLH genes control the 
neuronal versus glial fate decision in cortical progenitors. Neuron 29(2):401-413. 
 158 
Niwa H, Burdon T, Chambers I, Smith A. 1998. Self-renewal of pluripotent embryonic 
stem cells is mediated via activation of STAT3. Genes Dev 12(13):2048-2060.  
Niwa H, Miyazaki J, Smith AG. 2000. Quantitative expression of Oct-3/4 defines 
differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24(4):372-376. 
Ogi T, Shinkai Y, Tanaka K, Ohmori H. 2002. Polkappa protects mammalian cells 
against the lethal and mutagenic effects of benzo[a]pyrene. Proceedings of the 
National Academy of Sciences of the United States of America 99(24):15548-15553. 
Ohtsuka T, Ishibashi M, Gradwohl G, Nakanishi S, Guillemot F, Kageyama R. 1999. 
Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation. The EMBO 
journal 18(8):2196-2207. 
Okada Y, Matsumoto A, Shimazaki T, Enoki R, Koizumi A, Ishii S, Itoyama Y, Sobue G, 
Okano H. 2008. Spatiotemporal recapitulation of central nervous system development 
by murine embryonic stem cell-derived neural stem/progenitor cells. Stem Cells 
26(12):3086-3098.  
Okamura RM, Lebkowski J, Au M, Priest CA, Denham J, Majumdar AS. 2007. 
Immunological properties of human embryonic stem cell-derived oligodendrocyte 
progenitor cells. J Neuroimmunol 192(1-2):134-144.  
O'Rahilly R, Muller F. 1987. Developmental stages in human embryos. Carnegie 
Institute of Washington. 
O'Rahilly R, Muller F. 1994. Neurulation in the normal human embryo. Ciba Found 
Symp 181:70-82; discussion 82-79. 
Osumi N. 2001. The role of Pax6 in brain patterning. Tohoku J Exp Med 193(3):163-
174.  
Parent JM. 2003. Injury-induced neurogenesis in the adult mammalian brain. 
Neuroscientist 9(4):261-272 
Pera MF, Andrade J, Houssami S, Reubinoff B, Trounson A, Stanley EG, Ward-van 
Oostwaard D, Mummery C. 2004. Regulation of human embryonic stem cell 
differentiation by BMP-2 and its antagonist noggin. Journal of cell science 117(Pt 
7):1269-1280. 
Pevny L, Placzek M. 2005. SOX genes and neural progenitor identity. Curr Opin 
Neurobiol 15(1):7-13. 
Pevny LH, Sockanathan S, Placzek M, Lovell-Badge R. 1998. A role for SOX1 in 
neural determination. Development (Cambridge, England) 125(10):1967-1978. 
Philips GT, Stair CN, Young Lee H, Wroblewski E, Berberoglu MA, Brown NL, Mastick 
GS. 2005. Precocious retinal neurons: Pax6 controls timing of differentiation and 
determination of cell type. Dev Biol 279(2):308-321.  
Piccolo S, Sasai Y, Lu B, De Robertis EM. 1996. Dorsoventral patterning in Xenopus: 
inhibition of ventral signals by direct binding of chordin to BMP-4. Cell 86(4):589-598. 
Pruszak J, Sonntag KC, Aung MH, Sanchez-Pernaute R, Isacson O. 2007. Markers 
and methods for cell sorting of human embryonic stem cell-derived neural cell 
populations. Stem Cells 25(9):2257-2268.  
 159 
Qian X, Shen Q, Goderie SK, He W, Capela A, Davis AA, Temple S. 2000. Timing of 
CNS cell generation: a programmed sequence of neuron and glial cell production from 
isolated murine cortical stem cells. Neuron 28(1):69-80. 
Raballo R, Rhee J, Lyn-Cook R, Leckman JF, Schwartz ML, Vaccarino FM. 2000. 
Basic fibroblast growth factor (Fgf2) is necessary for cell proliferation and neurogenesis 
in the developing cerebral cortex. J Neurosci 20(13):5012-5023. 
Rakic P. 1972. Mode of cell migration to the superficial layers of fetal monkey 
neocortex. The Journal of comparative neurology 145(1):61-83. 
Rathjen J, Lake JA, Bettess MD, Washington JM, Chapman G, Rathjen PD. 1999. 
Formation of a primitive ectoderm like cell population, EPL cells, from ES cells in 
response to biologically derived factors. Journal of cell science 112 ( Pt 5):601-612. 
Real FX, Houghton AN, Albino AP, Cordon-Cardo C, Melamed MR, Oettgen HF, Old 
LJ. 1985. Surface antigens of melanomas and melanocytes defined by mouse 
monoclonal antibodies: specificity analysis and comparison of antigen expression in 
cultured cells and tissues. Cancer Res 45(9):4401-4411.  
Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A. 2000. Embryonic stem cell 
lines from human blastocysts: somatic differentiation in vitro. Nature biotechnology 
18(4):399-404. 
Reynolds B, Weiss S. 1992. Generation of neurons and astrocytes from isolated cells 
of the adult mammalian central nervous system. Science(255):1707–1710. 
Richards M, Fong CY, Chan WK, Wong PC, Bongso A. 2002. Human feeders support 
prolonged undifferentiated growth of human inner cell masses and embryonic stem 
cells. Nature biotechnology 20(9):933-936. 
Rohwedel J, Guan K, Hegert C, Wobus AM. 2001. Embryonic stem cells as an in vitro 
model for mutagenicity, cytotoxicity and embryotoxicity studies: present state and 
future prospects. Toxicol In Vitro 15(6):741-753. 
Rogers MB, Hosler BA, Gudas LJ. 1991. Specific expression of a retinoic acid-
regulated, zinc-finger gene, Rex-1, in preimplantation embryos, trophoblast and 
spermatocytes. Development (Cambridge, England) 113(3):815-824. 
Saha K, Jaenisch R. 2009. Technical challenges in using human induced pluripotent 
stem cells to model disease. Cell Stem Cell 5(6):584-595. 
Sakakibara S, Nakamura Y, Yoshida T, Shibata S, Koike M, Takano H, Ueda S, 
Uchiyama Y, Noda T, Okano H. 2002. RNA-binding protein Musashi family: roles for 
CNS stem cells and a subpopulation of ependymal cells revealed by targeted 
disruption and antisense ablation. Proceedings of the National Academy of Sciences of 
the United States of America 99(23):15194-15199. 
Sansom SN, Griffiths DS, Faedo A, Kleinjan DJ, Ruan Y, Smith J, van Heyningen V, 
Rubenstein JL, Livesey FJ. 2009. The level of the transcription factor Pax6 is essential 
for controlling the balance between neural stem cell self-renewal and neurogenesis. 
PLoS Genet 5(6):e1000511. 
Sasal Y, Lu B, Steinbelsser H, De Robertis EM. 1995. Regulation of neural induction by 
the Chd and Bmp-4 antagonistic patterning signals in Xenopus. Nature 378(6555):419. 
 160 
Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. 2004. Maintenance of 
pluripotency in human and mouse embryonic stem cells through activation of Wnt 
signaling by a pharmacological GSK-3-specific inhibitor. Nature medicine 10(1):55-63. 
Schmidt JV, Matteson PG, Jones BK, Guan XJ, Tilghman SM. 2000. The Dlk1 and Gtl2 
genes are linked and reciprocally imprinted. Genes Dev 14(16):1997-2002.  
Schwartz PH, Brick DJ, Stover AE, Loring JF, Muller FJ. 2008. Differentiation of neural 
lineage cells from human pluripotent stem cells. Methods 45(2):142-158. 
Schuldiner M, Yanuka O, Itskovitz-Eldor J, Melton DA, Benvenisty N. 2000. Effects of 
eight growth factors on the differentiation of cells derived from human embryonic stem 
cells. Proceedings of the National Academy of Sciences of the United States of 
America 97(21):11307-11312. 
Scolding NJ, Rayner PJ, Compston DA. 1999. Identification of A2B5-positive putative 
oligodendrocyte progenitor cells and A2B5-positive astrocytes in adult human white 
matter. Neuroscience 89(1):1-4. 
Seaberg RM, Smukler SR, van der Kooy D. 2005. Intrinsic differences distinguish 
transiently neurogenic progenitors from neural stem cells in the early postnatal brain. 
Dev Biol 278(1):71-85. 
Seldeslagh KA, Lauweryns JM. 1997. NCAM expression in the pulmonary neural and 
diffuse neuroendocrine cell system. Microsc Res Tech 37(1):69-76.  
Sharpe CR, Gurdon JB. 1990. The induction of anterior and posterior neural genes in 
Xenopus laevis. Development 109(4):765-774. 
Sheng HZ, Turnley A, Murphy M, Bernard CC, Bartlett PF. 1989. Epidermal growth 
factor inhibits the expression of myelin basic protein in oligodendrocytes. Journal of 
neuroscience research 23(4):425-432. 
Shevinsky LH, Knowles BB, Damjanov I, Solter D. 1982. Monoclonal antibody to 
murine embryos defines a stage-specific embryonic antigen expressed on mouse 
embryos and human teratocarcinoma cells. Cell 30(3):697-705. 
Shen Q, Qian X, Capela A, Temple S. 1998. Stem cells in the embryonic cerebral 
cortex: their role in histogenesis and patterning. Journal of neurobiology 36(2):162-174. 
Shi Y, Massague J. 2003. Mechanisms of TGF-beta signaling from cell membrane to 
the nucleus. Cell 113(6):685-700. 
Shimamura K, Rubenstein JL. 1997. Inductive interactions direct early regionalization 
of the mouse forebrain. Development (Cambridge, England) 124(14):2709-2718. 
Shimozaki K, Nakashima K, Niwa H, Taga T. 2003. Involvement of Oct3/4 in the 
enhancement of neuronal differentiation of ES cells in neurogenesis-inducing cultures. 
Development (Cambridge, England) 130(11):2505-2512. 
Shou J, Rim PC, Calof AL. 1999. BMPs inhibit neurogenesis by a mechanism involving 
degradation of a transcription factor. Nat Neurosci 2(4):339-345.  
Sidman R, Rakic P. 1982. Development of the human central nervous system. In: 
Histology and Histopathology of the Nervous System. Springfield:3–110. 
 161 
Siebzehnrubl FA, Buslei R, Eyupoglu IY, Seufert S, Hahnen E, Blumcke I. 2007. 
Histone deacetylase inhibitors increase neuronal differentiation in adult forebrain 
precursor cells. Exp Brain Res 176(4):672-678. 
Simpson TI, Price DJ. 2002. Pax6; a pleiotropic player in development. Bioessays 
24(11):1041-1051.  
Smas CM, Chen L, Sul HS. 1997. Cleavage of membrane-associated pref-1 generates 
a soluble inhibitor of adipocyte differentiation. Mol Cell Biol 17(2):977-988. 
Smas CM, Sul HS. 1993. Pref-1, a protein containing EGF-like repeats, inhibits 
adipocyte differentiation. Cell 73(4):725-734. 
Smas CM, Sul HS. 1997. Molecular mechanisms of adipocyte differentiation and 
inhibitory action of pref-1. Crit Rev Eukaryot Gene Expr 7(4):281-298.  
Smith AG. 2001. Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol 
17:435-462. 
Song H, Stevens CF, Gage FH. 2002. Astroglia induce neurogenesis from adult neural 
stem cells. Nature 417(6884):39-44. 
Solter D, Knowles BB. 1975. Immunosurgery of mouse blastocyst. Proceedings of the 
National Academy of Sciences of the United States of America 72(12):5099-5102. 
Spemann H, Mangold H. 1923. Induction of embryonic primordia by implantation of 
organizers from a different species. The International journal of developmental biology 
45(1):13-38. 
Stavridis MP, Lunn JS, Collins BJ, Storey KG. 2007. A discrete period of FGF-induced 
Erk1/2 signalling is required for vertebrate neural specification. Development 
(Cambridge, England) 134(16):2889-2894. 
Streit A, Stern CD. 1999. Establishment and maintenance of the border of the neural 
plate in the chick: involvement of FGF and BMP activity. Mechanisms of development 
82(1-2):51-66. 
Strubing C, Ahnert-Hilger G, Shan J, Wiedenmann B, Hescheler J, Wobus AM. 1995. 
Differentiation of pluripotent embryonic stem cells into the neuronal lineage in vitro 
gives rise to mature inhibitory and excitatory neurons. Mech Dev 53(2):275-287. 
Suh H, Consiglio A, Ray J, Sawai T, D‟Amour K, Gage F. 2007. In vivo fate analysis 
reveals the multipotent and self-renewal capacities of Sox2+ neural stem cells in the 
adult hippocampus. Cell Stem Cell (1):515–528. 
Sun Y, Pollard S, Conti L, Toselli M, Biella G, Parkin G, Willatt L, Falk A, Cattaneo E, 
Smith A. 2008. Long-term tripotent differentiation capacity of human neural stem (NS) 
cells in adherent culture. Molecular and cellular neurosciences 38(2):245-258. 
Suter DM, Krause KH. 2008. Neural commitment of embryonic stem cells: molecules, 
pathways and potential for cell therapy. J Pathol 215(4):355-368. 
Suter DM, Tirefort D, Julien S, Krause KH. 2009. A Sox1 to Pax6 switch drives 
neuroectoderm to radial glia progression during differentiation of mouse Takahashi K, 
Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. 2007. Induction of 
 162 
pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861-
872. 
Swiatek PJ, Lindsell CE, del Amo FF, Weinmaster G, Gridley T. 1994. Notch1 is 
essential for postimplantation development in mice. Genes Dev 8(6):707-719. 
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. 
2007. Induction of pluripotent stem cells from adult human fibroblasts by defined 
factors. Cell 131(5):861-872.  
Takahashi M, Palmer T, Takahashi J, Gage F. 1998. Widespread integration and 
survival of adult-derived neural progenitor cells in the developing optic retina. Molecular 
and cellular neurosciences(12):340–348. 
Takizawa T, Ochiai W, Nakashima K, Taga T. 2003. Enhanced gene activation by 
Notch and BMP signaling cross-talk. Nucleic acids research 31(19):5723-5731.  
Tanaka M, Hadjantonakis AK, Vintersten K, Nagy A. 2009. Aggregation chimeras: 
combining ES cells, diploid, and tetraploid embryos. Methods in molecular biology 
(Clifton, NJ 530:287-309. 
Tanaka S, Kamachi Y, Tanouchi A, Hamada H, Jing N, Kondoh H. 2004. Interplay of 
SOX and POU factors in regulation of the Nestin gene in neural primordial cells. Mol 
Cell Biol 24(20):8834-8846. 
Tanimizu N, Nishikawa M, Saito H, Tsujimura T, Miyajima A. 2003. Isolation of 
hepatoblasts based on the expression of Dlk/Pref-1. J Cell Sci 116(Pt 9):1775-1786. 
Taupin P, Gage FH. 2002. Adult neurogenesis and neural stem cells of the central 
nervous system in mammals. J Neurosci Res 69(6):745-749. 
Taylor MK, Yeager K, Morrison SJ. 2007. Physiological Notch signaling promotes 
gliogenesis in the developing peripheral and central nervous systems. Development 
134(13):2435-2447. 
Temple S. 2001. The development of neural stem cells. Nature 414(6859):112-117. 
Tesar PJ, Chenoweth JG, Brook FA, Davies TJ, Evans EP, Mack DL, Gardner RL, 
McKay RD. 2007. New cell lines from mouse epiblast share defining features with 
human embryonic stem cells. Nature 448(7150):196-199. 
Thompson LH, Andersson E, Jensen JB, Barraud P, Guillemot F, Parmar M, Bjorklund 
A. 2006. Neurogenin2 identifies a transplantable dopamine neuron precursor in the 
developing ventral mesencephalon. Exp Neurol 198(1):183-198.  
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, 
Jones JM. 1998. Embryonic stem cell lines derived from human blastocysts. Science 
282(5391):1145-1147. 
Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, 
Mourton T, Herrup K, Harris RC, et al. 1995. Targeted disruption of mouse EGF 
receptor: effect of genetic background on mutant phenotype. Science 269(5221):230-
234. 
 163 
Tropepe V, Hitoshi S, Sirard C, Mak TW, Rossant J, van der Kooy D. 2001. Direct 
neural fate specification from embryonic stem cells: a primitive mammalian neural stem 
cell stage acquired through a default mechanism. Neuron 30(1):65-78. 
Tropepe V, Sibilia M, Ciruna BG, Rossant J, Wagner EF, van der Kooy D. 1999. 
Distinct neural stem cells proliferate in response to EGF and FGF in the developing 
mouse telencephalon. Developmental biology 208(1):166-188. 
Trounson A. 2006. The production and directed differentiation of human embryonic 
stem cells. Endocr Rev 27(2):208-219. 
Tzukerman M, Rosenberg T, Ravel Y, Reiter I, Coleman R, Skorecki K. 2003. An 
experimental platform for studying growth and invasiveness of tumor cells within 
teratomas derived from human embryonic stem cells. Proc Natl Acad Sci U S A 
100(23):13507-13512.  
Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, Tsukamoto AS, Gage FH, 
Weissman IL. 2000. Direct isolation of human central nervous system cells. . Proc Natl 
Acad Sci U S A 97:14720–14725. 
Uwanogho D, Rex M, Cartwright EJ, Pearl G, Healy C, Scotting PJ, Sharpe PT. 1995. 
Embryonic expression of the chicken Sox2, Sox3 and Sox11 genes suggests an 
interactive role in neuronal development. Mech Dev 49(1-2):23-36. 
Vallier L, Alexander M, Pedersen RA. 2005. Activin/Nodal and FGF pathways 
cooperate to maintain pluripotency of human embryonic stem cells. Journal of cell 
science 118(Pt 19):4495-4509. 
Vescovi AL, Reynolds BA, Fraser DD, Weiss S. 1993. bFGF regulates the proliferative 
fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS 
progenitor cells. Neuron 11(5):951-966. 
Vinals F, Reiriz J, Ambrosio S, Bartrons R, Rosa JL, Ventura F. 2004. BMP-2 
decreases Mash1 stability by increasing Id1 expression. Embo J 23(17):3527-3537.  
Waddington C, Schmidt C. 1933. Induction by heteroplastic grafts of the primitive 
streak in birds. Roux‟s Arch EntwMech Org 128::522–563. 
Walther C, Gruss P. 1991. Pax-6, a murine paired box gene, is expressed in the 
developing CNS. Development 113(4):1435-1449.  
Wang B, Gao Y, Xiao Z, Chen B, Han J, Zhang J, Wang X, Dai J. 2009. Erk1/2 
promotes proliferation and inhibits neuronal differentiation of neural stem cells. 
Neurosci Lett 461(3):252-257. 
Weigmann A, Corbeil D, Hellwig A, Wuttner WB. 1997a. Prominin, a novel microvilli-
specific polytopic membrane protein of the apical surface of epithelial cells, is targeted 
to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci U S A 
94:12425–12430. 
Weinstein DC, Hemmati-Brivanlou A. 1999. Neural induction. Annu Rev Cell Dev Biol 
15:411-433. 
Weiss S, Reynolds BA, Vescovi AL, Morshead C, Craig CG, van der Kooy D. 1996. Is 
there a neural stem cell in the mammalian forebrain? Trends in neurosciences 
19(9):387-393. 
 164 
Wernig M, Tucker KL, Gornik V, Schneiders A, Buschwald R, Wiestler OD, Barde YA, 
Brustle O. 2002. Tau EGFP embryonic stem cells: an efficient tool for neuronal lineage 
selection and transplantation. J Neurosci Res 69(6):918-924.  
Whitworth E, Vinson GP. 2000. Zonal differentiation in the rat adrenal cortex. Endocr 
Res 26(4):973-978. 
Wichterle H, Lieberam I, Porter JA, Jessell TM. 2002. Directed differentiation of 
embryonic stem cells into motor neurons. Cell 110(3):385-397Wilson SI, Edlund T. 
2001. Neural induction: toward a unifying mechanism. Nature neuroscience 4 
Suppl:1161-1168. 
Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, Gearing DP, Wagner EF, 
Metcalf D, Nicola NA, Gough NM. 1988. Myeloid leukaemia inhibitory factor maintains 
the developmental potential of embryonic stem cells. Nature 336(6200):684-687. 
Wilson PA, Hemmati-Brivanlou A. 1995. Induction of epidermis and inhibition of neural 
fate by Bmp-4. Nature 376(6538):331-333. 
Wolpert L. 1994. Positional information and pattern formation in development. Dev 
Genet 15(6):485-490. 
Woo SM, Kim J, Han HW, Chae JI, Son MY, Cho S, Chung HM, Han YM, Kang YK. 
2009. Notch signaling is required for maintaining stem-cell features of neuroprogenitor 
cells derived from human embryonic stem cells. BMC Neurosci 10:97. 
Wu JQ, Habegger L, Noisa P, Szekely A, Qiu C, Hutchison S, Raha D, Egholm M, Lin 
H, Weissman S, Cui W, Gerstein M, Snyder M. Dynamic transcriptomes during neural 
differentiation of human embryonic stem cells revealed by short, long, and paired-end 
sequencing. Proceedings of the National Academy of Sciences of the United States of 
America. 
Xu C, Inokuma MS, Denham J, Golds K, Kundu P, Gold JD, Carpenter MK. 2001. 
Feeder-free growth of undifferentiated human embryonic stem cells. Nature 
biotechnology 19(10):971-974. 
Xu RH, Chen X, Li DS, Li R, Addicks GC, Glennon C, Zwaka TP, Thomson JA. 2002. 
BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol 
20(12):1261-1264.  
Xu S, Sunderland ME, Coles BL, Kam A, Holowacz T, Ashery-Padan R, Marquardt T, 
McInnes RR, van der Kooy D. 2007. The proliferation and expansion of retinal stem 
cells require functional Pax6. Dev Biol 304(2):713-721. 
Yang X, Klein R, Tian X, Cheng H, Kopan R, Shen J. 2004. Notch activation induces 
apoptosis in neural progenitor cells through a p53- dependent pathway. Developmental 
biology 269(1):81-94. 
Yao S, Chen S, Clark J, Hao E, Beattie GM, Hayek A, Ding S. 2006. Long-term self-
renewal and directed differentiation of human embryonic stem cells in chemically 
defined conditions. Proceedings of the National Academy of Sciences of the United 
States of America 103(18):6907-6912. 
Ye W, Shimamura K, Rubenstein JL, Hynes MA, Rosenthal A. 1998. FGF and Shh 
signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 
93(5):755-766. 
 165 
Ying QL, Stavridis M, Griffiths D, Li M, Smith A. 2003. Conversion of embryonic stem 
cells into neuroectodermal precursors in adherent monoculture. Nature biotechnology 
21(2):183-186. 
Yoon K, Gaiano N. 2005. Notch signaling in the mammalian central nervous system: 
insights from mouse mutants. Nat Neurosci 8(6):709-715. 
Yuan H, Corbi N, Basilico C, Dailey L. 1995. Developmental-specific activity of the 
FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes & 
development 9(21):2635-2645. 
Zeng X. 2007. Human embryonic stem cells: mechanisms to escape replicative 
senescence? Stem Cell Rev 3(4):270-279. 
Zhang SC. 2006. Neural subtype specification from embryonic stem cells. Brain 
pathology (Zurich, Switzerland) 16(2):132-142. 
Zhang SC, Ge B, Duncan ID. 2000. Tracing human oligodendroglial development in 
vitro. Journal of neuroscience research 59(3):421-429. 
Zhang S, Odorico J, Pedersen RA. 2005. Neural specification from human embryonic 
stem cells. In: Human embryonic stem cells. BIOS Scientific Publishers New York:153–
172.  
Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA. 2001. In vitro differentiation 
of transplantable neural precursors from human embryonic stem cells. Nature 
biotechnology 19(12):1129-1133. 
Zhang YW, Denham J, Thies RS. 2006. Oligodendrocyte progenitor cells derived from 
human embryonic stem cells express neurotrophic factors. Stem cells and 
development 15(6):943-952. 
Zhao S, Nichols J, Smith AG, Li M. 2004. SoxB transcription factors specify 
neuroectodermal lineage choice in ES cells. Mol Cell Neurosci 27(3):332-342. 
Zhou Q, Choi G, Anderson DJ. 2001. The bHLH transcription factor Olig2 promotes 
oligodendrocyte differentiation in collaboration with Nkx2.2. Neuron 31(5):791-807. 
Zhou Q, Anderson DJ. 2002. The bHLH transcription factors OLIG2 and OLIG1 couple 
neuronal and glial subtype specification. Cell 109(1):61-73 
Zimmerman LB, De Jesus-Escobar JM, Harland RM. 1996. The Spemann organizer 
signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86(4):599-606. 
Zimmerman L, Parr B, Lendahl U, Cunningham M, McKay R, Gavin B, Mann J, 
Vassileva G, McMahon A. 1994. Independent regulatory elements in the nestin gene 
direct transgene expression to neural stem cells or muscle precursors. Neuron 
12(1):11-24. 
 
 
 
 166 
Appendix 
 
Table A1: Primers for amplification of human transcripts 
Gene name  Forward primer 5'-3' Reverse primer 5'-3' 
AFP  TGGGACCCGAACTTTCCA  GGCCACATCCAGGACTAGTTTC  
ALB   GCACAGAATCCTTGGTGAACAG  ATGGAAGGTGAATGTTTTCAGCA  
Brachyury TGCTTCCCTGAGACCCAGTT GATCACTTCTTTCCTTTGCATCAAG 
CG-a AAATCCCTCTTCGGATCCAC AAACACCGACAATGTGACCA 
CG-b CCCGAGGTATAAAGCCAGGT  TCCTTGGATGCCCATGTC  
DCX AGACCGGGGTTGTCAAAAA TCAGGACCACAGGCAATAAA 
DLK1 CTGAAGGTGTCCATGAAAGAG GCTGAAGGTGGTCATGTCGAT 
FGF5 CAGCACCAAAGGCTCAGCTT  CCTTGCTTCTAACCCATCATATCC  
GAPDH TCTGCTCCTCCTGTTCGACA AAAAGCAGCCCTGGTGACC 
GATA6 ACTTGAGCTCGCTGTTCTCG CAGCAAAAATACTTCCCCCA 
GFAP CACCACGATGTTCCTCTTGA GTGCAGACCTTCTCCAACCT 
GSC  GAGGAGAAAGTGGAGGTCTGGTT  CTCTGATGAGGACCGCTTCTG  
HES1 CGGACATTCTGGAAATGACA  TACTTCCCCAGCACACTTGG 
HES5 CGACATCCTGGAGATGGC GAGTAGCCTTCGCTGTAGTCC 
ID2 GTCCTTGCAGGCTTCTGAAT  TCCGTGAATTTGTTGTTGTTG 
ID3 AAAGGAGCTTTTGCCACTGA CTTCCGGCAGGAGAGGTT 
MAP2 TTCGTTGTGTCGTGTTCTCA AACCGAGGAAGCATTGATTG 
MASH1 TCTTCGCCCGAACTGATGC CAAAGCCCAGGTTGACCAACT 
MEOX1 CCAGGACGAACTCCTCGTCAGC CAGTGCTCCCAAGCACCCCG 
Musashi1 AGGCGGGGGTGGATAAAGT TCTTCTTCGTTCGAGTCACCA 
Nanog TGATTTGTGGGCCTGAAGAAAA GAGGCATCTCAGCAGAAGACA 
NF1A ACCCCATCACATAGGGGTTT CTGGCTGGGACTTTCAGATT  
NF1B TTTGTGTCCAGCCACATCAT  GTGGCTTGGACTTCCTGATT  
NF1C TGGACCTCTACCTGGCCTAC  CTTGCTGTCCTCCTGGTCA  
NF1X GCTTACTTTGTCCACACTCCG  GGAAACTTAAGTGCCCGTTG  
OCT4 TCGAGAACCGAGTGAGAGGC CACACTCGGACCACATCCTTC 
OLIG2 CCTGAGGCTTTTCGGAGC GATAGTCGTCGCAGCTTTCG 
PAX6 TCCGTTGGAACTGATGGAGT GTTGGTATCCGGGGACTTC 
RBPJ AGAGTCTCAACCGTGTGCATT GTGCTTTCGCTTGTCTGAGTC 
REX1 GGTGGCATTGGAAATAGCAG  TGCCTAGTGTGCTGGTGGT  
SOX1 AACACTTGAAGCCCAGATGGA GCAGGCTGAATTCGGTTCTC  
SOX2 GCCGAGTGGAAACTTTTGTCG GCAGCGTGTACTTATCCTTCTT 
TAU AAGATCGGCTCCACTGAGAA CACACTTGGACTGGACGTTG 
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Table A2: Antibodies for immunocytochemistry, flow cytometry and Western blot 
Antigen Name Type Company Cat. No. ICC/FACS WB  
3CB2 mouse monoclonal Hybridoma Bank 3CB2 1:75   
b-Actin rabbit polyclonal abcam AB8227  1:5000 
BrdU mouse monoclonal Hybridoma Bank G3G4 1:1000   
CD133  rabbit monoclonal Cell Signaling C24B9   1:1000 
GATA6 rabbit polyclonal Santa Cruz SC9055 1:50   
GFAP  rabbit antiserum DAKO Z0334 1:500   
GFP goat polyclonal Serotech AHP975 1:1000   
HNF4-α  rabbit polyclonal Santa Cruz SC 8987 1:200   
MAP2  rabbit polyclonal Chemicon AB5622 1:1000   
Musashi1 rabbit polyclonal Chemicon AB5977 1:200   
Muscle actin mouse monoclonal DAKO M0635 1:50   
Nanog rabbit polyclonal abcam AB21624 1:200 1:500 
N-CAM  mouse monoclonal Hybridoma Bank VIN-IS-53 1:100   
Nestin mouse monoclonal Chemicon MAB5326 1:200  
OCT4 rabbit polyclonal abcam AB19857 1:100 1:500 
Olig2 rabbit polyclonal abcam AB33427 1:200   
PAX6 rabbit polyclonal Chemicon AB5409 1:1000 1:500 
RC2 mouse monoclonal Hybridoma Bank RC2 1:75   
Samd1 rabbit monoclonal Cell Signaling 9473   1:1000 
pSmad1/5/8 rabbit polyclonal Cell Signaling 9511   1:1000 
PSA-NCAM mouse monoclonal Chemicon MAB5324 1:200   
SOX1 rabbit polyclonal Abcam AB22572 1:200   
SOX2 rabbit polyclonal Abcam AB69893 1:200   
SSEA1 mouse monoclonal Hybridoma Bank MC480 1:5   
SSEA3 mouse monoclonal Hybridoma Bank MC631 1:5   
SSEA4 mouse monoclonal Hybridoma Bank 
MC813-
70 1:5   
TRA-1-81 mouse monoclonal Chemicon MAB4381 1:12   
TH mouse monoclonal Chemicon PO7101 1:500   
Tuj1 mouse monoclonal Sigma T8660 1:1000   
Vimentin mouse monoclonal Hybridoma Bank AMF-17b  1:75   
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List of plasmids used in the thesis 
 
FigureA1: Constitutively expressing green fluorescence protein plasmid 
 
 
 
FigureA2: Constitutively expressing DLK-1 plasmid (from Beata Surmacz)  
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FigureA3: Nestin enhancer driving green fluorescence protein plasmid 
 
 
 
 
FigureA4: Promoter-less luciferase reporter plasmid (Promega corp.)  
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FIgureA5: Schematic representation of Hes1-luc vector. (Masamizu et al., 2006) 
 
 
 
 
 
FigureA6: Schematic representation of CSL-luciferase vector. (Masamizu et al., 2006) 
 
 
 
 
 
 
FIgureA7: Schematic representation of CBF1 responsiveness luciferase reporter 
plasmid. (Mizutani et al., 2007) 
 
 
 
 
 
 
FigureA8: Schematic representation of CBF1 responsiveness GFP reporter plasmid. 
(Mizutani et al., 2007) 
 
 
 
 
 
 
